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In response to inflammation and nerve injury, nociceptive DRG (dorsal root ganglion) 
neurons become hyperexcitable and this hyperexcitability persists in chronic pain. A key 
feature of chronic pain states is enhanced secretion of neuropeptides (such as CGRP or 
Substance P) as a result partly of gene expression changes, and partly changes at the level of 
regulated secretion. To date however no studies have investigated what changes occur at 
the level of exocytosis and what changes in the secretory machinery are required to support 
enhanced neuronal transmission. The research described in this thesis addresses this 
fundamental question and identifies the role of two regulators of vesicle fusion, 
synaptotagmin 4 and 7 (syt4/7), in enhanced peptide secretion from nociceptors following 
exposure to neuronal growth factor (NGF). 
Synaptotagmins are vesicular membrane proteins that are known for their role in 
coupling excitation and increased calcium concentration to vesicle fusion and release of 
transmitters. In this thesis four synaptotagmin isoforms are described for the first time in 
DRG neurons using a combination of western blotting and immunofluorescence: syt2, syt4, 
syt7 and 11. Syt2 and 7 are low and high affinity Ca2+ sensors respectively that are important 
regulators of vesicle fusion. Syt4 and 11 are isoforms that are unable to bind calcium, and 
therefore their role in regulated secretion is unclear.  Syt4 is the more well-known isoform 
of the two, but studies published to date have provided conflicting views, supporting both 
an inhibitory and potentiating role. Our results have shown that all the above isoforms are 
expressed in peptide expressing DRG neurons and are present on CGRP containing vesicles.  
NGF is a well-known inflammatory mediator of the adult nervous system; it enhances 
peptide secretion in nociceptive DRG neurons that express its receptor TrkA and contributes 
to hyperalgesia by sensitising TRPV1 channels. Here we show that syt4 is present in the 
majority of TrkA positive DRG neurons, and that the enhancement in CGRP secretion 
following NGF exposure is reduced in neurons isolated from Syt4 knockout (KO) mice. In 
order to dissect further the role of syt4 and 7 in exocytosis in live DRG neurons, we have 
established a pHluorin-based fusion assay using total internal reflection (TIRF) microscopy. 
Using this technique, we found that syt4 and syt7 are functionally targeted to an 
overlapping population of vesicles, where they mediate fusion events with long fusion pore 
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open times and slow endocytosis. To our knowledge this is the first study to address directly 
the role of Syt4 in peptide secretion from nociceptors. Our results provide novel insight into 
the molecular mechanisms contributing to pain signalling and in particular the secretion of 
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1. Introduction  
1.1. Sensory processing 
The somatosensory system and nociception 
Information from an individual’s environment is processed by the somatosensory 
system which produces the conscious sensation of temperature, touch, body position and 
pain. This pathway starts with the sensory afferents that are activated by the specific stimuli 
on the surface or the inside of the body, and then convey this information through the 
dorsal root ganglia (DRG) to the spinal cord, where they form synapses with second order 
neurons (figure 1.1). These second order neurons then either pass their information on to 
other neurons in the spinal cord, or project towards the brain, and finally to the sensory 
cortex where the sensation is created (Todd, 2010). The sensory neurons in this pathway 
belong to the peripheral nervous system (PNS); their cell bodies form 31 pairs of DRGs along 
the spinal cord. DRG neurons are pseudiunipolar, which means that a single axon stem 
bifurcates into two branches, termed peripheral and central axons, and they each grow 
towards the periphery or the central nervous system (Matsuda et al., 1996; Nascimento, 
Mar and Sousa, 2018). As opposed to multipolar neurons, where inputs arriving on the 
somatodendritic compartment summate and elicit an action potential at the axon initial 
segment (AIS), adult DRG neurons lack a clearly defined AIS (Gumy et al., 2017) though 
proteins associated with it, such as ankyrin G, are enriched in cultured embryonic DRG 
neurons (Dzhashiashvili et al., 2007); instead, action potentials form on their peripheral 
axon endings and a putative AIS region might serve as a low-pass filter for electrical signals 
(Carr et al., 2009; Nascimento, Mar and Sousa, 2018).  
Different sensory afferents respond to different types of stimuli such as heat, cold, 
pressure, pH, itch, proprioception and pain, and this feature provides the basis of modality-
specific sensation in vertebrates. Whether they respond to one or multiple stimulus 
modalities, DRG neurons can be unimodal or polymodal, and thus DRG neurons give rise to 





Figure 1.1.1 Schematic anatomy of the spinal cord, dorsal root ganglia (DRG) (orange) and 
attached nerves. From the periphery, signal travel through the spinal nerve where sympathetic 
(blue) and motor neuron axons (green) run together with the peripheral DRG neuron axons. The 
central fibres form the dorsal root and enter the spinal dorsal horn, where they synapse onto second 
order neurons. Image was adapted from Nascimento et al., 2018.  
 
Classification of dorsal root ganglion neurons 
Soma size, conduction velocity and response profiles 
Classically, sensory neurons were categorized based on features such as cell size, axon 
diameter and myelination (which relates to conductance velocity), firing threshold, 
neurochemical properties and the type of stimulus they respond to. According to this 
traditional classification, we can distinguish small, medium and large diameter sensory 
neurons (recent reviews include Todd, 2010; Le Pichon and Chesler, 2014; Emery and 
Ernfors, 2018).  
Large diameter neurons (>50 µm) have heavily myelinated fibres (Aβ and 
proprioceptors), and conduct action potentials at a high speed (70-120 m/s). These are low-
threshold mechanoreceptors that specialize on sensations such as light touch, vibration and 
hair movements, and proprioceptors that help maintain posture and muscle reflexes. 
Medium diameter neurons (~30-50 µm) have Aδ fibres that are thinly myelinated, therefore 
conduct action potentials at a lower speed (5-70 m/s). They are associated with different 
types of innocuous and also noxious stimuli, and because of their faster conduction velocity 
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compared to C-fibres, they are thought to result in “fast” pain. Medium diameter axon 
endings arborize in the superficial laminae of the spinal dorsal horn, while large diameter 
fibres arborize in the deeper layers (III-V) (Todd, 2010). 
Small diameter DRG neurons (between 10 and 30 µm) give rise to C fibres, which are 
unmyelinated and have the lowest conduction velocity (around 0.5-2 m/s). Some of these 
fibres are low-threshold mechanoreceptor (C-LTMRs) activated by light touch, but most C 
fibres are specialized for painful or noxious stimuli – hence, called nociceptors. These 
nociceptors can be subdivided into two further groups: peptidergic and non-peptidergic 
neurons. Peptidergic DRG neurons express neuropeptides such as substance P (SP) or 
calcitonin-gene related peptide (CGRP) (Nilsson and Pernow, 1975; Wiesenfeld-Hallin et al., 
1984), while non-peptidergic neurons are defined by the binding of the lectin IB4 isolated 
from the plant Griffonia simplicifolia (Stucky and Lewin, 1999), and express Mas-related G 
protein-coupled receptors (Mrgprs), some of which have been linked to the sensation of itch 
(Dong et al., 2001; Han and Simon, 2011); both types of C fibres arborize in the superficial 
(I/II) layers of the spinal dorsal horn.  
 
mRNA and protein expression based classification 
The categories described above are not mutually exclusive and there are numerous 
overlaps between them, eg. some IB4+ neurons also express CGRP and other markers 
associated with peptidergic neurons (Carr, Yamamoto and Nagy, 1990; Price and Flores, 
2007). In the past ~30 years significant efforts have been made to distinguish these neurons 
by expressional markers such as ion channels and receptors that provide the basis for 
cellular functions. The gene expression profiles of DRG neurons revealed by these studies 
provide evidence for a much more complicated picture about sensory neuron function. Bulk 
RNA sequencing of DRG neuron populations provided useful insights into the variability of 
genes expressed in the different populations, but these experiments were not unbiased 
because they involved pre-sorting DRG neurons based on defined markers (Nav1.8+ / IB4+, 
Nav1.8+/IB4-, Parvalbumin+) (Chiu et al., 2014). Other studies refined these experiments by 
running single cell RNA sequencing on a large number of cells and thereby eliminating the 
pre-selection bias. Usoskin et al. performed RNA sequencing analysis on 799 cells and 
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identified 3,574 genes per cell and 4 main neuronal clusters with 11 subclasses in total 
(Usoskin et al. 2014, Figure 1.1.2). The four main clusters were termed NF (by neurofilament 
heavy chain), PEP (peptidergic), NP (non-peptidergic) and TH (by tyrosine hydroxylase). The 
NF cluster could be subdivided into 5 groups and contains proprioceptors and LTMRs (by the 
expression of, among other markers, parvalbumin, TrkB and TrkC). The NP group could be 
subdivided into three groups and included the unmyelinated nonpeptidergic C-fibres 
(although one group expressed CGRP and TrkA). By their expressional profile, these cells 
likely play a role in neuropathic pain and inflammatory itch. The PEP group on the other 
hand consists of thermosensitive C-fibres (based on the expression of TRPV1) and 
myelinated Aδ nociceptors, both of which can be characterized by strong expression of TrkA 
and CGRP. Finally, the TH group consist of C-LTMRs and sense mechanical pain and pleasant 




Another group performed high coverage RNA sequencing on 197 neurons and 
identified 10,950 genes per cell, followed by functional characterization using 
electrophysiology (Li et al., 2016). Due to the deep sequencing used in this study, the 
Figure 1.1.2 DRG neuron types and selected markers as defined by Usoskin et al. (2014). 
Abbreviations in the top row are the neuron groups: NF = neurofilament positive cells which 
represent large diameter, myelinated fibres, NP = nonpeptidergic, unmyelinated fibres, PEP = 
peptidergic fibres, TH = tyrosine hydroxylase expressing fibres, representing the mechanosensitive 
C-LTMRs. Selected markers (previously used in black, new ones defined by the study in red) are 
shown under the neuron groups. Note the expression of CGRP in the NP2 group. Figure was 
adapted from Usoskin et al., 2014).  
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authors found 10 main neuronal clusters termed C1-C10 and overall 14 subtypes. Clusters 
C1-6 include the small neurons that are generally mechanoheat nociceptors, but some of 
them are also sensitive to itch and pressure, and one cluster is the C-fibre LTMRs, which 
corresponds to the TH group in Usoskin et al. Clusters C7-10 are the large neurons and 
largely consist of mechanoreceptors and nociceptors sensitive to noxious mechanical 
stimulus (mechano-nociceptors), but some of them are also sensitive to heat due to TRPV1 
expression. The same data has been re-analysed by the same authors using a different 
method that merged two clusters and resulted in 9 groups (Li et al., 2018),  and a more 
recent single cell RNA sequencing of the whole mouse nervous system also identified 
peptidergic, non-peptidergic and neurofilament type as the three main sensory neuron 
groups, with several subgroups in each (Zeisel et al., 2018). These studies provide a complex 
picture of the diversity of sensory neurons and draw attention to the important conclusion 
that traditional markers used before cannot unequivocally define a certain population, eg. 
some IB4+ neurons also express CGRP and TRPV1 at high levels. Thus, when defining DRG 
neuron populations, studies should take into account not just molecular characteristics but 
also cell size, and physiological function (defined by electrophysiological properties and 
pharmacological tools, as well as in vivo behavioural experiment).  
The studies described above mainly focused on the characteristics of DRG neuron 
populations in normal conditions; however it is well known that sensory neurons undergo 
various physiological changes during pathological (chronic) pain. In the following section 
therefore we will define chronic pain and introduce the pathological changes occurring in 
these conditions, and the current theories of underlying mechanisms. 
 
1.2. Pain – changes occurring in somatosensory neurons in pathological states 
 
Pain is an unpleasant sensation that most people experience during their lives. 
Individuals with a rare disease called Congenital Insensitivity to Pain are unable to feel pain, 
which leads to injuries (eg. repeated burns or bone fractures) and reduced healing 
(Katherine Schon, 2018). Acute pain is therefore an important and useful mechanism that 
alerts the body of damage, diseases and danger. In some cases however, pain persists even 
after the removal of the painful signal and becomes chronic. Chronic pain is generally 
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defined as pain that lasts for 12 weeks or longer, and it significantly affects one’s quality of 
life (Aziz et al., 2015).  
There are many causes and therefore many types of chronic pain. Neuropathic pain 
arises from damage to the nervous system (the nerves, spinal cord or the brain), which can 
be caused by accidents or certain diseases (eg. multiple sclerosis, diabetes, cancerous tissue 
pressing on a surrounding nerve) (Jensen et al., 2011; von Hehn, Baron and Woolf, 2012). 
Inflammatory pain on the other hand is caused by peripheral tissue damage and involves 
inflammatory mediators such as prostaglandins, bradykinin, histamine, nerve growth factors 
(NGF) and chemokines being released at the site of inflammation by infiltrating immune 
cells. These inflammatory mediators activate their receptors on nearby nerve terminals, 
which in turn will also release inflammatory mediators such as CGRP and SP, but this 
receptor activation also induces signalling pathways which lead to hyperexcitability of the 
nerve fibre and peripheral sensitization (Ji, Xu and Gao, 2014). Peripheral sensitization is 
often accompanied by increased pain sensitivity to super-threshold stimulation (stimuli that 
normally feel painful) termed hyperalgesia, and abnormal pain sensation following 
innocuous stimuli (mechanical or thermal allodynia). NGF and CGRP are both important 
mediators of inflammation and have been intensely studied over the last few decades as 
they can provide efficient ways to alleviate pain using blockers and antibodies directed 
against them, or their receptors (Edvinsson, 2015; Chang et al., 2016; Bannister, Kucharczyk 
and Dickenson, 2017).   
 
Nerve Growth Factor (NGF) signalling 
 
NGF is one of the four neurotrophins along with BDNF, NT-3 and NT-4 that support 
neuronal survival, neurite growth and synapse assembly during development (Pezet and 
McMahon, 2006). Neurotrophins are secreted by neurons and their target tissues, which 
drives the growth of axons towards their targets but it also serves as a “pruning” factor for 






Figure 1.2.1 Neurotrophin receptors and downstream signalling pathways. Each neurotrophin 
activates its high-affinity receptor (arrows with solid lines), and NT-3 can also bind to TrkA and TrkB 
with low affinity (arrows with dashed lines). All the neurotrophins can bind to the P75 neurotrophin 
receptor (NTR), but with low affinity. Downstream signalling elements activated by P75 are c-
Jun/NFkB, while the three major pathways activated by the Trk receptors are the Ras/MAPK, 
PI3K/Akt and PLC pathways. For abbreviations, see List of abbreviations on page 9. Figure was 
adapted from Khan and Smith, 2015.  
 
NGF is synthesised as pro-NGF that binds to the receptor p75 while NGF binds to the 
tyrosine kinase receptor A (TrkA) with high affinity, but NGF and all other neurotrophins 
bind p75 with low affinity (Patapoutian and Reichardt, 2001). P75 is a tumor necrosis factor 
(TNF) receptor and it promotes apoptosis when TrkA signalling is reduced, thus the balance 
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of TrkA/p75 receptors and the levels of neurotrophins are important in determining the 
physiological effects of NGF (Chao, 2003). Upon NGF binding, TrkA molecules form dimers 
and are internalized as NGF-TrkA protein complexes in signalling endosomes through a 
dynamin-dependent mechanism (Bodmer, Ascaño and Kuruvilla, 2011), and are then 
retrogradely transported back to the soma along the axon (Delcroix et al., 2003). NGF and 
other signalling molecules transported with the complex activate the Ras-raf-MAPK, PI3K-
akt and PLC-DAG-PKC signalling pathways in the soma (figure 1.2.1).  
The constant, baseline production of NGF by innervated tissues ensures that during 
embryonic development, the NGF-dependent signalling pathways promote axonal growth, 
sprouting and neuronal survival (White et al., 1996; Patel et al., 2000). In the first two weeks 
following birth, sensory neurons stop depending on NGF as a survival factor but it can still 
promote axonal re-growth following injury (Lindsay, 1988). This change of NGF-dependence 
during development is attributed to a switch in gene expression at these early stages, when 
about half of the small diameter, nociceptive DRG neurons (those that are IB4 positive) 
downregulate TrkA and upregulate the GDNF receptor Ret (Bennett et al., 1996; Molliver et 
al., 1997). The expression of signalling pathway elements and ion channels also changes 
within the first two post-embryonic weeks, for example ERK/MAPK, PI3K and PKCδ are all 
upregulated in the adults, as measured by microarray (Zhu and Oxford, 2011). These 
changes in gene expression and neuronal phenotype likely underlie the change from the 
reliance of DRG neurons on NGF for survival to sensitization to noxious stimuli such as heat 
and capsaicin (Winter et al., 1988; Zhu et al., 2004).  
During tissue inflammation, activated immune cells produce cytokines that stimulate 
other immune and other cells such as neurons, to start producing more NGF. It has been 
described in multiple inflammatory conditions that local or systemic NGF levels increase in 
both humans and mouse models (Bonini et al., 1996; Di Mola et al., 2000; Stanzel, 
Lourenssen and Blennerhassett, 2008). Conversely, administration of NGF induces 
hyperalgesia and decreases heat pain threshold (Andreev NYu et al., 1995; Dyck et al., 1997) 
and increases the capsaicin sensitivity of the DRG cultures (Winter et al., 1988), while 
antagonists can be used to relieve pain (Hefti et al., 2006; Chang et al., 2016). These heat 
and capsaicin sensitive phenotypes indicate that NGF acts specifically on TRPV1 expressing 
sensory neurons. One major mechanism of NGF induced hyperalgesia is the upregulation of 
several pain-related genes such as TRPV1 channels (Ji et al., 2002), sodium channels (Gould 
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et al., 2000; Kerr et al., 2001; Mamet, Lazdunski and Voilley, 2003), neuropeptides and BDNF 
(Lindsay and Harmar, 1989; Apfel et al., 1996; Park et al., 2010), which are then transported 
back through the peripheral axon to the site of inflammation (Lindsay and Harmar, 1989; 
Park et al., 2010). Moreover, these gene expression changes can result in phenotypic switch, 
where nerve fibres start expressing neuropeptides or TRPV1 channels that did not do so 
before, which further contributes to increased pain sensation (Latremoliere and Woolf, 
2009). Apart from changing the gene expression, NGF also induces the sensitization of 
TRPV1 channels locally at the axon endings through direct phosphorylation of the channels 
by PKC acting downstream of PI3K, causing membrane translocation and increased activity 
of TRPV1 channels. This, coupled with the increased levels of voltage-gated ion channels 
leads to neuronal hyperexcitability and increased secretion of already upregulated CGRP, SP 
and BDNF. These factors further sensitize neurons and contribute to the inflammation and 
peripheral sensitization (Ji, Xu and Gao, 2014).  
 
 Calcitonin-gene related peptide 
As mentioned in section 1.2, CGRP is a neuropeptide expressed in nociceptive sensory 
neurons in the DRGs and trigeminal ganglia and has been historically used to define this 
neuron population in studies. Due to its role in inflammatory and neuropathic pain states, 
CGRP and its receptors have been the subject of intense study over the last few decades in 
the search for more effective pain management strategies.    
Structure, receptor 
 CGRP is a small, 37 amino acid peptide that goes through both C- and N-terminal 
cleavage to create the active peptide. Due to the alternative splicing of its gene, CGRP 
appears in two forms (α-CGRP and β-CGRP) that only differ by a few amino acids in mice, 
rats and human, but α-CGRP is the main form in the nervous system (Amara et al., 1985; 
Steenbergh et al., 1986) (figure 1.2.2).  
The CGRP receptor, like most other neuropeptide receptors, is a G-protein coupled 
receptor (GPCR) formed of the calcitonin receptor-like receptor (CLR) and receptor activity 
modifying protein-1 (RAMP1) (Choksi et al., 2002). CGRP binding to its receptor on neurons 
and blood vessels activates adenylate cyclase and increases cAMP levels, which activates 
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several PKA dependent pathways resulting in phosphorylation of ATP-sensitive potassium 
(KATP) channels and increased nitric oxide levels (Nelson et al., 1990; Russell et al., 2014). 
CGRP also affects gene expression in an autocrine and paracrine manner in DRG neurons 
through activation of the cAMP response element binding protein (CREB) (Anderson and 




Figure 1.2.2 Processing and synthesis of CGRP. The CALC1 gene encodes both Calcitonin and CGRP. 
The expression of the calcitonin coding exon occurs primarily in the thyroid, while in neuronal cells 
the CGRP coding exon is expressed. The CGRP mRNA is translated into pro-CGRP, and further 
processing creates the mature CGRP. Figure was adapted from Russell et al., 2014.  
 
Pathophysiology 
One of the primary physiological roles of CGRP is vasodilatation which can induce 
swelling and redness at the site of inflammation; immune cells can infiltrate through the 
dilated blood vessels, secreting inflammatory mediators and contributing to the above 
described peripheral sensitization (Brain et al., 1985; Russell et al., 2014). CGRP and other 
neuropeptides are also trafficked anterogradely from the soma to the spinal cord, where 
they contribute to central sensitization in response to pain signalling. Neurons that become 
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hyperexcitable following peripheral inflammation, start secreting more transmitters such as 
CGRP, SP and glutamate in the spinal dorsal horn (Iyengar, Ossipov and Johnson, 2017). 
CGRP binding to its receptors on second order neurons activates signalling pathways that 
cause increased evoked and spontaneous activity and altered gene expression, while 
activation of PKA/PKC pathways lead to phosphorylation of the NR1 subunit of NMDA 
receptors, increased membrane excitability and central sensitization (South et al., 2003; 
Latremoliere and Woolf, 2009; Woolf, 2011) (figure 1.2.3). Over time, these and other 
processes will induce plasticity changes that result in the increased responsiveness of spinal 
cord neurons to stimulation, which manifests in hyperalgesia and allodynia.  
 
Figure 1.2.3. Receptors and signalling pathways activated by CGRP. CGRP first binds to its receptor 
complex formed by calcitonin receptor-like receptor (CLR), receptor activity modifying protein 1 
(RAMP1) and the receptor component protein (RCP). The Gs protein activates adenylyl cyclase (AC) 
to produce more cAMP, which leads to the activation of PKA and various downstream signalling 
targets. Activation of extracellular receptor–activated kinase (ERK) and cAMP response element 
binding protein (CREB), leads to altered gene expression. PKA may also stimulate the production of 
nitric oxide (NO) through the activation of nitric oxide synthase (NOS) to promote vasodilatation. An 
important effect of PKA activation is the phosphorylation of ion channels, which may increase 
neuronal excitability. Figure was reused from Iyengar, Ossipov and Johnson, 2017.  
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CGRP is stored in dense core vesicles together with other neuropeptides, BDNF and 
glutamate (Matteoli et al., 1988; Salio et al., 2007), and its release is stimulated by an 
increase in intracellular Ca2+ concentration (L. Y. Huang and Neher, 1996). Most of the 
knowledge regarding the exocytotic machinery regulating CGRP release comes from studies 
using botulinum toxins in DRG and trigeminal neurons, which showed that CGRP release is 
SNARE-regulated and Ca2+-dependent (Meng et al., 2007, 2009; Meng, Dolly and Wang, 
2014). Ca2+-independent mechanisms of CGRP release from DRG neurons have also been 
reported (Chai, Wang, Huang, Y. Y. Wang, et al., 2017), this type of exocytosis will be 
described in a later section. Although the physiological effects of CGRP have been 
extensively studied, there is little detailed knowledge regarding the molecules governing its 
release. Below is an overview of the current knowledge on of molecules regulating 
exocytosis, with a focus on peptide secretion from different cell types.  
 
1.3. Regulation of exocytosis 
Types of secretory vesicles and their cargo 
In neurons, neuropeptides and other neurotransmitters are stored in different vesicle 
populations. Low molecular weight “classical” neurotransmitters (such as GABA, glycine, 
acetylcholine, glutamate, ATP) are released from small (40-50 nm) clear core synaptic 
vesicles (SV) through fast and spatially localized mechanism at the presynaptic active zone. 
Larger neuropeptides (such as CGRP, SP or NPY) and some growth factors (BDNF, GDNF) are 
stored in large dense core vesicles (LDCVs) that are ~75-100 nm in neurons (but can be 
around 300-400 nm in endocrine/neuroendocrine cells (Albillos et al., 1997; Zhao et al., 
2016; Merighi, 2018)), which are characterized by an electron dense core from  where their 
name comes from (figure 1.3.1) (Zhang et al., 1995; Salio et al., 2006; Merighi et al., 2011).  
A third class of secretory vesicles consists of smaller (~50 nm) dense core vesicles that 
contain monoamines, though these are less prevalent (recent reviews discussing secretory 





Figure 1.3.1 Electron micrograph showing the synaptic architecture in the spinal dorsal horn. Clear, 
small synaptic vesicles (SSV) and dense core vesicles (LGVs, large granular vesicles) are shown in the 
central terminal of a DRG neuron that is organised in a multisynaptic glomerulus. Immunogold 
labelling of CGRP (smaller particles) and substance P (larger particles) shows that they are co-stored 
in LGVs. An enlarged LGV is shown in the inset (arrow). Arrowheads point at the electron dense 
synapses, where SSVs are packed closely together, while LGVs reside farther away from the synapse. 
Figure was adapted from Merighi, 2017. 
 
The basic exocytic machinery controlling the fusion of secretory vesicles, including the 
SNAREs essential for fusion, are thought to be the same or similar for LDCVs and SVs, but 
there are also some fundamental difference between these vesicle populations. It should be 
noted that most of the work exploring LDCVs has been done either on non vertebrates or 
mammalian endocrine cell preparations such as chromaffin cells or cell lines such as PC12 
cells or Ins1 cells but there are fewer studies in neurons compared to those addressing SVs 
(Taraska et al., 2003; Tsuboi and Rutter, 2003; Obermüller et al., 2005; Merighi, 2017). It is 
unclear at this point if and how neuronal and non-neuronal LDCVs differ, though size seems 
to be one example (see above).  
Neuropeptides are synthesised as pro-peptides in the rough endoplasmic reticulum, 
and are then transported to the Golgi apparatus where they may undergo further post-
translational modifications (figure 1.3.2). The pro-peptides are then packaged into immature 
secretory vesicles (ISVs) through budding from the trans-Golgi network, a process which is 
thought to be driven by the interaction of granin molecules, pro-hormones and membrane 
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lipids (Beuret et al., 2004). The low luminal pH (~6.3) and high calcium concentrations inside 
the trans-Golgi network induce the aggregation of granins (chromogranins and 
secretogranins) (Chanat, Weiß and Huttner, 1994; Yoo, 1996), which can also interact with 
lipid rafts composed of cholesterol, phosphatidylinositol-4-phosphate (PI4P) and DAG in the 
membrane (Hosaka et al., 2002; Sun et al., 2013).  
Once the ISV is formed, a crucial part of LDCV biogenesis is the gradual decrease of pH, 
to ~5-5.5 in mature LDCVs due to increased proton pump density in the vesicle membrane 
(Wu et al., 2001).  This acidification activates the prohormone convertases and 
carboxypeptidases necessary for cleaving pro-peptides and creating the active 
neuropeptides (Steiner et al., 1992; Jean Husten and Eipper, 1994). An important 
morphological difference between immature and mature secretory vesicles is the clathrin 
coat, which is lost during maturation (Tooze and Tooze, 1986). Clathrin, together with 
adaptor protein-1 (AP-1) and the neuronal AP-2 helps remove missorted proteins, lysosomal 
enzymes and membrane proteins such as VAMP4 from immature vesicles through budding 
of constitutive-like vesicles (Dittié, Hajibagheri and Tooze, 1996; Hinners et al., 2003; 
Grabner et al., 2006) 
Immature and mature secretory vesicles can also differ in size, as ISVs are usually 
smaller and only contain one type of peptide; they undergo homotypic fusions and content 
mixing during their maturation process (Tooze, 1991; Wendler et al., 2001). Early studies 
found that fusion between immature LDCVs is largely regulated by syntaxin-6 (Wendler et 
al., 2001) and synaptotagmins-4 (Ahras, Otto and Tooze, 2006). More recently, Hid-1 was 
shown to regulate the process in pancreatic B cells (Du et al., 2016).  After homotypic fusion, 
LDCVs become larger, but this is followed by condensation and size reduction while they are 
transported to the axon terminals in neurons (Merighi, 2018). During this transport process, 
LDCV maturation continues and pro-peptides are cleaved to create the bioactive 
neuropeptides. When they arrive at the release sites, mature LDCVs contain a cocktail of 
neuropeptides and sometimes, small neurotransmitters that can be released together or 




Figure 1.3.2 Constitutive and regulated secretory pathways. Figure was reused from Kim et al., 
2006.  
 
An important difference between LDCVs and SVs is the release sites: SVs are docked in 
large clusters called the readily releasable pool (RRP) at the presynaptic sites, while LDCV 
exocytosis is not spatially restricted and can happen on the soma or along the axons at 
extra-synaptic sites (figure 1.3.1) (Hökfelt et al., 2000; Salio et al., 2006; Merighi, 2018). As 
neuropeptides are synthesised in the soma and do not have a known re-uptake mechanism, 
LDCVs have to be continually resupplied as opposed to SVs that are recycled through kiss-
and-run or clathrin-mediated endocytosis, assembled again in the endocytic system and can 
be reused in several exocytosis-endocytosis cycles (Granseth et al., 2006; Balaji and Ryan, 
2007; Rizo and Xu, 2015; Xie et al., 2017).   
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The difference in the release sites also has important implications in the calcium 
signals required for exocytosis. SV release requires a robust intracellular calcium increase 
(10-100 µM) in the vicinity of voltage gated Ca2+ channels (VGCCs) (Matthijs Verhage et al., 
1991; Acuna et al., 2015), thus a single action potential can be enough to elicit secretion. For 
LDCV exocytosis, an overall smaller increase in intracellular Ca2+ concentration is sufficient, 
but as it can happen far from the active zone and VGCCs, it needs a higher frequency of 
action potentials to induce a more general elevation of internal Ca2+ (M Verhage et al., 
1991; Matthijs Verhage et al., 1991; Merighi et al., 2011). Such differences in the calcium 
dependence suggest that there might be differences in the calcium sensors governing the 
fusion of different vesicle types.  
 
The exocytotic machinery 
Despite the above described differences, the basic mechanisms and proteins 
governing exocytosis and fusion of membranes are thought to be largely the same. First, for 
the vesicle fusion with the plasma membrane a major energy barrier has to be overcome 
due to the negatively charged surfaces of the membranes (figure 1.3.3 A). For this, a core 
fusion complex at the plasma membrane has to assemble, which consists of membrane 
linked SNARE proteins (SNAP25, syntaxin-1) and SM proteins (Munc18); the vesicular 
SNAREs (VAMPs) connect the vesicle to the complex. The exocytotic process involves at 
least 3 steps: vesicle docking, priming and fusion (figure 1.3.3 B). To create the docking 
platform, first Munc18 binds to the closed conformation of syntaxin1, which converts to 
open conformation after the binding of the MUN domain of the priming factor Munc13-1. 
RIM, like Munc13-1, is an active zone protein which on one hand recruits Munc13-1 to the 
active zone and activates it by disrupting its homodimerization (Deng et al., 2011). On the 
other hand, RIM and Munc13 help vesicle tethering by binding to the vesicular Rab3 
proteins, and also recruit Ca2+ channels to the release machinery (Mittelstaedt, Alvaréz-
Baron and Schoch, 2010; Han et al., 2015). Primed vesicles are attached to the plasma 
membrane through the pre-fusion SNARE complex. Complexin, a small soluble protein 
probably binds to the partially assembled SNAREs and activates the progressive zippering of 
the trans-SNARE proteins, pulling the membranes closer. It may also act as a “clamp” to 
keep the proteins in a partially zippered state and prevent early fusion, as deletion of 
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complexin increases spontaneous release (Schneggenburger and Rosenmund, 2015). The 
clamp is removed by Ca2+ binding to vesicular synaptotagmins, which triggers the opening of 
the fusion-pore (Zhou et al., 2017). This Ca2+ binding is thought to provide the remaining 
energy required for membrane fusion and phospholipid mixing (Südhof, 2013). After fusion 
pore opening, vesicle fusion can go multiple ways. The pore can either briefly open then 
close; the vesicle is then retrieved and recycled during “kiss-and-run” exocytosis or stays at 
the membrane during “kiss-and-stay” ready for another vesicle fusion. Alternatively during 
full fusion, the fusion pore opens wider than the vesicle diameter and the vesicle membrane 
fully collapses into the plasma membrane.   
 
 
Figure 1.3.3 Steps of regulated exocytosis and main proteins involved. A, shows the energy levels 
of a vesicle undergoing docking, priming and fusion pore opening. Calcium binding to 
synaptotagmins is thought to provide the energy needed for fusion pore opening. B, Steps of 
exocytosis. Syntaxin, Munc18 and SNAP25 form a core complex for vesicle docking, followed by the 
partial assembly of the SNARE complex together with VAMP2 (Syb2). The final fusion step is 
triggered by increased calcium concentration. Figure was reused from Südhof, 2013. 
 
 
Somatic secretion in DRG neurons 
There are relatively few studies looking at exocytosis in DRG neurons, due the 
difficulties they present: most studies on neurons focus on synapses, but DRG neurons in 
culture do not form synapses unless they are co-cultured with dorsal horn neurons (Ferron 
et al., 2014; Shaib et al., 2018), limiting studies on pure DRG cultures to somatic secretion. 
The existence of somatic secretion in DRG neurons used to be in question until Huang & 
Neher (1996) described Ca2+-dependent exocytosis in rat cultured DRG neurons for the first 
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time. Using capacitance measurements and Ca2+ chelation they demonstrated that the 
secretion rate  (~1.8 vesicles/s/µm2) and Ca2+ requirement (< 10 µM) were comparable to 
LDCV secretion from endocrine cells, and were also able to measure SP release from DRG 
somata in single-cell immunoblotting experiments (L. Y. Huang and Neher, 1996). The 
function of this somatic secretion remained in question, though they hypothesised that it 
might play a role in paracrine signalling within the DRGs and since then studies found that it 
is important for neuro-glia communication within the DRG (Zhang et al., 2007; Kung et al., 
2013).  
Interestingly, one group found calcium-independent but voltage-dependent (CIVD) 
secretion from the somata of cultured DRG neurons (Zhang and Zhou, 2002). They 
demonstrated this using capacitance and amperometry measurements of catecholamine 
release, and pharmacological block of calcium channels and internal calcium stores and they 
found some CGRP release in these Ca2+-free conditions by radioimmunoassay. Later the 
same group showed that CIVD was coupled to a rapid calcium and dynamin-independent 
form of endocytosis that was also regulated by PKA (Zhang et al., 2004), and that CIVD 
secretion induced by low intensity stimulation (<5 Hz) only occurred on the soma but not on 
dorsal horn synapses in co-culture (Zheng et al., 2009). They were also able to identify the 
machinery involved in CIVD secretion: it involves N-type calcium channels (Cav2.2) as a 
voltage sensor, which links the SNARE complex and the vesicle to the calcium channel 
through its synprint region (Chai, Wang, Huang, Y. Wang, et al., 2017). They identified ATP 
as a cargo of this type of secretion, and showed using TIRF imaging that both SVs and NPY-
containing LDCVs undergo CIVD secretion. They suggested that because CIVD secretion 
dominates during tonic, low-frequency firing, this type of secretion might be more relevant 
in proprioception and normal sensation rather than pain (Chai, Wang, Huang, Y. Wang, et 
al., 2017). On figure 1.3.4, we have listed proteins that may be present on LDCVs or have a 





Figure 1.3.4 Cartoon of an LDCV with associated SNARES and other vesicular proteins that have 
been reported in DRG neurons in large scale mRNA and proteomic profiling studies. References 
that were used for the construction of this figure are in table 1.3.4.   
 
Reference  Selected proteins of interest Technique 
(Shaib et al., 
2018) 
CAPS2 (CAPS1)  Single vesicle exocytosis and 
calcium imaging, TIRF/STED 
(Meng et al., 
2016) 
Munc18, syntaxin1 and SNAP25 
together with VAMP1 mediate CGRP 




(Zhao et al., 
2011) 
Delta opioid receptor (DOR), TRPV2 Proteomics analysis of DCV 
fraction 
(Goswami et al., 
2014) 
SYT1, 5, 7, 9, TRPV1, TRPA1, VAMP1, 
2  
RNA sequencing of TRPV1 
lineage neurons 
(Xiao et al., 
2002) 




SNAP25, VAMP1, Rab3, Syt1, 2, 11 Proteomic analysis of membrane 
enriched fraction 
(Usoskin et al., 
2014) 
CGRP, SP, SNAP25, syntaxin, 
Munc18, VAMP1,2, complexin, 
CAPS1, TRPV1, 2, TRPA1, syt1, 2, 4, 5, 
6, 7, 9, 11 
RNA sequencing of whole DRG 
(Reinhold et al., 
2015) 
Syt4, VAMP1, SNAP25, Rab1 qPCR analysis of RNA extracts 
Table 1.3.4. List of references and proteins identified for the construction of figure 1.3.4.  
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 The fusion pore and regulation of cargo release 
The fusion pore that opens during synaptic vesicle fusion with the plasma membrane 
was originally captured over 30 years ago using snap freezing and electron microscopy in 
frog neuromuscular junctions (Heuser and Reese, 1981). The formation of the pore was then 
studied using amperometry and conductance measurements mostly in chromaffin cells, 
neutrophils and mast cells which established that fusion pores are usually around 1-2 nm in 
diameter initially and the pore expanded rapidly after opening (Spruce et al., 1990; Lollike, 
Borregaard and Lindau, 1995; Albillos et al., 1997). With regards to the composition of the 
pore, some studies argued that it was made of proteins that form a channel between the 
vesicle and plasma membrane because it had conductance similar to ion channels (Lollike, 
Borregaard and Lindau, 1995). But because of the high variability in conductance (and size), 
some proposed a hemi-fusion model, where proteins would merely help in assembling the 
fusion pore that is entirely lipidic (Nanavati et al., 1992). According to this model, a hemi-
fusion state precedes fusion where the cytosolic layer of the vesicle membrane fuses with 
the cytosolic layer of the plasma membrane. A more recent study provided strong live-cell 
evidence for this hypothesis using confocal and super-resolution STED imaging in chromaffin 
cells (Zhao et al., 2016). They found that LDCVs first undergo a hemi-fusion state that can 
progress to full fusion, full fission, and even full fusion can reverse back to hemi-fusion. It 
now seems likely that fusion pores are proteolipidic (Bao et al., 2016), and SNARE TM 
domains actively promote fusion pore formation and expansion. It has been proposed that a 
minimum of three SNARE complexes are sufficient for fusion but that increasing the number 
of SNARE complexes will increase the rate of fusion and pore extension (Weber et al., 1998; 
Dhara et al., 2016; Bao et al., 2018; Sharma and Lindau, 2018).  
Some vesicles fuse with full collapse of the vesicle membrane into the plasma 
membrane (termed full fusion, FF), which allows complete content release into the synaptic 
cleft but also complete transfer of integral vesicle proteins into the plasma membrane . 
Another mode of fusion is kiss-and-run (KR), where the vesicle transiently fuses with the 
plasma membrane and is quickly recovered through dynamin and Ca2+ dependent 
endocytosis (figure 1.3.5A) (Fulop, Doreian and Smith, 2008; Chiang et al., 2014; Wen et al., 
2016). The significance of controlling vesicle fusion lies in the differential cargo release and 
the retrieval of integral vesicular proteins if their diffusion through the pore is limited. As 
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often different sized cargoes are co-stored in vesicles, the fusion pore could serve as a filter 
for content release based on size and also the type of stimulus. Small neurotransmitters can 
fit through a small initial fusion pore of ~1-2 nm, as was shown in pancreatic β-cells and 
chromaffin cells, with larger molecules filtered out (Fulop, 2005; Braun et al., 2007). LDCVs 
are thought to undergo mostly FF for complete content release, and larger molecules are 
generally released more slowly than smaller ones (Barg, Olofsson and Rorsman, 2001). For 
example, NPY-EGFP (~40 kDa) is released rapidly (<200 ms), while the larger tissue 
plasminogen activator (tPA-EGFP ~100 kDa) is released over several seconds from 
chromaffin cells (Perrais et al., 2004; Weiss et al., 2014; Bohannon et al., 2017). 
 
Figure 1.3.5 Schematic showing the classical model of exocytosis (A) and a new model (B) 
proposed by Chiang et al. (2014) (A) According to the classical model, vesicle fusion can go two 
ways: either full collapse of the vesicle into the plasma membrane, allowing complete content 
release, or kiss-and-run fusion, where a small (2-5 nm) transient fusion pore opens and closes. 
According to a different model (B), vesicle fusion is much more dynamic and involves shrinking or 
enlargement of the vesicle rather than collapsing. The shrinking and eventual full fusion are 
controlled by membrane tension generated by F-actin, while pore closure is generated by dynamin 
and Ca2+. Figure was adapted from Chiang et al. (2014) and Wen et al. (2016).   
 
Similar relationship between molecular weight and release speed were observed in 
hippocampal neurons, and the interaction of cargo proteins with the vesicle matrix also 
seems important, as the release of cargo that binds to the luminal matrix is further slowed 
down (de Wit, Toonen and Verhage, 2009; Zhang et al., 2019).  
The major LDCV matrix protein components are chromogranins and secretogranins. 
Granins aggregate at acidic pH, which is maintained inside the vesicle by the function of 
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vesicular ATP-ase proton pumps (Yoo, 1996). The granins, together with other vesicle 
components such as catecholamines (chromaffin cells and some neurons) and matrix-bound 
peptides form a dense mixture that can have a significant impact upon transmitter release. 
The roles of Chromogranin A and B (CgA, CgB) in DCV formation and cargo release have 
been well studied. One laboratory surveyed the effect of single CgA or CgB KO, and double 
CgAB KO on catecholamine release in chromaffin cells by amperometry and EM (Domínguez 
et al., 2012). Catecholamines release is significantly reduced in chromaffin cells of CgA or 
CgB KO mice, and there is also a reduction in the number of exocytic events (Díaz-Vera et 
al., 2012). In the absence of CgA, the filling of LDCVs with catecholamines and their capacity 
to concentrate cargo is disrupted, resulting in reduced release (Montesinos et al., 2008). 
CgB KO had similar effects in catecholamine release as the CgA KO, and proteomic analysis 
of LDCVs showed an upregulation of CgA (Díaz-Vera et al., 2010). Double KO of CgA/B 
resulted in an even more pronounced decrease of catecholamine release, and the average 
size of LDCVs significantly increased and their catecholamine content was reduced, 
suggesting impaired LDCV biogenesis (Díaz-Vera et al., 2012). Other studies reported similar 
results from chromaffin cells, with reduced transmitter release, LDCV number and volume 
density in the absence of CgA (Kim et al., 2005; Pasqua et al., 2016) (figure 1.3.6 A). Absence 
of CgB on the other hand in pancreatic islet cells of CgB KO mice resulted in reduced insulin, 
glucagon and somatostatin secretion, while LDCV morphology and biogenesis appeared 
normal, suggesting that CgB is more important for exocytosis in these cells (Obermüller et 
al., 2010).   
A recent study in chromaffin cells found that fusion mode (FF or KR) on its own does 
not necessarily determine the speed of cargo release; whether the cargo is soluble or bound 
to the LDCV matrix is also important (Zhang et al., 2019) (figure 1.3.6). This study looked at 
co-release of matrix-bound catecholamines and soluble ATP from LDCVs and found that 
when the fusion pore is non dilated (ie. during kiss-and-run fusion), the release of ATP 
molecules is unrestricted but the release of catecholamines is restricted due to their binding 
to CgA. When CgA was knocked-down however, catecholamine release increased to the 
same levels as ATP during kiss-and-run fusion. This study demonstrated therefore, the 




Despite their importance in neuroendocrine and endocrine cells, double KO of CgA/B 
did not have a significant effect on LDCV number, morphology or LDCV fusion in 
hippocampal neurons (Dominguez et al., 2018). In DRG neurons, it would appear that both 
chromogranins and secretogranins are expressed, as they have been identified on both 
TRPV1-positive and -negative DRG neurons by RNA sequencing (Goswami et al., 2014); CgB 
has been successfully used a LDCV marker in a proteomic study (Zhao et al., 2011). 
Interestingly, CgA was found downregulated in rat DRG neurons following nerve injury, 
possibly suggesting altered LDCV biogenesis in these neurons, which could underlie altered 
peptide release (Xiao et al., 2002).  
 
Figure 1.3.6 The role of chromogranin A in chromaffin cells. A, EM images of normal and altered 
LDCVs (arrows) in inactive scrambled shRNA or CgA-shRNA treated chromaffin cells.  Note the empty 
LDCVs in CgA-KD cells. Scale bar = 500 nm. B, proposed role of CgA and vesicle matrix in controlling 
cargo release in chromaffin cells. In normal control cells, the vesicle matrix retains some 
catecholamine (CA) from being released during kiss-and-run (KAR) fusion, resulting in its sub-quantal 
release, while the soluble ATP is fully released. During full fusion (FF), the whole vesicle content is 
expelled. In CgA-KD cells, the vesicle matrix is disrupted and thus both catecholamines and ATP are 
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fully released (quantal release), regardless of the types of fusion. Figure was adapted from Zhang et 
al., 2019. 
Modulation of fusion pore dynamics by Ca2+ 
Ca2+ concentration and stimulus strength are important regulators of fusion pore 
dynamics, but there are conflicting findings as to precisely how changes in Ca2+ affect fusion. 
Several patch clamping studies on chromaffin cells established that basal firing rates induce 
KR with a narrow fusion pore that limits content release, while strong firing (15 Hz) or 
raising intracellular Ca2+ to >100 µM promoted fusion pore dilation and full content release 
which were interpreted as FF (Fulop, 2005; Elhamdani, 2006; Fulop and Smith, 2006). As 
opposed to these results results, one earlier study on chromaffin cells found using patch 
amperometry that increasing Ca2+ concentrations in the patch pipette promoted faster 
fusion pore closure and transient KR type fusion (Alés et al., 1999). An important caveat of 
the latter study is that it was based on spontaneous release while the later ones used 
physiological stimulation, which might account for the differences. 
Using high resolution confocal microscopy, Chiang et al. (2014) provided strong 
evidence in chromaffin cells that, as opposed to the studies above, low Ca2+ promotes pore 
expansion while high Ca2+ promotes pore constriction, and termed their model Ω-exo-
endocytosis. According to this model, the Ω fusion profile can change in 7 different ways 
instead of only two (FF or KR): they redefined FF as vesicle shrinkage and flattening rather 
than fusion pore dilation, and KR can happen through shrinking, enlarging or without size 
change, before pore closure, which is triggered by strong Ca2+ influx, but the transition 
between different states is flexible (figure 1.3.5 B). The same group later refined this model 
and proposed a “dynamic pore theory” which says that fusion pore size and cargo release 
depends on the competing forces of expansion (generated by F-actin) and constriction 
(generated by dynamin and Ca2+) (figure 1.3.5 B) (Shin et al., 2018) ). In support of this 
theory they found that fusion pores can expand much more than previously assumed, as a 
maximum pore size of 490 nm was measured in chromaffin cells. Whether similar fusion 
pore regulation exists for SVs and in other cell types (eg. neurons) too however remains to 





1.4. Techniques for studying single vesicle exocytosis 
Electrophysiological techniques 
The two main approaches used for studying neurotransmission and vesicle exocytosis 
are electrophysiological and optical techniques. Each has its advantages and disadvantages 
and thus deciding which approach suits one’s experimental needs most is crucial for 
maximizing the advantages. Amperometry can be used to measure the release of oxidizing 
neurotransmitters, such as catecholamines and monoamines. For this technique, a carbon 
fibre microelectrode is positioned in close proximity of the cell and is held at a voltage that 
is higher than the redox potential of the neurotransmitters. When the cell is depolarized 
and the transmitters are released, they are quickly oxidized on the surface of the electrode, 
which can be detected as amperometric spikes (figure 1.4.1). These spikes are often 
preceded by a low amplitude “foot” signal, which is produced by small amounts of 
transmitter being released through opening of an initial fusion pore. The amplitude and the 
duration of the pre-spike foot give information about the fusion pore size and life-
time/stability, respectively (Chow, von Rüden and Neher, 1992; Albillos et al., 1997).  
Capacitance measurements can be used to directly measure both endo-and exocytosis 
based on the alterations in the cell membrane surface area. However, in contrast to 
amperometry, it requires a physical connection between the electrode and plasma 
membrane to establish the patch clamp recording and measurements are restricted to 
recordings in which electrical parameters of the cell are tightly controlled (Hartmann and 
Lindau, 1995; Debus and Lindau, 2000). This mostly restricts the technique’s applicability to 
round cell bodies such as chromaffin cells or large nerve terminals; it has been successfully 
used on isolated DRG neurons, although recordings were restricted to small neurons that 
had been isolated for only a few hours and lacked processes (L. Y. Huang and Neher, 1996; 
Zhang and Zhou, 2002; Chai, Wang, Huang, Y. Wang, et al., 2017). Capacitance 
measurements can suffer from possible artefacts arising from neuronal processes distorting 
measurements, or gating charge movements and may also be contaminated from fusion of 





Figure 1.4.1 Example traces of amperometric currents from PC12 cells stimulated with KCl. 
Catecholamine release from single vesicles appears as spikes of various amplitudes on the top trace. 
The bottom trace shows an individual spike on a larger scale, which start with a pre-spike foot signal, 
indicating the initial opening of the fusion pore, followed by complete expulsion of vesicle content, 
indicated by the spike.  Figure was adapted from Jackson, 2007. 
 
Optical techniques 
In parallel to electrophysiological methods, imaging techniques have also been 
developed to study vesicle exocytosis. Although electrophysiology has a superior time 
resolution and is especially useful for studying fast synaptic transmission, to study slower 
neuropeptide release and vesicle recycling that can happen over seconds-minutes (Betz and 
Bewick, 1992; Bauer et al., 2004; Perrais et al., 2004), imaging techniques may be better 
suited. Moreover, the conductance of LDCV fusion pores in chromaffin cells can be higher 
than what can be measured by electrophysiology but can be measured by a combination of 
fluorescent dyes (Sharma and Lindau, 2018; Shin et al., 2018). Another advantage of imaging 
techniques is that they can give valuable information about the location and history of 
fusing vesicles. 
Styryl dyes are amphipathic molecules that increase their fluorescence when bound 
the membranes and thus can be used to study vesicle cycling (Wu et al., 2009). They bind 
membranes rapidly but they have different membrane affinities and thus their destaining 
rate is different. For example, the dye FM2-10 has a faster destaining rate than FM1-42, and 
this feature has been exploited to study different rates of endocytosis (Klingauf, Kavalali and 
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Tsien, 1998; Richards, Guatimosim and Betz, 2000). In these experiments, vesicles are 
loaded with dyes during stimulation, followed by dye washout from the bath solution. 
During a second round of stimulation, the exocytosis and destaining rate of previously 




Figure 1.4.2 Cartoons showing the theoretical background of styryl dyes (a, b) and pHluorins (c). a-
b, For experiments using styryl dyes, dye uptake and release can be assessed. During dye uptake, 
vesicles with different fusion dynamics are loaded with the dye differently, as those fusing with fast 
transient kiss-and-run fusion will maintain the dye even after washout, compared to vesicles 
undergoing full fusion and slow endocytosis. Subsequently, dye release can be monitored during 
vesicle fusion after stimulation. In this case, a short fusion pore opening limits dye release and thus 
these vesicles stay fluorescent after fusion. C, pHluorin molecules (round tag inside the vesicle) fused 
to vesicular membrane proteins (shown in blue) or cargo proteins are quenched inside the vesicle, 
due to the acidic pH, maintained by vesicular proton pumps. Upon fusion, a proton efflux from the 
vesicle lumen increases the pH and the pHluorin fluorescence swiftly increases. This is followed by 
vesicle endocytosis and reacidification, and gradual decrease of the fluorescence. Figure was 





Dye unloading from vesicles gives an estimate of how long a vesicle is in contact with 
the plasma membrane and how long a fusion pore is open for. However, one disadvantage 
of this technique is that dye washout is required after dye loading in order to reduce 
background fluorescence. As this can take several minutes, the detection of fast vesicle 
recycling events is limited. Additionally, FM dyes are non-specific and will label all 
membranes.  
 A more specific way of studying vesicle exocytosis is the use of fluorescently tagged 
proteins. One advantage of this approach over styryl dyes is that it allows the tagging and 
examination of specific vesicular proteins, but it also requires the transfection of cells, which 
can be done either by transient transfection or by viral vectors. The specificity of the protein 
tagging also makes the interpretation of fluorescent signals less straightforward, as different 
fluorescently-tagged proteins can report different fusion characteristics.  
 
 
Figure 1.4.3 Comparison of mEGFP, pHluorin and mCherry tagged to NPY for reporting vesicle 
fusion in Ins1 cells.  mEGFP has a pKa of 6 and hence, while the NPY-EGFP is visible before fusion, it 
exhibits a small increase in fluorescence upon fusion before cargo release and fluorescence loss. 
pHluorin has the highest pKa among the examined constructs, hence it is invisible before fusion and 
exhibits a sharp increase in fluorescence before release. mCherry has a pKa of 4.5 and its 
fluorescence stays the same before dropping, indicating cargo release. Figure was adapted from 




The most widely used among these fluorescent molecules are the pH-sensitive 
pHluorins (figure 1.4.2 C). Their popularity is due to their neutral pKa (~7.4) (Miesenböck, De 
Angelis and Rothman, 1998), which makes them invisible in the acidic pH of a secretory 
vesicle prior to fusion, but upon fusion pHluorin fluorescence increases by ~8-9 fold, making 
vesicle fusion events easy to detect (Gandasi et al., 2015).  Other fluorescent proteins, such 
as EGFP, Venus or mCherry have a lower pKa and thus are visible prior to fusion (figure 
1.4.3). Fluorescent proteins can be useful to study different aspects of exo/endocytosis and 
vesicle trafficking depending on their targeting partner. If they are fused to a soluble cargo, 
such as NPY, then cargo release can be monitored by the disappearance of fluorescence 
upon fusion. In this case, fluorescent proteins other than pHluorin (such as mCherry or GFP) 
can be used to monitor the movement of vesicles before and during exocytosis. pHluorins 
on the other hand are useful when tagged to vesicular membrane proteins to study fusion 
pore behaviours and endocytosis, as the fate of the vesicle can be followed after exocytosis 
(Gordon, Leube and Cousin, 2011; Xu et al., 2011; Chanaday and Kavalali, 2018).   
In cortical neurons, experiments using pHluorin tagged to different sized cargo 
proteins (such as semaphoring 3A, tPA, BDNF and NPY) have shown that certain cargoes are 
retained at the surface of the plasma membrane as stable cargo deposits that can last for 
minutes (de Wit, Toonen and Verhage, 2009). The appearance of these cargo deposits 
depends on interaction with the LDCV matrix. Regarding fusion pore behaviours, using a 
combination of EGFP-tagged PLC1 Cδ1 PH (PH-EGFP) domain, which selectively labels the 
cytoplasmic leaflet of both the plasma membrane and vesicular membrane, and Alexa 532 
dye in the bath solution, Zhao et al. (2016) was able to prove the existence of a hemi-fusion 
intermediate (figure 1.4.4). They were able to capture fusion states using STED imaging 
where the PH-EGFP diffused into the vesicular membrane upon contact of the vesicle with 
the plasma membrane, but the A532 dye did not diffuse into the vesicle, indicating that the 
fusion pore did not open (figure 1.4.4 A,B). Importantly, the above described 
electrophysiological techniques would not be able to detect such intermediates. Moreover, 
using the same technique they were also able to resolve fusion pores of 12-430 nm in size 





Figure 1.4.4 Visualization of DCV fusion pores and hemi-fusion intermediates with STED imaging. 
Chromaffin cells were transfected with PH-EGFP, which specifically labels the plasma membrane 
(PM) and the fusing vesicle, while A532 was also present in the bath solution to show fusion pore 
opening. Cartoons on A and B show the interpretation of the fluorescent images below. A, A vesicle 
is simultaneously labelled with PH-EGFP and A532 upon fusion with the plasma membrane. B, There 
is a delay between PH-EGFP and A532 labelling of the vesicle, indicating a hemi-fused intermediate. 
C upper left, an Ω-profile of a PH-EGFP labelled vesicle, upper right, line profile of the dotted line 
across the bottom of the vesicle. WH = full width at half-maximum. Bottom, reconstituted XY plane of 
the fusing vesicle above, at the fusion pore level (indicated in grey on the inset). Figure was adapted 
from Shin et al., 2018 and Zhao et al., 2016.  
 
To summarize, the different techniques can report various vesicle fusion 
characteristics because they each measure different points of the exocytotic process and 
operate at various time resolutions. A cell-attached capacitance measurement might 
accurately report the opening and conductance of a fusion pore on the millisecond time 
scale . An amperometry recording reports the release of oxidizable cargo at similar time 
scales, but it does not provide information about fusion pore dynamics (only about the 
initial opening of the fusion pore through the pre-spike foot) or the fate of the vesicle. 
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Optical measurements on the other hand, might be less accurate to report the initial phase 
of fusion pore opening, but they report cargo release and fusion dynamics changes with 
>100 ms to several seconds resolution. Hence, the combination of different techniques 
should be considered to best understand vesicle fusion and transmitter release.  
 
 
1.5. Synaptotagmins – coupling excitation to Ca2+ mediated exocytosis 
Synaptotagmins (“synapto” refers to a synaptic vesicle protein, “tagmin” refers to its 
phospholipid binding activity) (M.S. Perin, Johnston, 1991) are a protein family of 17 known 
isoforms in mammalian cells (figure 1.5.1). They contain a short N-terminal sequence 
followed by a transmembrane domain and two C2 domains (C2A, C2B), and a C-terminal 
regions; this structure is highly conserved across species from Drosophila to humans, but 
only the C2 region is homologous across the isoforms (M S Perin et al., 1991; M.S. Perin et 
al., 1991; Südhof, 2002; Craxton, 2004) (figure 1.5.1). The first discovered isoform, 
synaptotagmin-1 (syt1), was originally named p65 referring to the molecular weight it was 
identified at (Matthew, 1981). It contains two Ca2+-binding C2 domains homologous to the 
PKC C2 region (Perin et al., 1990), and its main function was to couple stimulation to calcium 
dependent exocytosis ah shown in in vitro fusion assays (Bai et al., 2004; Bhalla, Tucker and 
Chapman, 2005; Rizo, Chen and Araç, 2006).  
Early biochemical studies determined that syts bind phospholipids and syntaxin in a 
Ca2+ dependent manner through their C2 domains (Brose et al., 1992; Davletov and Südhof, 
1993; Chapman and Jahn, 1994), but the two C2 domains have different functions. While 
the C2A domain is responsible for Ca2+-dependent phospholipid binding (Davletov and 
Südhof, 1993), the membrane distal C2B domain mediates Ca2+-dependent homo-and 
hetero-oligomerization with other syts (Chapman et al., 1996, 1998; Osborne et al., 1999), 
Ca2+  channels (Kim and Catterall, 1997; Sheng, Yokoyama and Catterall, 1997) and synaptic 
proteins such as syntaxin, AP2 adaptor complex proteins and SNAP25 (Chapman et al., 1995, 
1998). The different isoforms also have different Ca2+-sensitivities (Li et al., 1995). In the 
presence of lipids, the Ca2+ concentration dependence of syt1, 2 and 9 are in the high (>100) 
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micromolar range, while that of syt3, 5, 7 and 10 are in the low (<10) micromolar range 
(Sugita et al., 2002; Volynski and Krishnakumar, 2018). 
 
Figure 1.5.1 Structure of mouse synaptotagmins. All syts have a TM domain and two C2 domains, 
but their linker regions between the TMD and C2A domain, and the C/N terminals are variable. Syt7 
alternatively spliced forms are shown on the bottom. Syts can be classified into five groups (shown 
by brackets on the right) based on homology. Image was reused from Gustavsson & Han (2009).  
 
It has thus been proposed that the presence of these low and high-affinity Ca2+ 
sensors can accommodate a wide range of Ca2+ dependence of exocytosis in neurons and 
endocrine cells (Pinheiro, Houy and Sørensen, 2016) (figure1.5.2). An example for this is the 
differential distribution of syt1, 2 and 9 in the brain, each of which has slightly different Ca2+ 
sensitivities and trigger transmitter release with different kinetics. In the calyx of Held 
synapses, syt2 is the main Ca2+ sensor, which triggers neurotransmitter release with the 
fastest kinetics out of these three isoforms (Xu, Mashimo and Südhof, 2007). In the limbic 
system syt9 is the dominant isoform and triggers release with relatively slower kinetics 
while Syt1 dominates in the forebrain (Xu, Mashimo and Südhof, 2007). Thus, their 
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Figure 1.5.2 Schematic diagram showing the half maximal calcium concentrations, [Ca2+]1/2, of 
indicated C2 domain containing proteins required for membrane binding. Purple indicated low 
affinity, light blue indicates medium affinity, and red indicated high affinity groups of proteins. 
Figure was adapted from Pinheiro et al. (2016). 
 
syt1 
Being the first identified isoform, syt1 has been the most extensively studied. Early on, 
it was identified as the low-affinity Ca2+ sensor of the synchronous component of 
transmitter release in hippocampal neurons, as synchronous release largely disappears in 
syt1 KO mice (Geppert et al., 1994; Goda and Stevens, 1994; Li, Davletov and Südhof, 1995). 
Later studies confirmed this and solidified syt1 as the main Ca2+ sensor of transmitter 
release in neurons and endocrine cells, where the Ca2+ sensitivity of release is largely 
determined by the Ca2+ affinity of syt1, as shown by introducing mutations in the syt1 C2 
domains (Fernández-Chacón et al., 2001; Voets et al., 2001; Rhee et al., 2005). In chromaffin 
cells, Ca-dependent lipid binding by syt1 is required for the fusion of vesicles that fuse soon 
after stimulation (readily releasable pool of vesicles or RRP), as this fast release component 
disappears in syt1 KO cells (Voets et al., 2001; Sørensen et al., 2003).  
Multiple later studies established that syt1 likely has other functions, such as clamping 
Ca2+-dependent spontaneous “mini” release along with complexin (Xu et al., 2009) and in 
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vesicle priming/docking to help maintain RRP size in a Ca2+-independent manner in 
hippocampal neurons (Bacaj et al., 2015) and in chromaffin cells (de Wit et al., 2009; 
Mohrmann et al., 2013). In support of the notion that synaptotagmins might have a role in 
steps upstream of vesicle fusion is the finding that syt2 (which is highly homologous to syt1) 
contributes to positional priming (the positioning of SVs close to calcium channels) that is 
required for synchronous release at rat calyx of Held synapses (Young and Neher, 2009).  
 
Syt7 
Another component of transmitter release is asynchronous (“slow”) release which is 
maintained over hundreds of milliseconds and has much higher Ca2+ sensitivity than 
synchronous release, suggesting that a separate Ca2+ sensor regulates this type of release 
(Sun et al., 2007). Syt7 has a high Ca2+ affinity and the slowest dissociation kinetics from 
phospholipids among syts (Bhalla, Tucker and Chapman, 2005; Hui et al., 2005), making it an 
ideal protein to regulate slow release. Syt7 is a Ca2+ sensor of lysosome exocytosis in 
fibroblasts (Martinez et al., 2000), the main Ca2+ sensor of insulin secretion in pancreatic β-
cells (Gao et al., 2000; Li et al., 2007; Gustavsson et al., 2008) and is localized on the plasma 
membrane as well as secretory vesicles (Sugita et al., 2001; Fukuda et al., 2004).  
Functional studies using electrophysiology found that syt7 is the main Ca2+-sensor of 
asynchronous SV release in hippocampal neurons, calyx of Held synapses, retinal ribbon 
synapses and zebrafish neuromuscular junction (Wen et al., 2010; Bacaj et al., 2013; Luo, 
Bacaj and Südhof, 2015; Li et al., 2017; Luo and Südhof, 2017), although its deletion did not 
have any effect on SV release at inhibitory synapses between cultured cortical neurons 
(Maximov et al., 2008). A study examining the role of syt7 on four different facilitating 
synapses in the mouse brain found that syt7 was required for synaptic facilitation, and 
suggested that it does so by increasing the probability syt1-mediated SV fusion (Jackman et 
al., 2016). In chromaffin cells, syt1 and syt7 appear to be the main proteins regulating fast 
and slow exocytosis of LDCVs respectively, as deletion of syt1 or syt7 eliminated the fast or 
slow component of release respectively, while double KO eliminated 70-80 % of total 
secretion (Schonn et al., 2008). There is therefore good evidence that syt7 regulates slow 
transmitter release in many cell types.  
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Some suggested that like syt1, syt7 also has a role upstream of fusion triggering, as 
syt7 was found to work together with calmodulin to replenish SVs during repetitive 
stimulation in hippocampal neurons (Liu et al., 2014) and LDCVs in chromaffin cells (Schonn 
et al., 2008). However, other studies found no effect of syt7 on the rate of SV replenishment 
in hippocampal neurons or retinal ribbon synapses (Bacaj et al., 2015; Luo, Bacaj and 
Südhof, 2015). The reason for these discrepancies between studies is not clear, but could be 
due to small differences between experimental procedures, cell types or even the 
interpretation of results.  
Besides the above described roles of syt7, it is also reported to regulate fusion pores 
and thus selective transmitter release. In mouse embryonic fibroblasts, the release of 
different sized fluorescent dextran cargo from lysosomes was fuller in syt7 KO cells and it 
was concluded that syt7 restricts fusion pore expansion (though whether pore size or the 
speed of opening is affected was inconclusive) (Jaiswal et al., 2004). Additionally, the C2 
domains of syt7 were essential for its function in controlling fusion pore dynamics as shown 
in chromaffin cells. When Ca2+-binding to its C2B domain was disrupted by a mutation, more 
KR and less FF events were observed, suggesting that the C2B domain controls fusion pore 
expansion, perhaps by stabilizing it, in a Ca2+-dependent manner but both C2 domains were 
needed to open the fusion pore (Segovia et al., 2010).  
Due to its high Ca2+-sensitivity, syt7 responds to Ca2+ concentration increase faster 
than syt1, as evidenced by the fact that syt7-bearing vesicles fuse closer to the time of 
stimulation than syt1 vesicles in chromaffin cells (Rao et al., 2017). The same group has 
found that following mild (25 mM KCl) stimulation, syt7 mediated events are favoured 
compared to syt1 events, and this trend reverses with increasing (56 and 80 mM) KCl 
concentration (Rao et al., 2014; Bendahmane et al., 2019). The authors concluded that Syt7 
is activated by lower Ca2+ increase after mild stimulation, and restricts fusion pore 
expansion to slow down cargo release. Syt1 on the other hand can only sense higher Ca2+ 
concentration after strong stimulation, and mediates pore widening and fuller cargo release 




Figure 1.5.3 Putative roles of syt1 and syt7 in mediating vesicle fusion. Strong stimulation and 
higher Ca2+ rise at nanodomains close to Ca2+ channels preferentially activated syt1 bearing LDCVs, 
which mediates fast fusion pore widening and full cargo release. Syt7 on the other is well suited for a 
lower, more uniform rise in Ca2+ after milder stimulation due to its higher sensitivity and slow 
membrane unbinding kinetics, and it restricts fusion pore opening and cargo release. Figure was 
reused from Rao et al. (2014).  
 
The differences between syt1 and syt7 appear to arise from small differences in their 
C2B domains, as replacing the syt1 C2B domain with that of syt7 could not rescue the syt1 
phenotype (reduced transmitter release) in syt1 KO mice (Xue et al., 2010), and their two C2 
domains have different relative importance for their function (Bacaj et al., 2013). 
Nevertheless, these findings suggest that cells can achieve precise control of fusion pore 
dynamics and cargo release through sorting different synaptotagmin isoforms onto vesicles, 
and how accessible their C2 domains are to Ca+2 (by positioning to Ca2+-channels/interaction 
with other proteins) (the various roles of syt7 were recently reviewed in MacDougall et al., 
2018).   
 
Syt4 
Out of the seven syt isoforms that lack Ca2+ binding ability (Syt4, 8, 11, 12, 13, 14, 15), 
syt4 has been the most extensively studied. It harbours a single point mutation resulting in 
an aspartate to serine substitution in its C2A domain, and thus lacks Ca2+ -dependent 
phospholipid binding by this domain in mammalian cells (Ullrich et al., 1994; Poser, 
Ichtchenko and Shao, 1997), though in Drosophila it retained its Ca2+ binding ability and 
functions as a postsynaptic Ca2+ sensor  (Dai et al., 2004; Yoshihara et al., 2005; Barber et 
al., 2009). syt4 can still bind syntaxin through its C2A domain, and interestingly, its C2B 
domain possesses Ca2+-binding properties which promotes its homo- and hetero-
oligomerization (Thomas et al., 1999).  
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The expression of syt4 can be induced by forskolin in PC12 cells and electrical activity 
in neurons, and its expression levels also change during development (Vician et al., 1995; 
Ferguson et al., 1999). In the brain, syt4 has important roles in the proper functioning of 
synaptic transmission in the hippocampus and cerebellum, as syt4 KO mice have impaired 
learning, memory and motor coordination (Ferguson et al., 2000). On the cellular level, Syt4 
is localized to both SVs and LDCVs,  as well as the Golgi (Ferguson et al., 1999; Ibata et al., 
2000; Zhang et al., 2009), and is generally considered an inhibitory isoform, as it inhibits 
exocytosis in PC12 cells and neurons (Machado et al., 2004; Moore-Dotson, Papke and 
Harkins, 2010). In hippocampal neurons, syt4 negatively regulates BDNF release and thus 
indirectly affects synaptic transmission and plasticity (Dean et al., 2009). However, its 
function seems more complex than simply inhibiting release, as it was found to regulate the 
Ca2+ sensitivity of release by promoting exocytosis at low, and inhibiting it at high Ca2+ influx 
at pituitary nerve terminals (Zhang et al., 2009), and by establishing the linear Ca2+ 
dependence of transmitter release in cochlear hair cells (Johnson et al., 2010). 
It is likely that syt4 functions at least partly through interacting with other isoforms 
and affecting their Ca2+/phospholipid/SNARE binding. In Drosophila, it forms hetero-
oligomers with syt1 to inhibit neurotransmission (Littleton et al., 1999), while in pancreatic 
β cells, syt4 developmentally regulates the Ca2+ -sensitivity of insulin secretion through 
interacting with syt7 (Huang et al., 2018). This latter study found using proximity ligation 
assay that syt4 and syt7 interact, and suggested that syt4 increases the Ca sensitivity of 
insulin secretion in mature β cells through either directly inhibiting syt7 on vesicles or 
through decreasing the sorting of syt7 onto vesicles at the level of the Golgi. As opposed to 
the inhibitory roles of syt4 but supporting the notion that it functions together with other 
Ca2+ sensors, syt4 and 7 were both required for basal and evoked somatodendritic 
dopamine release in hippocampal neurons, as measured by radioassay in syt4/syt7 siRNA 
knockdown neurons (Mendez et al., 2011). It is unknown how the interaction of syt4 with 
syt7 alters syt7 function, possible mechanisms include changing its Ca2+ affinity or regulating 
fusion pore dynamics.  
Several studies looking at fusion pore regulation by syt4 were conducted on PC12 cells 
using amperometry and capacitance recordings. These studies found that overexpression of 
syt4 resulted in decreased fusion pore stability and reduced pore open time (Wang et al., 
2001), and promoted KR events with narrow fusion pores (Wang et al., 2003). A different 
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study also found that syt4 promoted KR events, but their results indicated that these LDCV 
fusion events had increased pore size and lifetime (Zhang, Zheng and Jackson, 2010). 
Experiments in pituitary peptidergic nerve terminals supported this latter study: in wild type 
nerve terminals, LDCV fusion pores were significantly larger than in those from syt4 
knockout mice (Zhang et al., 2009). Thus, it is still not clear how syt4 exactly affect fusion 
pore kinetics although studies agree that it promotes KR and has no effect on SV fusion.  
Interestingly, syt4 is mostly localized to the Golgi in undifferentiated PC12 cells, but 
following NGF differentiation or forskolin treatment it is trafficked to LDCVs which undergo 
Ca2+-dependent exocytosis (Fukuda et al., 2003; Fukuda & Yamamoto, 2004). Since syt4 was 
shown to be phosphorylated in PC12 cells after NGF treatment (Mori et al., 2008), this 
points towards the possibility that post-translational modifications may alter its function. 
Indeed in hippocampal neurons, syt4 phosphorylation on DCVs was found to promote DCV 
dissociation from microtubules, increased their capture and the release of NPY cargo at 
presynaptic release sites (Bharat et al., 2017) (figure 1.5.4). However, whether similar 
mechanisms work in DRG neurons has not been investigated.  
In summary, syt4 is a calcium-insensitive isoform that is mostly localized to DCVs but 
its precise function in secretion and vesicle fusion remains poorly characterized. In DRG 
neurons, syt1 and 2 are known receptors for botulinum-A but syt4 or syt7 have not been 
described in these cells, nor have syt4 or syt7 KO mice been assessed for pain behavioural 
phenotypes. Moreover, while the physiological effects and receptors of NGF on DRG 
neurons are well characterized, the possible role of syt4 and its phosphorylation in NGF-




Figure 1.5.4 Summary figure of known role of syt4 in vesicle trafficking in hippocampal neurons 
and of TrkA signalling in DRG neurons. Bharat et al. (2017) found in hippocampal neurons, syt4 
located of DCVs is phosphorylated by JNK. The phosphorylation of syt4 promotes detachment of 
DCVs from microtubules (in green) and from the motor protein KIF1 and increased capture at the 
plasma membrane (PM). In DRG neurons on the other hand, NGF can bind to its receptors p75 and 
TrkA, and TrkA activation leads to phosphorylation of TRPV1, which in turn leads to increased 
neuronal excitability, vesicle fusion and increased surface presentation of TrkA receptors (Tanaka et 
al., 2016).  Whether the activation of p74 by NGF in DRG neurons has similar outcomes as in 





1.6. Aims and objectives 
 
Sensory neurons increase their neuropeptide secretion during chronic inflammation 
both in the periphery and the CNS, but the secretory machinery that enables this 
maintained secretion is unexplored. This thesis focuses on the role of synaptotagmins in this 
process as potential calcium sensors that regulate peptide release from DRG neurons. In 
order to address this question, a second major aim of the work was to establish a method 
for characterizing and quantifying exocytosis from DRG neurons directly.  
 
Therefore the experimental objectives of the research were to:  
 Describe the synaptotagmin isoforms expressed in the peptidergic DRG neurons 
 Identify putative isoforms controlling neuropeptide secretion in DRG neurons 
 Establish a method for studying synaptotagmin-mediated exocytosis in DRG neurons 
 Study the function of identified synaptotagmins in regulating secretion from DRG 
neurons and explore the impact of phosphorylation of synaptotagmin-4 on 







2. Materials and Methods 
2.1. List of antibodies  
Primary antibodies 
Name  Host Application Source 
Synaptotagmin 2 Rabbit 
ICC (1/500) 
WB (1/1000) 
Synaptic systems, 105123 
Synaptotagmin 4 Rabbit 
ICC (1/1000) 
WB (1/1000) 





Santa Cruz, sc271936 
Synaptotagmin 4 Rabbit 
IP, WB 
(1/1000) 
Synaptic Systems, 105 043 
Synaptotagmin 7 Rabbit 
ICC (1/200) 
WB (1/1000) 






Santa Cruz, sc135411 
TrkA Rabbit ICC (1/100) Alomone labs ANT-018 
CGRP Mouse ICC (1/1000) Sigma-Aldrich C71113 
TRPV1 Goat ICC (1/200) Santa Cruz sc-12498 
Substance P Guinea pig ICC (1/100) Abcam ab10353 




ICC (1/1000) Synaptic Systems, N0301-At488-
S 
Secondary antibodies 
Name  Host Application Source 
Alexa Fluor 488 
anti-rabbit  
Donkey ICC (1/1000) 




Alexa Fluor 594 
anti-goat 
Donkey ICC (1/1000) Thermo Fisher 23235 
Alexa Fluor 488 
anti-mouse 
Donkey ICC (1/1000) Thermo Fisher A-21203 
 
2.2. DNA constructs 
Plasmid name Details 
Synaptotagmin 2-pHluorin 
Synaptotagmin 4 gene was replaced by synaptotagmin 2 in 
the syt4-phluorin construct; cloning done by GenScript 
Synaptotagmin 4-phluorin From Anantharam lab (University of Michigan, US) 
Synaptotagmin 7-pHluorin From Anantharam lab (University of Michigan, US) 
NPY-mCherry From Barg lab (Uppsala University, Sweden) 
VAMP2-pHluorin From Barg lab (Uppsala University, Sweden) 
NPY-pHluorin From Anantharam lab (University of Michigan, US) 
Synaptotagmin 4-mCherry 
pHluorin gene was replaced by mCherry in the syt4-





Site directed mutagenesis was done by Genscript to 
change the Serine at the 135 site to Alanine in the 




All animals had free access to food and water prior to sacrifice. C57BL/6 mice were 
from an in-house breeding colony and were originally purchased from Charles River (UK).  
Synaptotagmin-4 mutant mice used in this project were from the in-house breeding 
colony of Professor Walter Marcotti and Dr Stuart Johnson and were originally obtained 
from H. Herschman (UCLA). Syt4 KO mice were generated by replacing a section of the syt4 
gene encoding the C2A domain with a targeting construct containing the same gene 
sequence, but which was disrupted using a neomycin resistance cassette (Ferguson et al., 
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2000) (figure2.3.1). 129SvJ embryos containing the Syt4/neoR gene fragment were raised 
and then crossed with C57BL/6 mice, to obtain heterozygous mice for the mutation. Syt4 
heterozygous (+/-) mice were then crossed to obtain homozygous mutants.  
 
 
Figure 2.3.1 Schematic of the syt4 gene structure used to create syt4 KO mice. Figure from 
Ferguson et al., 2000. 
 
Syt7 mutant mice (used for ELISAs and antibody validation in chapter 3) and syt2 
mutant mice (used for antibody validation in chapter 3) were from the breeding colony of 
Professor Walter Marcotti and were purchased from the MRC Harwell Institute. Both gene 
knockouts were generated by “knockout-first” conditional allele targeting strategy (Coleman 
et al., 2015). Briefly, a “targeted mutation 1a” (tm1a) allele containing a lacZ cassette, FRT 
sites and loxP sites upstream of a critical exon (a gene sequence that is essential for protein 
function) was inserted into the syt2 or syt7 genes by homologous recombination. A 
syt7<tm1b> allele was then generated by crossing <tm1a> mice with global “Cre deleter” 
mice, resulting in the deletion of the critical exon (exon 7). Due to the remaining lacZ 
cassette, β-galactosidase is expressed in the relevant tissues instead of syt7. The 
syt2<tm1d> mice were generated by crossing syt2<tm1a> mice with mice globally 
expressing FLP1 recombinase, followed by crossing with “Cre deleter” mice, resulting in full 
knockout of the critical exon (exon 3) without the expression of β-galactosidase.  
Adult, 6-12 weeks old C57BL/6, syt7<tm1b> and syt4 mice were sacrificed using a 
Schedule 1 method in accordance with the animals (Scientific Procedures) Act 1986. 
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Synaptotagmin 2 <tm1d> mice were sacrificed at P14, as syt2 KO mice are only viable for 
~20 days (Pang et al., 2006).  
 
Figure 2.3.2 Schematic showing the “knockout-first” conditional allele targeting strategy for 




Name Sequence Details 
Reverse 5’ GCAAGGAGAGCTCTTGGATGTG 3’ Syt 4 genotyping 
Forward 1 (mutant, 
expected band at 
250 bp) 
5’ AAC CAC ACT GCT CGA CAT TGG G 
3’ 
Syt 4 genotyping 
Forward 2 (wild 
type, expected band 
at 300 bp) 
5’ CAC TTC CCT CAC GTC AGA GGA G 
3’ 
Syt 4 genotyping 
SYT2,4,7 forward 1 5’ CTACTCTTGTGCCAGGGTGTGGTC 3’ Sequencing 
SYT2,4,7 SYT 
forward 2 
5’ CAGGCGGAAGCGGAGGC 3’ Sequencing 
SYT2,4,7 SYT 
forward 3 
5’ GGTGGCACTTTTCGGGGAAATG 3’  Sequencing 
SYT2,4,7 SYT reverse 5’ CATGTCTGCTCGAAGCGGC 3’ Sequencing 
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NPY forward 1 5’ GAGACCCAAGCTGGCTAGCC 3’ Sequencing 
NPY forward 2 5’ CGGCATGACTTTTTCAAGAGTG 3’ Sequencing 
NPY reverse 1 5’ GTGGCTAGCCAGCTTGGGTCTC 3’ Sequencing 
 
2.5. Solutions and buffers 






















Normal external solution – pH=7.3-7.4 
KCl 2 mM 
NaCl 145 mM 
MgCl2 1 mM 
NaHCO3 5 mM 
CaCl2 2.5 mM 
HEPES 10 mM 
Glucose 10 mM 
High potassium external solution – pH=7.3-7.4 
KCl 40 mM 
NaCl 107 mM 
MgCl2 1 mM 
NaHCO3 5 mM 
CaCl2 2.5 mM 
HEPES 10 mM 








Tris Base 25 mM 
Glycine 192 mM 
SDS 1 % 
Transfer buffer 
Tris Base 25 mM 
Glycine 192 mM 
Methanol 20 % 
TBS (Tris-Buffer Saline) 
Tris base 20 mM 
NaCl 137 mM 
Tween-20 0.1 % 
pH = 7.6, adjusted with HCl 




4 % 6 % 
Acrylamide 30 % 666 µl 1 ml 
Tris-HCl 
(pH=6.8) 
0.5 M 1.25 ml 1.25 ml 
SDS 10 % 50 µl 50 µl 
H2O - 3.3 ml 3 ml 
APS 10 % 30 µl 30 µl 
TEMED - 15 µl 15 µl 
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7.50% 10% 12% 14% 15% 
Acrylamide 30 % 
6.25 ml 8.33 ml 10 ml 
11.67 




6.25 ml 6.25 ml 6.25 ml 6.25 ml 6.25 ml 
SDS 10 % 250 µl 250 µl 250 µl 250 µl 250 µl 
H2O - 12 ml 10 ml 8.2 ml 6.6 ml 5.7 ml 
APS 10 % 250 µl 250 µl 250 µl 250 µl 250 µl 
TEMED - 25 µl 25 µl 25 µl 25 µl 25 µl 
 
Other often used reagents 
 
Name Supplier Catalog number 
DMEM/F12 Thermo Fisher 31331-028 
Heat inactivated fetal 
bovine serum 
Sigma-Aldrich F0804-50ML 
Pen/Strep Millipore TMSAB2C 
HBSS Thermo Fisher 14170-088 
Laminin Sigma-Aldrich L2020 




NGF-β from rat Sigma-Aldrich N2513 
RPMI-1640 GE Healthcare SH30027.01 
Trypsin Sigma-Aldrich T7409-1G 
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Collagenase Sigma-Aldrich C5138-100MG 
RIPA buffer Sigma-Aldrich R0278-50ML 
Protease inhibitor 
cocktail III 
Thermo Fisher 12841640 
Laemlli buffer Bio-Rad 161-0747 
β-Mercaptoethanol Sigma-Aldrich M7522 
 
 

























ZymoPURE II Plasmid 
Kits 
Zymo Research D4200 









2.6. Mouse dorsal root ganglia isolation and culture 
Dissection and culture preparation 
The mouse DRG dissection and dissociation procedure used in this thesis was modified 
based on (Malin, Davis and Molliver, 2007). Following schedule 1 sacrifice, mice were moved 
to the dissection area. The skin in the back, starting from the neck was cut open using iris 
scissors. The skin was pulled to the sides using surgical forceps to expose the spine, which 
was removed by cutting through the ribs, muscles and any connective tissue. After removal 
of the spine, it was cleared from excess tissues using scissors until the midline of the spine 
was visible, where it was then cut into two halves and one of them was placed onto a tissue 
paper. The other half was placed on a plastic 100 mm Petri dish and moved under a 
stereomicroscope, where the rest of the dissection was carried out. To remove the ganglia, 
starting at the cervical region, the dorsal root was grasped using fine forceps and pulled to 
lift the DRG slightly, then the spinal nerve (located underneath the ganglion) was carefully 
cut using vannas scissors. Care was taken not to touch or damage the DRG itself in the 
process. After most of the spinal nerve and dorsal/ventral roots were cut away from the 
DRG, it was carefully placed in an Eppendorf tube containing ice cold Hank's Balanced Salt 
Solution (HBSS). This isolation procedure was repeated for all DRGs in both halves of the 
spine.  
After dissection, the tube containing the ganglia was transferred into a laminar flow 
hood. For enzymatic digestion, ganglia were first incubated in 1.25mg/ml collagenase 
solution for 30 minutes inside a 37°C incubator, after which collagenase was removed and 
2.5mg/ml trypsin solution was added for further 30 minutes. After digestion, ganglia were 
washed with full culture media (DMEM/F12 containing 10% fetal bovine serum and 1% 
pen/strep) to deactivate enzymes, and spun down at 1000 RPM for 1 minute. The wash step 
was repeated, followed by mechanical dissociation of ganglia by triturating with a 19G 
needle about 3 times, followed by triturating with a 23G needle about 3-4 times. Cell 
suspension was topped up with additional culture media and spun down at 1000 RPM for 3 
minutes. Supernatant was discarded and cell pellet resuspended in full culture media, after 
which cells were seeded for experiments. Half the media was changed the following day, 




DRG culture conditions 
Different protocols exist for culturing primary DRG neurons which differ in isolation 
process and culture media, depending on how long the culture needs to be maintained for 
and on experimental context. As primary DRG cultures contain a mixture of primary non-
dividing neurons as well as dividing cells, including glial cells, conditions must be adapted 
accordingly to ensure adequate support of neuronal survival. To prevent the proliferation of 
dividing cells that would consume nutrients from the media, mitotic inhibitors can be used 
in long-term (more than ~3 days) culture media (Malin, Davis and Molliver, 2007; Owen and 
Egerton, 2012). Moreover, although growth factors are not necessary for the survival of 
adult DRG neurons, they affect axon growth and can modulate the expression of receptors 
and ion channels and in turn the neuronal phenotype (Lindsay, 1988; Winter et al., 1988). 
Therefore long-term (more than ~3 days) cultures often need to be supplemented with 
growth factors such as NGF or BDNF depending on experimental context. In this thesis we 
used short term (<3 days) cultures, as in early experiments we determined that using our 
culture protocol neuronal survival was high, and cells grew extensive neurites within 2-3 
days in vitro (DIV) (figure 2.6.1). Non-neuronal cells only became more abundant after 4 





Figure 2.6.1 DIC images of DRG cultures at different stages. 1, 2, 4 or 6 days in vitro (DIV) cultures 
develop progressively more complex neurite network. (top) At 1DIV, neurons start growing neurites 
that become more extensive by 2 DIV. Satellite supporting cells can be observed on many neuron 
soma at this stage (shown on insets and yellow arrows). (bottom) By 4DIV, the neurons grow an 
even more extensive neurite net but non-neuronal cells are also more abundant. DRG neurons can 
be morphologically distinguished from glial cells: healthy DRG neurons have a well outlined, round 
cell bodies while glial cells are elongated, less well-defined and smaller than DRG neurons.  Yellow 
arrowheads point out glial cells, while red arrowheads point out neurons. Rectangles with dashed 
lines indicate sections that have been enlarged in the insets. Inset at 4 DIV shows glial cells, while the 
inset at 6 DIV shows glial cells and a neuron. Scale bars on large imaged are 100 µm, and on the 








Electroporation of DRG neurons 
Mouse DRG neurons were transfected using Amaxa Basic Nucleofector Kit (VPI-1003) 
using a protocol that was modified from the manufacturer’s instructions. In initial 
experiments, the number of DRG neurons was estimated using a hemocytometer and it was 
determined that on average 1.5-2 x 105 cells were harvested from one mouse. After the last 
centrifugation step of the culture preparation protocol, the whole cell pellet was 
resuspended in 30 µl transfection mixture (containing 82% Nucleofector solution and 18% 
Supplement solution, both of which were included in the Nucleofector Kit) for each slide or 
dish (for example, if 4 slides were used then 4 x 30 = 120 µl transfection mixture was 
prepared). The cell suspension was divided into separate tubes if multiple transfections 
were carried out, and between 2-3 µg total DNA was added to them for each DNA construct.  
The cell/DNA suspensions were then transferred to glass cuvettes, inserted into a 
Nucleofector device and the “Rat DRG neurons G-013” program was applied to transfect the 
neurons. The cuvette was taken out of the device and recovery media (RPMI 1640 + 1% FBS) 
was added to the cell mixture to 500 µl final volume, after which the cells were carefully 
transferred to a 500 µl Eppendorf tube and placed to the incubator for about 5-10 minutes, 
or until the laminin coating was washed off the slides or dishes. After the recovery step, cells 
were spun down on a small bench centrifuge for about 10 seconds, then resuspended in full 
DRG media and seeded onto TIRF slides or dishes. When cells were plated onto dishes, 
initially only a 100 µl cell suspension was plated to leave cells to settle on the surface, and 
they were flooded with additional 2 ml of full media after an hour. The next day, half the 
media was changed to fresh media. It was determined using a GFP construct included in the 
transfection kit that after 1 DIV, most transfected neurons expressed GFP in only the soma 
and occasionally in neurites, and by 4 DIV GFP expression increased substantially, and it 
appeared in the extensive neurite net (figure 2.6.2). The transfection efficiency was on 
average 20% (measured after 1 DIV and 4 DIV from one culture). In subsequent experiments 
it was determined that 2 DIV (~ 40 hours) was sufficient to express the pHluorin and 






Figure 2.6.2 DRG neurons expressing GFP after transfection by electroporation. GFP expression is 
shown after 1 and 4 DIV on the left, and merged with DIC on the right to show expression in the 
whole culture. After 1 DIV (top), GFP expression is largely restricted to the soma. After 4 DIV 




2.7. Western blot 
Sample lysis 
2 DIV neurons were washed with PBS once then lysed with ice cold RIPA buffer 
containing protease inhibitors. The volume of lysis buffer used depended on the well format 
cells were cultured in, eg. DRG neurons from one mouse on two wells of a 12 well plate 
were lysed with 150 µl lysis buffer. Cell lysate was collected into a 1.5ml tube and vortexed 
for one minute. In case of whole brain lysates, mouse brains were cut into smaller pieces 
and homogenized for about two minutes using a motor pestle. Tubes were incubated at 4°C 
in an end-over-end rotator for an hour, and were vortexed for one minute every 15 
minutes. Samples were then spun down at 11,000 x g for 20 minutes at 4°C and 
supernatants were stored at -20°C until protein quantification. 
Protein quantification and sample preparation for loading 
Samples were analysed using a BCA kit according to manufacturer’s instructions. 
Briefly, DRG or brain lysates were diluted to 1/50 or 1/100 respectively, then samples and 
BSA standards were pipetted into a 96 well plate in triplicates. Following the addition of the 
BCA reagent, the plate was incubated at 37°C for 2 hours, and the optical density at 595 nm 
was measured using a plate reader. Sample protein concentrations were interpolated from 
a standard curve that was generated in Prism software using a second order polynomial fit.  
Samples were kept on ice at all times. To prepare sample for loading, the required 
amount of protein from lysates was mixed with 25% laemlli buffer containing 10% β-
Mercaptoethanol as a reducing agent and lysis buffer to have the same final volume for all 
samples. Samples were then heated up to 95°C for 5 minutes, then briefly spun down and 
cooled on ice for another five minutes or frozen down at -20°C before loading. 
SDS-PAGE and protein transfer 
12% resolving gel and 4% stacking gel was made according to the recipes in section 
2.5.2 above. Gels were then placed in a gel tank, which was filled up with running buffer and 
samples were then loaded on to the gel. Samples were then run at 100-120V typically for 2 – 
2.5 hours.  
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For protein transfer, transfer buffer was made according to the recipe in section 2.5.2. 
The sponges, filter papers and nitrocellulose membrane were soaked in the transfer buffer, 
and assembled with the gel in a plastic cassette. This transfer sandwich was then placed in a 
tank and topped up with 1 litre of transfer buffer, and ran for 1 hour at 100V.  
Antibody staining and visualization 
Following protein transfer, the membrane was blocked using milk-TBST for 1 hour at 
room temperature, and then incubated with primary antibodies in milk-TBST overnight at 
4°C. Next day the membrane was washed three times for 15 minutes in TBST and incubated 
in the secondary antibody mixture (1/5000 dilution in milk TBST) for 1 hour at room 
temperature. The membrane was washed three times for 15 minutes in TBST, then dried 
and imaged in a LI-COR device.  
 
2.8. DNA extraction from ear samples 
Ear samples were obtained from Syt4 mice for genotyping. The tissue was digested in 
200µl lysis buffer (100mM Tris, 5mM EDTA, 200mM NaCl, 0.2% SDS) containing 0.5 mg/ml 
Proteinase K (03115 836 001, Roche) at 55°C for about 3 hours or until the tissue was 
completely dispersed. To inactivate the enzyme, the temperature was increased to 95°C for 
5 minutes, then the samples were placed on ice for 5 minutes and centrifuged at 13,000xg 
for 10 minutes at 4°C. Supernatants were retained and had 200µl ice cold isopropanol 
added. Tubes were gently inverted a few times until DNA fibres appeared, followed by 
centrifugation at 13,000xg for 15 minutes at 4°C. Supernatants were discarded and the DNA 
pellets washed with 70% ethanol, followed by a final centrifugation step for 10 minutes at 
4°C. Supernatants were discarded and DNA pellet resuspended in 40µl endotoxin free H2O 







2.9. PCR genotyping 
The following master mix was used for the Syt4 PCR reactions:  
 
Master mix recipe 
Final 
concentration 
5x Taq Buffer (M891A, 
Promega) 
 1x 
MgCl2 (25mM, A351H, 
Promega) 
1.5mM 
Forward primer (10µM, wt / 
mutant) 
0.4µM 
Reverse primer (10µM) 0.4µM 
dNTP(10mM) 0.2mM 








For each DNA sample, two PCR reactions were set up (one for each forward primer), 
then the reaction was carried out using the following program: 
1) Denaturation: 94°C 5 min 
2) Denaturation: 94°C 1 min 
3) Annealing: 55°C 1 min 
4) Elongation: 72°C 1 min 
5) 30 cycles (29 
times go to step 
2) 
  
6) Final elongation 72°C 5 min 
7) Final hold 12°C  




Samples were then loaded on to a 2% agarose gel containing SYBRsafe DNA gel stain 
(S33102, Invitrogen) and ran for about 1 hour at 120V.  
 
2.10. Immunoprecipitation 
For syt4 immunoprecipitation and mass spectrometry analysis, cultured DRG neurons 
(1DIV) were treated with external solution containing 100ng/ml NGF for 30 minutes. Cells 
were washed with PBS once and then cell lysate and protein quantification was done as 
described above (2.7.2). Typically 30-50µg (3-4%) of protein was retained for western 
blotting as input lysate. The rest of the lysate, containing about 800 µg protein was then 
pre-cleared with 25µl of sepharose A/G beads (ab193262, Abcam) for 1 hour at room 
temperature with end-over-end rotation. The sample was spun at 800 x g for 1 minute and 
the supernatant retained. 5 µg anti-synaptotagmin 4 antibody was added and incubated for 
1 hour at room temperature with end-over-end rotation, after which the pre-cleared 
sepharose beads were added back and left overnight at 4°C with end-over-end rotation. 
Next day the sample was spun at 800 x g for 1 minute and the supernatant retained. Beads 
were washed three times with lysis buffer, then proteins were eluted by heating at 70°C for 
20 minutes in 100 µl laemmli buffer with 25mM Tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP, Sigma-Aldrich, 646547). Eluted proteins were then either frozen down 
or further processed for mass spectrometry.   
 
2.11. Mass spectrometry 
The below protocol was provided by and used with the help of Mark Collins at The 
University of Sheffield. All steps described in sections “Mass Spectrometry” and “Proteomics 
data analysis” were carried out by Mark Collins in the Biological Mass Spectrometry Facility.  
Coomassie staining and gel cutting 
Before gel loading, eluted samples were alkylated by incubating with 50mM 
iodoacetamide (Sigma-Aldrich, I6125) for 30 minutes at room temperature. Samples were 
then loaded onto a 12% acrylamide/SDS gel and ran at 120V for about 2 hours. Gels were 
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then fixed in a 40% methanol/2% acetic acid solution for 30 minutes and stained overnight 
with colloidal coomassie solution containing 20% methanol and 20% coomassie stain (B-
2025, Sigma-Aldrich) in H2O to visualise protein bands. The next day gels were destained 
with 20% methanol for an hour before cutting out the syt4 bands at around 50 kDa. The gel 
pieces were then collected in Eppendorf tubes containing 50% acetonitrile/50mM 
ammonium bicarbonate, and destaining was continued at 37°C with shaking at 600 rpm. The 
destaining solution was replaced every hour, five times in total until gel pieces were 
colourless, at which point 1 ml of 100% acetonitrile was added to the gel pieces for 15 
minutes. 
Digestion 
Enzyme solution was prepared from bovine trypsin (90057, Pierce MS grade) and used 
at 1 ng/µl in 50 mM ammonium bicarbonate solution. Gel pieces were digested for 1 hour at 
37°C with shaking at 700 RPM, then temperature was reduced to 25°C and digestion 
continued overnight.  
Protein extraction 
The next morning, 100% acetonitrile was added to each sample and incubated at 37°C 
with shaking at 600 RPM for 20 minutes. Supernatants were collected, and 0.5% formic acid 
was added to the gel pieces and incubated at 37°C with shaking at 600 RPM for 20 minutes. 
100% acetonitrile was then added to the samples, followed by a further incubation at 37°C 
for 20 minutes. Supernatants were collected and the procedure repeated twice, after which 
100 ul 100% acetonitrile was added to each sample and incubated at 37°C for a further 15 
minutes. Supernatants were once more collected and peptide mixtures dried down.  
Mass Spectrometry 
Extracted peptides were re-suspended in 0.5% formic acid and analysed by nano-liquid 
chromatography tandem mass spectrometry (LC-MS/MS) on an Orbitrap Elite (Thermo 
Fisher) hybrid mass spectrometer equipped with a nanospray source, coupled with an 
Ultimate RSLCnano LC System (Dionex). The system was controlled by Xcalibur 2.1 (Thermo 
Fisher) and DCMSLink 2.08 (Dionex). Peptides were desalted on-line using a micro-
Precolumn cartridge (C18 Pepmap 100, LC Packings) and then separated using a 60 min 
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reversed phase gradient (4-32% acetonitrile/0.1% formic acid) on a PepMap C18 column, 15 
cm x 50 µm ID, 2 µm particles, 100 Å pore size (Thermo). The Orbitrap Elite was operated 
with a cycle of one MS (in the Orbitrap) acquired at a resolution of 60,000 at m/z 400, with 
the top 20 most abundant multiply-charged (2+ and higher) ions in a given chromatographic 
window subjected to MS/MS fragmentation in the linear ion trap. A Fourier-transform mass-
spectrometry (FTMS) target value of 1E6 and an ion trap MSn target value of 1E4 was used 
and with the lock mass (445.120025) enabled. Maximum FTMS scan accumulation time of 
500 ms and maximum ion trap MSn scan accumulation time of 100 ms were used. Dynamic 
exclusion was enabled with a repeat duration of 45 s with an exclusion list of 500 and 
exclusion duration of 30 s. 
Proteomics data analysis 
MS data were analysed using MaxQuant version 1.6.0.16 (PMID: 19029910). Data was 
searched against a mouse UniProt sequence database (downloaded June 2015) using the 
following search parameters: trypsin with a maximum of 2 missed cleavages, 7 ppm for MS 
mass tolerance, 0.5 Da for MS/MS mass tolerance, with acetyl (Protein N-term), oxidation 
(M) and phosphor (STY) set as variable modifications and carbamidomethylation (C) set as a 
fixed modification. A protein false discovery rate (FDR) of 0.01 and a peptide FDR of 0.01 
were used for identification level cut offs. Label free quantification was performed using 
MaxQuant calculated protein intensities with matching between runs (with a 2-minute 




Coverslip coating for immunofluorescence 
For methods requiring cells being plated onto a glass surface, the culture surface was 
coated with 0.1% (2.5mg/µl) poly-L-lysine (PLL). PLL drops were pipetted on the glass and 
incubated for 1 hour at room temperature, after which the plates or dishes were washed 





Prior to fixation, cells were washed once with PBS and then fixed with 4% 
paraformaldehyde/4% sucrose for 10 minutes on ice. Cells were washed again with PBS 3 
times and permeabilised with PBS containing 0.2% Triton for 15 minutes, followed by 
blocking for 2 hours with a mix of 1% bovine serum albumin and 5% normal donkey serum 
(NDS) in 0.02% of PBS-Triton. Primary antibodies were prepared in blocking solution 
containing 2% NDS and cells were incubated overnight at 4°C. Next day the cells were 
washed 3 times for 15 minutes in 0.02% PBS-Triton and incubated in secondary antibodies 
for 2 hours at room temperature. They were washed again 3 times for 15 minutes in PBS, 
and the coverslips mounted on glass slides in mounting media (Vectashield, Vector labs, H-
1000). 
 
2.13. CGRP ELISA 
Plate coating for western blotting and ELISA  
For Western blotting and ELISA, cells were plated onto laminin-coated 12- or 96 well 
plates, respectively. 20 uM laminin was pipetted in the centre of the wells and kept at 37°C 
for two hours. Wells were washed with PBS twice, then plates were kept in incubator with 
PBS in the wells to prevent laminin coating from drying out.  
 
ELISA procedure 
To measure CGRP release from DRG neuron cultures, for each experiment, cells from 
one mouse were plated on to a 96 well plate into 9 wells, to have 3 replicate wells for each 
stimulation condition: control, KCl treated and capsaicin treated (figure 2.13). Plating DRG 
neurons from each mouse into the same number of wells (9) ensured lower variability in the 
number of cells between experiments. Neurons were maintained for three days in full 




Figure 2.13 Typical layout of ELISA experiments. All DRG neurons from one mouse were plated onto 
9 well in a 96 well plate and cultured for 3 days. At 3 DIV, wells were treated with control solution 
(“B” – basal), KCl solution (“KCl”) or capsaicin solution (“Cap”) in triplicates. Supernatants from each 
well were transferred to a corresponding designated well on the ELISA plate to measure CGRP 
content.  
 
For the stimulation, media was removed and cells were washed with pre-warmed 
external solution once, followed by 30 minutes incubation at 37°C in either 60 µl normal 
external solution, high potassium solution or normal external solution containing capsaicin. 
For NGF treatment experiments, cells were first incubated with external solution containing 
100 ng/ml NGF or control external solution for the indicated times, then the supernatants 
from 3 random wells were retained and the rest discarded. Supernatants were then either 
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directly added to the ELISA plates, or were spun at 13,000xg at 4°C for 30 minutes and 
frozen at -80°C for short term storage.  
ELISA experiments were carried out according to manufacturer’s protocol. Briefly, 
samples and standards of known concentration were added to wells coated with anti-CGRP 
along with biotinylated CGRP and anti-CGRP antibody and were incubated for 2 hours. Wells 
were then washed and incubated with streptavidin-horseradish peroxidase for an hour, 
followed by incubation with the substrate solution. The colour reaction was stopped after 
an hour using 2N HCl solution and the optical density read at 450 nm using a microplate 
reader. Results were analysed using GraphPad Prism software where the sample CGRP 
concentrations were interpolated from the 5 point standard curve with the sigmoidal curve 
fit function.  
 
2.14. Bacterial work and DNA preparation 
DNA used to transfection experiments were prepared using DH5alfa competent 
bacteria (Invitrogen, 18265-017). LB media was prepared from LB Broth granules (Fisher 
Scientific, BPE9723-2) by dissolving 25 g of granules in 1 L of distilled water. Agar plates 
were prepared from LB agar tablets (Sigma-Aldrich, L7025). Bacteria were transformed by 
adding 2µl DNA to 50µl of competent cells that were heat shocked at 42°C for 20 seconds, 
and recovered in LB media for 1 hour at 37°C without antibiotics. Bacteria were then 
streaked on agar plates containing the appropriate antibiotics and grown overnight at 37°C. 
The next day single colonies were isolated and grown in liquid culture containing antibiotics 
for 15-18 hours at 37°C. Midiprep was performed using a ZymoPURE II plasmid midiprep kit 
according to manufacturer’s instructions. Briefly, 50 ml bacterial culture per prep was 
centrifuged and the pellet lysed and passed through a DNA binding matrix, from which 








2.15. Image deconvolution and colocalization analysis 
Fixed cells were imaged on a DeltaVision/GE OMX optical microscope, using 488 nm 
and 568 nm lasers, and 60x oil planapochromat objective lense (NA 1.42). Image 
deconvolution was done automatically on the z-stacks using the DeltaVision OMX softWoRx 
6.0 software.  
Colocalization analysis was performed using the JACoP plugin (Bolte and Cordelieres, 
2006) in ImageJ. In each cell, three regions were selected near the plasma membrane, 
where Pearson’s correlations (r values) and Mander’s coefficients (MOC) were calculated on 
the image stacks. Pearson’s correlation provides an initial estimate of colocalization based 
on a scatter plot of pixel intensities in the two channels, while Mander’s coefficient gives the 
fraction of each channel that has positive values on the other channel, ie. fraction of 
channel A overlapping with channel B and vica versa. Pearson’s correlation values range 
from -1 to 1 for complete negative or positive correlation, while Mander’s coefficient gives 
values between 0 and 1 for completely non-overlapping or overlapping images. The 
resulting numbers from each cell were then pooled and statistically compared.  
 
2.16. Epifluorescent imaging for immunocytochemistry 
Epifluorescent images used for figures in chapters 3 and 5.3 were collected using a 
Leica DMIRB inverted epifluorescent microscope equipped with a Hamamatsu C4742-95 
CCD camera and a 40x objective lens with 0.7 NA. The camera was controlled using 
MicroManager software version 1.4.14. Care was taken to use the same exposure time for 
each channel between images in each experiment.  
2.17. Confocal imaging 
Confocal imaging was performed using an inverted Nikon A1 microscope, with a CFI 
Plan Apochromat VC 60x oil objective (NA 1.4) at a resolution of 4.83 pixels/µm using Nikon 






2.18. Live cell imaging  
For live cell imaging experiments, a combination of PLL and laminin coating was used 
to improve cell adhesion and survival during perfusion. TIRF grade slides (Ibidi 80196) or 
dishes (Ibidi, 81158) were first coated with PLL as described earlier, followed by laminin 
coating.  
Dye loading for calcium imaging 
For calcium imaging on figure 2.18.2, Cal-520 AM dye was used (21130, AAT Bioquest). 
1 µl 2mM (1000x) stock of Cal-520 was mixed with 1 ml of external solution and triturated 
for ~ 30 seconds with a P1000 pipette. Care was taken to protect the dye from light. Cells 
were removed from the CO2 incubator and the culture media was aspirated, followed by 
washing with external solution once. Then, 250 µl of Cal-520 AM (1x) was added to the 
imaging slide and neurons were incubated at 37 °C for 30 minutes. Cal-520 was then 
removed and replaced with external solution. Cells were recovered at 37 °C for 30 minutes 
before imaging at 31 °C.  
 




Figure 2.18.1 Schematics of theoretical background of TIRFM compared to epifluorescence 
microscopy. ϴ=incident angle, ϴc=critical angle, n1 = sample refractive index, n2 = coverslip refractive 
index. Image reused from (Mattheyses, Simon and Rappoport, 2010). 
 
All live-cell imaging in this thesis was done using TIRF microscopy. This technique 
allows the visualization of objects very close (within ~100 nm) to the solid imaging surface 
(eg. coverslip or bottom of the tissue culture dish) in the evanescence field generated by a 
laser light (Axelrod, 2003). By only exciting fluorophores in this thin region, we can achieve 
very low background fluorescence and can image only those vesicles that are in the close 
proximity of the cell membrane with high resolution and low photobleaching of the cells. To 
achieve total internal reflection, the incident angle of the laser beam has to be larger than a 
critical angle. In this case the laser beam reflected back from the sample without crossing 
through it, but the energy of the laser generates an electromagnetic field called the 
evanescent field. The width of the evanescent field depends on the incident angle and the 
sample refractive index must be less than the coverglass reflactive index to achieve TIRF. In 
our case, the refractive index of the slides used was 1.52, while the refractive index of 
aqueous solutions (such as the external solution used) is ~1.3.  
For experiments in this thesis, a Ti-NS N-STORM microscope was used, equipped with 
488nm, 561nm and 647nm lasers and a Semrock Quad filter. The microscope was connected 
to an Andor DU-897 X-8714 camera and cells were viewed using a SR Apo TIRF 100x 
objective lens. Temperature was maintained at ~ 31°C. Exposure time was set to 50 ms for 
each experiment, to get a 10 fps acquisition rate for each of the two channels (red and 
green) for the dual colour experiments; for single colour experiments, this was set to 100 
ms. Image size was set to 512x512 with no binning. Laser alignments and TIRF illumination 
were done manually before each experiment. For laser alignment, the laser light was 
switched on and then dials connected to mirrors that direct the laser beam were used to 
correct the laser path to hit a reference point above the microscope. At this point, the 
microscope was in epifluorescent mode. The TIRF illumination was set up on the computer 
software using a scrolling wheel controlling a motor to gradually increase the incidence 
angle, while the sample illumination was visually observed. TIRF illumination was achieved 
when the background fluorescence suddenly dropped, the sample appeared bright and 
contrasted, and further increase of the incidence angle resulted in no fluorescence 
excitation being observed.  
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Cells were carefully chosen for each experiment that had the optimal level of protein 
expression (cells that were not too bright). A perfusion pump was used to perfuse the 
external or KCl solution on the cells. It was determined empirically that it took ~3 min 40 
seconds for the solution to reach the imaging chamber using slow, 1 ml/s perfusion speed, 
and a valve was used to manually switch between the solutions that were running in the 
same tube. Due to this, the KCl solution mixed with the external solution (this was visualised 
using a blue dye) and likely resulted in a gradual rather than abrupt increase in KCl 
concentration around the cells and non-synchronised stimulation of the culture, which was 
visualised using calcium imaging (figure 2.18 below). Thus, for each experiment the imaging 
was started about 3 minutes after switching to the KCl solution, resulting in a ~30-40 
seconds baseline followed by recording for another 2-3 minutes. Because the exact time at 
which KCl reached and stimulated the cells could not be precisely determined, we were 
unable to analyse the timing of fusion events with respect to stimulation. Typically 3-4 cells 
were recorded from each chamber and 10-15 minutes washout/rest period was allowed 
between cells using continuous perfusion of external solution.  
 
Figure 2.18.2 Calcium signals in DRG neurons after KCl stimulation. Cells that were loaded with Cal-
520 were used to test our stimulation setup. Cells were continuously imaged after opening 40 mM 
KCl, dotted line at 3 minutes shows when the recording was normally started for the live-cell imaging 
experiments in this thesis. The KCl reached cells after about an additional minute and induced 





Live-cell recordings were analysed in ImageJ 1.52n. To analyse pHluorin recordings, a 
circular region of interest (ROI) was manually drawn around each event (typically 0.6-0.8 µm 
in size, but this depended on the size of the event which in some cases was around 1.3 µm) 
using the oval selection tool. The fluorescence time course from each channel was 
measured from each ROI using the multi measure function in ImageJ, and exported into 
Excel. For background subtraction, to correct for photobleaching and also for fluorescence 
changes originating from outside the ROI, rectangular ROIs were selected near the fusion 
events at a cellular region that did not have any detectable vesicle fusion events or vesicle 
movements within it. Fluorescence from the background ROIs was also exported into Excel, 
and subtracted frame-by-frame from the fusion event time-courses. As the fusion events on 
our videos were not temporally synchronized and occurred at different times after 
stimulation, they were manually aligned in Excel using the “offset” function for the initial 
peak of fluorescence to start at 4 seconds (figure 2.18.3). 
Previous studies have shown that the fluorescence increase upon VAMP2-pHluorin 
fusion occurs in a fraction of a second (<100 ms), and it may have a plateau phase lasting 
from 1 s to several seconds, followed by an exponential decay phase (Gandhl and Stevens, 
2003; Tsuboi and Rutter, 2003; Obermüller et al., 2005). To examine whether similar 
behaviour can be observed in sensory neurons, we measured three parameters to describe 
an event: the absolute fluorescence increase upon fusion (amplitude), the half-height 
duration (HHD or event width) and the decay time-constant (τ), figure 2.18.3 C. The 
fluorescence increase at fusion was almost always rapid and occurred within 1-2 frames; 
this is due to the fact the protons escaping through the fusion pore are less likely to be 
limited by pore size (proton diameter=0.1 nm, compared to initial pore diameter of 1-2 nm 
(Barg, Olofsson and Rorsman, 2001). The HHD of the fluorescence trace can be used to 
describe the time while the fluorescence stayed near maximum, and is thought to 
approximate the fusion pore open time (Malarkey and Parpura, 2011). The fluorescence 
decay time may represent either vesicle endocytosis and reacidification during KR fusion, or 
vesicle collapse into the membrane during FF (Wang et al., 2017). Bafilomycin, a vesicular H+ 
ATP-ase inhibitor can be used to distinguish between these two fusion types, as during KR 
events bafilomycin prevents vesicle reacidification, slowing down the decay of the 
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fluorescence signal but will not affect FF events (Dean et al., 2009; Rao et al., 2014). In this 
thesis however, we did not distinguish between FF or KR events and used the above 
described three parameters (amplitude, decay time and HHD) to describe fusion events 
using different pHluorin constructs.  
 
 
Figure 2.18.3 Detecting fusion events with pHluorin. A, neurites from a DRG neuron that was 
transfected with syt7-pHluorin. Yellow circles (ROIs) indicate regions where vesicle fusion events 
were detected (ie. sharp increase in fluorescence). B, An example pHluorin trace in green, showing 
the HHD and exponential decay fit for decay time-constants (τ) in black. Red trace shows the 
corresponding NPY-mCherry signal decreasing upon fusion as the NPY cargo is released. C, montages 
on the left show three examples of events with different fusion/endocytosis kinetics (scale bars = 0.5 
µm, red star indicates fusion), the corresponding traces are shown on the right. Top: the event 
disappears abruptly with a fast exponential decay back to baseline, middle: the fluorescence decays 
linearly after fusion with slightly slower kinetics, bottom: the fluorescence stays at its maximum 




Another important consideration when interpreting decay time constant is that the 
diffusion rate of the pHluorin-tagged proteins from the vesicle membrane to the plasma 
membrane will affect the fluorescence signal. The diffusion rate of syt7 is ~1 μm2/sec in 
artificial liposomes, while it is faster, around 2.5 µm2/s for VAMP and other SNAREs (Bacia et 
al., 2004; Dittman and Kaplan, 2006; Vasquez et al., 2014). These diffusion rates will be 
affected by interactions with other proteins in a cellular environment; but nevertheless our 
measurements of syt- and VAMP-pHluorin decay times in chapters 4 and 6 might partly 
reflect differences in the protein diffusion rates.  
 
 
Figure 2.18.4 Analysis of pHluorin fusion events. A, example of an event (shown over the total 
recording period , 1800 frames or 180 seconds) before background subtraction (purple line, 
“event”), after background subtraction (green line, “event-bg”) and the local background (bg) in light 
brown. Arrow indicated the time of fusion. B, examples of several background-subtracted events 
before temporal alignment, coloured arrows show the time of fusion for each colour-matched event. 
C, the same events as on B after temporal alignment, shown on a 20 s (or 200 frame) time scale. 






Amplitude and HHD were calculated in Origin Pro, and decay time was calculated in 
GraphPad Prism from the background subtracted fluorescent traces. To measure amplitude 
and HHD, the traces were plotted and analysed using the “quick peak finder” function in 
Origin (figure 2.18.5). Amplitudes were measured inside an ROI window from 3-5 s, using 
the following settings:  
ROI box:  
3-5, fixed  
Baseline:  
Mode: constant (Yminimum) 
Range: Curve within ROI 
Find Peaks:  
Direction: Positive 
Peak finding settings: Local maximum (1)  
Peak filtering: By number (1) 
Rest of the settings were automatic; in the quantities tab, make sure “Height” is ticked. 
 
Figure 2.18.5 Example pHluorin traces and settings for HHD measurements on OriginPro. Yellow 
box indicates the “ROI” box. 
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Therefore, the absolute values of fluorescence increase were measured and reported 
as amplitude. The same “quick peak finder” function was used to calculate HHD but with the 
following settings:  
ROI box:  
2.5-15, fixed  
Baseline:  
Mode: constant (Yminimum) 
Range: Curve within ROI 
Find Peaks:  
Direction: Positive 
Peak finding settings: Local maximum (1)  
Peak filtering: By number (1) 
Area:  
Integration from Baseline 
Rest of the settings were automatic; in the quantities tab, make sure “HHD” is ticked. 
 
Figure 2.18.6 Example pHluorin traces and settings for HHD measurements in OriginPro. Yellow 




As the above example shows, the HHD measurements were reliable with fast decaying 
events (eg. the HHD result for event 1 on figure 2.18.6 was 1.35), but in case of very slowly 
decaying events, these measurements had a cut-off due to the fixed ROI and were less 
reliable (eg. the HHD result for event 2 on figure 2.18.6 was 10.2 s).  
Exponential decay time constants were measured in GraphPad Prism by fitting the 
background-subtracted traces with a “one-phase decay” function, with the starting point set 
to 4 s (peak of fluorescence). In case of slowly decaying events that could not be fit with an 
exponential curve within our time window (4-20 s), those were placed in a 40 s bin. 
Frequency histograms were also plotted in GraphPad Prism using the bin sizes specified in 
each figure legend. To generate averaged traces for figures, the background-subtracted 
traces were first normalized in GraphPad Prism using the built-in “normalize” function 
where 0 and 1 was defined as the first and the largest value in each dataset.  
Kymograph analysis 
KymoAnalyzer v1.01 plugin in ImageJ was used to analyse Syt4mCherry trafficking 
dynamics. KymoAnalyzer is an open source plugin that was developed by Neumann et al. 
(Neumann et al., 2017) that is available at https://www.encalada.scripps.edu/kymoanalyzer, 
and the analysis was performed according to the authors’ user’s manual. Briefly, 
kymographs were generated from neurites and vesicle movements were tracked using the 
polyline tool in ImageJ. The software then calculated the vesicle motility parameters 
(velocity, pause duration and frequency, mobile vesicles, etc.) from each kymograph, which 
were then pooled from different experiments for statistical analysis in GraphPad Prism. Data 
distribution normality was tested in the software, and Mann-Whitney test was used to 
compare data sets.  
Statistical analysis 
All statistical analysis was done in GraphPad Prism software and mean ± SD is shown 
on in results unless otherwise stated. To calculate significance between soma and neurites 
in chapter 4, due to the smaller n numbers student’s two-tailed t-test was used. In cases of 
larger data sets in chapter 6, normality distribution was determined using the built-in 
“Normality and lognormality test” in Prism, as well as by visually inspecting the frequency 
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histograms of each dataset. As most of the data in this chapter was non-normally 
distributed, non-parametric Mann-Whitney test was used to compare results between two 
conditions. For figure 6.5, Kruskal-Wallis test (non-parametric one-way ANOVA) was used 
with Dunn’s post hoc test. For ELISA experiments, results for different conditions from 
independent experiments (the number of these is specified in results) were compared using 





3. Characterization of synaptotagmins in cultured DRG neurons 
3.1.  Introduction 
A limited number of studies have examined the presence of synaptotagmins in DRG 
neurons, there are only a few studies about specific isoforms (Morenilla-Palao et al., 2004; 
Wang et al., 2016; López-Benito et al., 2018). Several high throughput gene expression and 
proteomics studies done on sensory neurons found multiple isoforms expressed, though 
none looked at their role specifically. According to a large-scale RNA sequencing analysis 
done by Usoskin et. al, several isoforms are expressed in the CGRP expressing DRG neuron 
populations (figure 3.1A) (Usoskin et al., 2014). Interestingly, syt4 and syt11, two non-
calcium binding isoforms were ubiquitously expressed in almost all peptidergic populations. 
Moreover, two studies found that syt4 mRNA was 2-fold upregulated in damaged neurons 
in neuropathic pain models. Loose ligation of the sciatic nerve in mice, and tight ligation of 
the spinal nerve in rats resulted in the upregulation of syt4 (Xiao et al., 2002; Reinhold et al., 
2015). In the latter study they suggested that, since other synaptic proteins (SNAP25, 
VAMP1 and Rab3) were downregulated, and syt4 is generally considered an inhibitory 
isoform, perhaps the changes occurring after nerve damage serve to reduce synaptic 
activity. 
One study that performed proteomic profiling of the membrane-enriched fraction of 
DRG neuron lysates did identify syt1, 2 and 11 in this fraction, but their protein abundance 
only slightly but not significantly changed in neuropathic (spared nerve injury, meaning the 
transection of two branches of the sciatic nerve) and inflammatory (Complete Freund’s 
Adjuvant (CFA) administration) pain models (Rouwette et al., 2016). In this study, the 
authors also identified SNAP25, VAMP1 and Rab3 but only Rab3 was significantly 
downregulated and only in the neuropathic pain model. The reason for these differences 
between studies is not clear but it is possible that these proteins are more strongly 
downregulated on the mRNA level following injury but their protein levels are more even at 
the membrane, which the study by Rouwette et al. focused on. 
Another proteomic study that analysed the protein content of the LDCV fraction in 
DRG neurons identified syt2 (Zhao et al., 2011). Furthermore, in an unpublished proteomics 
study from M. Nassar and M. Collins at the University of Sheffield, syt11, 2, 4, 6 and 5 were 
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identified in order of abundance in DRG neuron lysates (figure 3.1B). Based on the findings 
of the above studies we decided to initially focus on two Ca2+ -binding and two non-Ca2+ -
binding isoforms. As syt4 was identified as a possible target in the neuropathic pain models 
(Xiao et al., 2002; Reinhold et al., 2015) and that both syt4 and syt11 proteins were 
ubiquitously expressed in the neuropeptide expressing population (figure 3.1A) and were 
abundant in full DRG lysates (figure 3.1B), we decided to pursue these two proteins further 
despite the fact that they are non-Ca2+ binders. As for the Ca2+ -binders, syt2 was both 
abundant in whole DRG lysates (figure 3.1B) and was specifically expressed in the 
peptidergic population that express high levels of CGRP (figure 3.1A), moreover this protein 
is known to be abundant in the spinal cord  (Marquèze et al., 1995; Berton et al., 1997). 
Finally, although it wasn’t identified in the above mentioned studies, we also decided to 
focus on syt7 as its mRNA was expressed in all of the peptide expressing DRG neurons 
(figure 3.1A), and its Ca2+-binding properties make it an ideal candidate for slower LDCV 
exocytosis (section 1.2.6). We started our investigation by using immunocytochemistry and 
western blotting to characterize syt expression in our culture system. Our main goal was to 
identify possible candidates that might have a role in controlling peptide secretion, 










Figure 3.1 mRNA and protein expression of different synaptotagmin isoforms in DRG neurons. A, 
mRNA expression of the indicated syt isoforms in the DRG neuron populations that express the 
neuropeptides CGRP (Calca) and Substance P (Tac1). The populations defined by Usoskin et. 
al(Usoskin et al., 2014) are peptidergic (PEP) and nonpeptidergic (NP). Colour coding from blue to 
bright yellow indicate the level of mRNA expression. Synaptotagmins shown have been selected as 
the isoforms that have the highest expression in peptidergic neurons and are of interest. B, syt11, 2, 
4, 6 and 5 (in order of abundance) were identified in a proteomic study done by M. Nassar and M. 
Collins at the University of Sheffield, where they analysed the proteome of whole mouse DRG 
lysates. Relative abundance is the IBAQ number that was plotted for each protein (the total protein 





3.2. Syt2, 4, 7 and 11 are expressed in cultured DRG neurons 
We assessed syt expression in cultured DRG neurons using two techniques. Western 
blotting was used to validate antibodies in cells cultured from knockout (KO) mice and to 
assess general protein expression in the syt4 mouse strain which was used in later chapters 
(see Methods). All of the syt antibodies recognize the more easily accessible, cytoplasmic 
part of the proteins (see details about antibodies in Materials). The syt2, 4 and 7 antibodies 
were validated using KO mice (figure 3.2.1 and 3.2.2). For syt2 and 7, whole brain lysates 
were used for this purpose due to their known strong expression in this tissue, and GAPDH 
was used as a loading control. The syt2 antibody recognized a band at ~60 kDa, which 
disappeared in the KOs, while GAPDH was unaffected. Although the molecular weight of all 
synaptotagmins is around 47 kDa, they often appear at higher molecular weights due to 
oligomerization with other proteins (see section 1.2.6), and according to the antibody 
specifications, the syt2 antibody products on our blots were at the expected weight. It also 
weakly labelled two additional bands at lower molecular weights which are probably 
nonspecific labelling, as they persisted in the knockouts. The syt7 antibody recognized 
multiple bands between ~40-60 kDa, corresponding to the various splice variants of syt7 
(Sugita et al., 2001), which disappeared in the KOs. Once again one strong band at ~40 kDa 
persisted in the KO lysate, while GAPDH labelling was unaffected. Thus, both of these 
antibodies exhibited some non-specific activity. 
 
Figure 3.2.1 Validation of the specificity of syt2 and syt7 antibodies in knockout brain lysates. A, 
syt2 western blot of wild type (syt2+/+), knockout (syt2-/-) syt2<tm1b>, and also C57/bL6 wild type 
mouse brain lysates. D, syt7 western blots of knockout (syt7-/-) and wild type (Syt7+/+) syt7<tm1b> 
mouse brain lysates. GAPDH staining was used as loading control. 
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The syt4 antibody was validated in DRG neurons cultured from KO syt4 mice, as part 
of the experiments to determine the expression of the various syt isoforms in the DRG 
neurons. In these experiments, various amounts of protein from the DRG lysates were 
loaded onto the gels, and the t-SNARE syntaxin 1 (STXN1) was used as a neuron specific 
loading control; unexpectedly however, STXN1 staining appeared consistently weaker in 
syt4 KO DRG lysates (figure 3.2.2 and 3.2.3). Whether this is genuinely due to down-
regulation of STXN1 in syt4 KO mice is unclear, as is why or how the expression of syt4 
would affect STXN1 expression (for discussion, see section 3.5).   
Similarly to syt2 and syt7 antibodies, the syt4 antibody also labelled several non-
specific bands in the DRG lysates (figure 3.2.3A). At the expected molecular size of ~42 kDa, 
just below a persistent band at ~45 kDa, the syt4 staining disappeared in the KOs, indicating 
the location of the syt4-specific band. Unfortunately we were unable to validate the syt11 
antibody, but according to source specifications the antibody recognizes a band at ~65 kDa 
corresponding to syt11, although several additional bands were observed in our blots (figure 
3.2.2B). Interestingly, especially the syt11 but also the syt2 staining was weaker in the cells 
cultured from syt4 KO mice, while syt7 signal was largely unaffected by genotype (figures 
3.2.2B and 3.2.3B). Regarding overall expression in cultures, Syt2 and 7 required more 
protein lysate to be loaded on the gels for strong bands (40-60 µg protein, figure 3.2.2A) 
while syt4 and 11 produced strong bands in ~ 10 µg protein lysate (figure 3.2.3A), suggesting 
that syt2 and 7 have lower expression levels compared to syt4 and 11. This agrees with the 
mRNA levels detected by Usoskin et al. (figure 3.1A), and suggest that sy2 and 7 may have 




Figure 3.2.2 Western blots of syt2 and 7 in DRG neurons cultured from syt4+/+ and syt4-/- mice. A, 
blots of the calcium-binding syt2 and syt7. 20, 40, 60 µg protein was loaded as indicated above the 
blots. Note the multiple syt7 bands corresponding to multiple splice variants. Syntaxin 1 (STX1) was 
used a neuronal loading control. B, Quantification of syt2 and syt7 protein expression (n=2 blots). 
Their signal was not normalized to STX1, as STXN1 expression was affected by the genotype, we 





Figure 3.2.3 Western blots of syt4 and 11 in DRG neurons cultured from syt4+/+ and syt4-/- mice. A, 
blots of the non calcium-binding syt4 and 11. 5, 10, 20 µg protein was loaded as indicated above the 
blots. Note on the syt4 blot, the antibody recognizes a double band at 45 kDa but only the lower 
band is absent in the knockout. Syntaxin 1 (STXN1) was used as neuronal loading control. B, 
Quantification of syt4 and syt11 protein expression (n=2 blots). Their signal was not normalized to 
STXN1, as STXN1 expression was affected by the genotype, we presented the raw signal values 
instead (STXN1 values were pooled from the 4 blots).   
 
To assess the population-level expression of synaptotagmin isoforms, DRG neurons 
were cultured from wild type C57/bL6 mice and immunostained for syt2, 4, 7 or 11 and 
CGRP, a marker of peptidergic neurons. Cells were initially imaged on an epifluorescent 
microscope, but as synaptotagmin expression was low as suggested from western blots 
above and antibody specificity was poor, the fluorescence signal was weak and therefore we 
switched to using confocal microscopy. All images were then analysed by comparing the cell 
fluorescence to the mean no primary control fluorescence + 3 times SD to decide whether a 
cell was positive for a marker. These results showed that the co-expression of syt2 with 
CGRP was the highest, 54% on average (n = 89 cells from 3 cultures), while syt4, 7 and 11 
had a co-expression of 30, 39 and 33% respectively (n = 68, 77 and 44 cells from 2 
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experiments, figure 3.2.6A).  We can conclude that while all isoforms colocalized with CGRP 
in the culture to an extent, they were expressed at varying degree in CGRP negative cells as 
well. As expected from high protein levels in DRG lysates, syt4 had a ubiquitous expression 
in the culture, suggesting that its function is not limited to a certain population. As expected 
for a vesicular localization, all isoforms had a punctate staining pattern, but syt4 also had a 
strong Golgi/ER-like staining pattern in most cells (arrows on figure 3.2.4 A), as reported 
previously in other cell types (Ibata et al., 2000), consistent with it having a role in vesicle 
maturation and trafficking in multiple populations of DRG neurons as supported by the 
ubiquitous expression (Ahras, Otto and Tooze, 2006). Interestingly, we consistently 
observed syt2 staining in the nucleus (figure 3.2.4 B). At this point it is unclear whether this 
is real staining or non-specific binding of the antibody, as to our knowledge syt2 nuclear 
staining has not been observed before but the antibody clearly has non-specific targets 
(figure 3.2.1A).  
Soma size is a common descriptor used to categorize DRG neuron populations (see 
section 1.1.2), thus we also looked at the size distributions by measuring the Feret 
diameters of differently labelled cells. This showed that most of the examined proteins were 
expressed in small to medium size neurons (20-30 µm in diameter). Syt7 and syt11 mostly 
marked small diameter neurons (<20 µm), while CGRP, syt2 and syt4 marker a wider range 
of soma diameters (figure 3.2.6 B). Taken together, syt2, 4, 7 and 11 are all expressed in 
cultured DRG neurons as detected by western blots and immunofluorescence, and are all 






Figure 3.2.4 Syt4 and 11 immunofluorescence in cultured DRG neurons. A-B, confocal images of 
neurons immunostained for CGRP and syt4 or syt11. Areas on merged images indicated with white 
rectangles have been enlarged and are shown as gray-scale images on the right. Arrow on the 
bottom right image on A point at Golgi structures in the syt4 staining. Images have been contrast 
enhanced by 0.3% for clarity. Scale bars = 40 µm in large images, 20 µm on insets on A and 10 µm on 




Figure 3.2.5 Syt2 and 7 immunofluorescence in cultured DRG neurons. A-B, confocal images of 
neurons immunostained for CGRP and syt7 or syt2. Areas on merged images indicated with white 
rectangles have been enlarged and are shown as gray-scale images on the right. Images have been 




Figure 3.2.6 Quantification of colocalization of syt immunostaining with CGRP. A, bar graphs 
showing % of all stained neurons that were positive for both syt2, 4, 7 or 11 and CGRP (mean ± SD). 
Means are shown above the bars. B, scatter dot plot of soma diameters (µm) of cells positive for 
CGRP, syt2, 4, 7 or 11 (means ± SD are shown). 
 
3.3. Antibody validation using syt-pHluorin constructs 
In order to further validate our syt2, 4 and 7 antibodies in immunocytochemistry, 
cells were transfected with syt2, 4 and 7-pHluorin constructs that were used in later 
chapters, and labelled for the same synaptotagmins with the antibodies used above and for 
anti-GFP (figure 3.3). During imaging, the transfected cells were easily recognisable 
compared to non-transfected ones by the strong GFP signal. The red synaptotagmin signal 
(which indicated both endogenous and overexpressed syts) mostly overlapped with the 
green anti-GFP signal. This was especially striking on the neurites, where most individual 
puncta were clearly stained for both red and green (see arrows on figure 3.3 A and C). In the 
cell body of transfected cells, the overexpressed proteins accumulated around the nucleus, 
presumably in the Golgi/ER compartments, while the synaptotagmin stain also appeared 
spread out in the soma, perhaps indicating some endogenous staining. In summary, the syt 





Figure 3.3 Further validation of syt2, 4 and 7 antibodies using immunocytochemistry. A-C show 
DRG neurons that were transfected with syt4-, 7- or 2-pHluorin (green) and were stained with 
antibodies for the same synaptotagmins (red). Scale bars: A: 25 µm on large image and 10 µm on 







3.4. Colocalization analysis of synaptotagmins with CGRP in DRG neuron 
somata 
So far we have established expression of four syt isoforms in DRG neuron cultures and 
examined more specifically their expression in peptidergic neurons. As our aim was to 
identify the isoform(s) that might control peptide secretion, we next performed 
colocalization analysis of CGRP and syt labelled vesicles.  
2 DIV DRG neurons were immunolabelled for CGRP and syt2, 4, 7 or 11 and automatic 
imaging-coupled deconvolution was used to improve the resolution. Pearson’s correlation 
and Manders overlap coefficient (MOC) were used to quantify colocalization on z-stacks; we 
selected 2-3 rectangular ROIs (depending on cell size and shape) on each neuron near the 
plasma membrane for analysis, reasoning that vesicles in close proximity to the plasma 
membrane are more likely to represent a mature, releasable pool of peptidergic vesicles. 
These colocalization algorithms are sensitive to background noise and therefore positioning 
ROIs to certain regions with good contrast and many vesicles (eg. away from the nucleus) 
helped improve accuracy. Running the analysis on smaller image stacks also required less 
computing power and was therefore faster. TRPV1 has been previously reported to localize 
to CGRP containing vesicles (Meng et al., 2007) and here we used it as a control for our 
analysis of colocalization. 
We found that most isoforms had a low and occasional colocalization with CGRP which 
was highly variable between ROIs (figure 3.4 A-H). Figure 3.4I-L shows a visualization of this, 
where we plotted the red and green fluorescence along a line that was drawn through one 
of the representative ROIs, each peak represents a fluorescence puncta. These line scans 
also show that the red and green fluorescence peaks rarely overlap. The results of the 
Pearson’s correlation were 0.23 ± 0.2 for syt2 (n = 71 ROIs), 0.37 ± 0.1 for syt11 (n = 33 
ROIs), 0.26 ± 0.2 for syt7 (n = 70 ROIs), 0.28 ± 0.2 for syt4 (n = 41 ROIs) and 0.26 ± 0.2 for 
TRPV1 (n = 41 ROIs, figure 3.4M), which shows low correlation between CGRP and the 
respective proteins. We used MOC to assess the fraction of CGRP vesicles overlapping with 
the different syt isoforms, in other words what percentage of CGRP can be found on the 
respective syt-labelled vesicles. Again this was highly variable probably due to variability in 
signal/noise ratio and the automatic threshold assigned by the program; the mean MOCs 
were 0.4 ± 0.3 for syt2, 0.5 ± 0.2 for syt11, 0.52 ± 0.2 for syt7, 0.4 ± 0.2 for syt4 and 0.4 ± 0.2 
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for TRPV1 (figure 3.4N). This would suggest that in each dual labelled group, roughly 40-50% 
of CGRP would be in the respective syt-labelled vesicles, implying that multiple syt isoforms 
could reside in the same peptide-containing vesicle population. We also examined the soma 
diameters of the corresponding neurons used in the analysis and found similar results as 
before (figure 3.2.6 B); most labelled cells represented small/medium diameter range 
neurons. In conclusion, all the examined syt isoforms colocalized with CGRP to an extent but 
none was correlated with it strongly, and although syt11 had the highest Pearson’s 
correlation and syt7 the highest MOC, TRPV1 also only poorly colocalized with CGRP. 
However, as these experiments are highly dependent on antibody specificity and 





Figure 3.4 Colocalization analysis of CGRP with syt2, 4, 7 and 11. A, C, E, G are representative 
deconvolved images of labelled DRG neuron somata, scale bars = 5 µm. B, D, F, H are enlarged 
sections of the above images as indicated by white rectangles, scale bars = 0.5 µm. All images have 
been contrast-enhanced by 5% for clarity. I-L, red and green fluorescence were measured along a 5 
µm line that was fitted along a representative ROI for each syt. Normalized fluorescence is shown 
against distance. M-O, Box-and-whiskers plot of Pearson’s correlations, Manders’ coefficients and 
soma sizes, averaged from across 2-3 cultures.  
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3.5. Syt4 or syt7 KO do not affect basic CGRP release 
So far we found varying levels of colocalization and co-expression of the examined syt 
isoforms with CGRP in DRG neurons, suggesting that multiple syts are likely to contribute to 
the formation, trafficking and/or secretion of CGRP. To further evaluate the function(s) of 
syts in peptide secretion, we next measured CGRP secretion from DRG neurons isolated 
from KO mice. We narrowed our focus to syt4 and syt7 for the following reasons. Syt7 is a 
high affinity calcium sensor that is a major syt isoform on LDCVs in adrenal chromaffin cells 
and pancreatic islet cells (Gustavsson et al., 2008; Schonn et al., 2008) and has previously 
been reported to play a key  role in sustained transmitter release by serving as a sensor of 
residual calcium that builds up after repetitive stimulation which is thought to regulate the 
fusion of LDCVs not tightly coupled to VGCCs (Liu et al., 2014; Jackman et al., 2016). These 
features make syt7 a possible candidate for regulating sustained peptide release during 
chronic pain states. Syt4 on the other hand is a non-calcium binding isoform that we found 
highly expressed in DRG neurons and is upregulated in neuropathic pain (section 3.1). It is 
also primarily found on LDCVs and known to interact with syt7 in pancreatic β-cells (Zhang 
et al., 2009; Huang et al., 2018). Syt7 and syt4 KO mice both survive well into adulthood, as 
opposed to syt2 KO mice that die around P21 (Pang et al., 2006), making their use more 
accessible.  
First, DRG neurons from Syt4 KO or heterozygous (HET) littermates were cultured and 
CGRP release was measured at 3 DIV using ELISA. Cells were stimulated either with external 
solution (basal release) or 40 mM KCl or 1 µM capsaicin. KCl was chosen as a generic 
stimulant of excitable cells, while capsaicin only stimulates the TRPV1 positive cell 
population. 40 mM KCl induced a significant increase in CGRP release both in het and KO 
mice (figure 3.5 B-C). The mean increase in CGRP release was from 0.4 ± 0.1 ng/ml to 0.95 ± 
0.1 ng/ml in the KO, and from 0.3 ± 0.1 to 1 ± 0.2 ng/ml in HET mice. The mean capsaicin 
evoked CGRP release was similar in the KO and HET mice (0.75 ± 0.1 ng/ml and 0.8 ± 0.1 
ng/ml respectively), and this was significant in the HET mice (p=0.02) and nearly reached 
significance in the KO mice as well (p=0.08). Exclusion of calcium in the solution blocked 
CGRP release, showing that it was via the regulated pathway. We confirmed the KO 
genotype by immunocytochemistry and PCR; syt4 staining was markedly reduced in cells 
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cultured from syt4 KO mice (figure 3.5 A). Absence of syt4 therefore did not have a 
significant effect on basal or evoked CGRP release. 
The above experiments were repeated in Syt7 KO and wild type littermate mice. The 
mean KCl-induced CGRP release was from 0.36 ± 0.15 ng/ml to 1.4 ± 0.5 ng/ml in the wild 
type, and from 0.38 ± 0.3 ng/ml to 1.2 ± 0.5 ng/ml in KO cells, which was significant in the 
wild types, and nearly reached significance in the KOs (p = 0.06) (figure 3.5 B, C). This lack of 
significance in the KOs was however likely due to lower n number in this group. Capsaicin 
induced CGRP release to similar levels in the wild type and KO cells: from 0.36 ± 0.15 ng/ml 
to 0.9 ± 0.1 ng/ml in the wild types, and from 0.38 ± 0.3 ng/ml to 0.9 ± 0.2 ng/ml in the KO 
cells, although this was only significant in the wild types (figure 3.5 D, E). Loss of syt7 
therefore did not cause a pronounced defect in stimulated CGRP release. These experiments 
suggest that neither syt4 nor syt7 are critical regulators of stimulated CGRP secretion from 






Figure 3.5 Basal and evoked CGRP release are unaffected in syt4 and syt7 KO mice. A, 
representative epifluorescent images of CGRP and syt4 staining in syt4 wild type and KO mice. Syt4 
staining disappears in the KOs. B, CGRP release (ng/ml) from syt4 heterozygous (het) or KO mice 
after no stimulation (basal), 40 mM KCl, 1 µM capsaicin (CAP) or 1 µM capsaicin where CaCl2 was 
replaced by equimolar EGTA. Mean ± SEM are plotted, n = 3 KO and 3 heterozygous (het) mice). *p = 
0.023, **p = 0.005, ***p = 0.0007, one-way ANOVA with Sidak’s multiple comparisons. C, fold-
change in CGRP release (min-max spread with mean), normalized to baseline. D, CGRP release as on 
B, from syt7<tm1b> KO or wild type mice. N = 2 KO and 6 wild type mice. *p = 0.038, ****p <0.0001, 






Previously, several synaptotagmin isoforms were found in DRG neurons (section 3.1) 
but in this chapter we focused specifically on four isoforms: syt2, 4, 7 and 11.  First the 
expression of each isoform was confirmed in DRG neurons cultured from syt4 KO and wild 
type mice by western blotting, and by immunofluorescence in cells cultured from C57BL/6 
mice. Then, their expression and localization was correlated with that of the neuropeptide 
CGRP and found that multiple synaptotagmin isoforms are present on CGRP containing 
LDCVs, and finally functional ELISA experiments showed that syt4 and syt7 are not 
indispensible for CGRP release in cultured DRG neurons. 
 The western blots revealed high protein levels of syt4 and 11 in DRG neuron lysates 
and conversely lower protein levels of syt2 and syt7. The strong syt4 and syt11 expression is 
consistent with the result of Collins & Nassar (figure 3.1 B). Interestingly we also found 
lower protein levels of syt2, syt11 and syntaxin 1 in syt4 KO DRG lysates (figure 3.2.2 and 
3.2.3). This could be explained by a potential disruption of the ubiquitin-proteasomal 
degradation pathway as all of the above proteins are degraded through ubiquitination (Chin, 
Vavalle and Li, 2002; Hakim et al., 2016). Syt4 and syt11 are highly homologous, both can 
inhibit vesicle fusion and other synaptotagmin isoforms (Poser, Ichtchenko and Shao, 1997; 
Bhalla, Chicka and Chapman, 2008), and both have been identified as substrates of the E3 
ubiquitin ligase parkin (Wang et al., 2016). In the absence of parkin, Syt11 accumulates due 
to decreased degradation, which results in decreased dopamine release through impaired 
endocytosis and vesicle replenishment. This leads to the subsequent apoptosis of 
dopaminergic neurons and the developments of Parkinson’s disease (Wang et al., 2018). 
The protein levels of syt4 are similarly regulated by parkin and syt4 is also accumulated in 
the brains of parkin KO mice (Kabayama et al., 2017). Thus, perhaps parkin and the 
ubiquitin-proteasomal degradation pathway are reversely affected in the syt4 KO mice 
towards increased activity, which could explain the observation of weaker syt11, as well as 
syt2 and syntaxin 1 western blot bands in the syt4 KO lysates.  
The immunostaining experiments showed that syt4 was present in most neurons in 
our cultures, consistent with Usoskin et al. who found ubiquitous expression of syt4 in DRG 
neurons. Syt4 labelled Golgi-like structures as well as vesicles, as observed by punctate 
staining throughout the cell. As it has been established by multiple studies that syt4 labels 
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the Golgi and secretory vesicles in endocrine cells and neurons (Thomas et al., 1999; Ibata et 
al., 2000; Zhang et al., 2009), we can safely assume that the staining pattern seen in our 
experiments indeed shows Golgi localization. However, future experiments could address 
the colocalization of syt4 with Golgi and mature/immature secretory vesicle markers (such 
as syntaxin 6, secretogranin II, TGN38, Rab3A (Ibata et al., 2000; Fukuda et al., 2003; Ahras, 
Otto and Tooze, 2006) to strengthen this finding. The ubiquitous nature of syt4 expression 
and its localization pattern suggests that, like in PC12 cells, syt4 also likely plays a role in 
LDCV maturation and trafficking in multiple DRG neuron populations (Fukuda et al., 2003; 
Ahras, Otto and Tooze, 2006). It should also be noted however that syt4 expression is 
induced by neuronal activity (Vician et al., 1995; Ferguson et al., 1999), and as DRG isolation 
and dissociation is a major stress for cells and can even be considered as a model of nerve 
lesion (Malin, Davis and Molliver, 2007), the isolation procedure itself might as well induce 
the expression of syt4. 
Immuno-colocalization with CGRP revealed that all of the synaptotagmin isoforms 
examined were expressed in peptidergic neurons, and this was expected based on their 
mRNA expression pattern from Usoskin et al. (figure 3.1A). A second observation of the 
immunostaining experiments was the weak fluorescence signal produced by syt2, 7 and 11 
staining. A weak signal could arise due to low protein expression, which was confirmed by 
western blot for syt2 and 7, or from non-specific antibody staining. Indeed, the latter option 
was confirmed in western blots where the syt2, 4 and 7 antibodies all recognised non-
specific bands in the knockout cells. Although the syt11 antibody could not be validated, the 
discrepancy between the strong western blot signal and weak immunocytochemistry signals 
suggest that this antibody may also have non-specific targets. Non-specific staining in 
immunocytochemistry can increase background and affect the quantification, as the 
threshold to decide whether a neuron was positive or negative for a given protein was set 
based on the fluorescence intensity of no-primary antibody controls, but the synaptotagmin 
signal was often only slightly higher than the threshold.  
On the other hand, the weak staining is also likely the result of low protein expression 
in the case of syt2 and syt7, which might indicate that neurons do not need to express high 
copy numbers of these proteins as they serve highly specific functions inside the cells and 
their sorting onto vesicles is precisely controlled (Mutch et al., 2011). Low signal caused by 
low protein levels could be improved by using signal amplification techniques, for example 
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by streptavidin-based detection of biotinylated primary antibodies (Ness et al., 2003; Wang, 
Gibbons and Freeman, 2011). Nevertheless, these results indicate that syt2 and 7 are likely 
expressed in multiple DRG populations at low levels while the non-calcium binding syt4 and 
11 are expressed in multiple populations but at higher level, and that there are also likely 
overlaps between the expression patterns of the different isoforms. 
The subcellular colocalization analysis showed a similar picture to the population level, 
as all the synaptotagmin isoforms had vesicular staining but none colocalized strongly or 
exclusively with CGRP. The low colocalization of multiple syt isoforms with CGRP could 
suggest that they all play a role in regulating secretion. As the same staining procedure was 
used for these and the co-expression experiments, the same limitations also apply here. It 
was shown before that on average there are about 7-15 syt1 molecules on one SV, but 
much fewer, about 5-6 are sufficient to trigger Ca2+ -dependent release (Takamori et al., 
2006; Mutch et al., 2011; Dittrich et al., 2013). Though there might be more molecules on 
the larger LDCVs, due to the low copy number per vesicle one can expect low fluorescence 
signal even in high resolution images. Two types of colocalization algorithms were used in 
this thesis: Pearson’s correlation is sensitive to low signal-to-noise ratio but does not require 
a threshold, while the MOC analysis requires the user to set a threshold on the images 
(Bolte and Cordelieres, 2006; Dunn, Kamocka and McDonald, 2011). This is automatically 
calculated by the program but if the fluorescent spots are not bright enough compared to 
the background, then the threshold is set too low and the program calculates false positive 
colocalization. The threshold can be adjusted by the user to only include brighter spots, this 
however introduces bias. All the above complications could have resulted in the high 
variability of colocalization seen in our results. 
The difficulty of analysing colocalization of any subcellular structures smaller than 200 
nm will remain when using diffraction-limited light microscopy. Significant advances have 
been made in the past ~ten years in developing super-resolution imaging methods that go 
far beyond the diffraction limit and can be used to precisely visualize the molecular 
architecture of small organelles such as secretory vesicles and quantify colocalization. These 
techniques include stimulated emission depletion (STED), stochastic optical reconstruction 
microscopy (STORM), structured illumination microscopy (SIM) (Sahl, Hell and Jakobs, 2017), 
and they can even be combined with electron microscopy (Schirra and Zhang, 2014; Peddie 
et al., 2017). Such techniques could be utilized to visualize and accurately measure the cargo 
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content of vesicles harbouring one or multiple syt isoforms, and unambiguously answer the 
question whether multiple syt isoforms reside on the same vesicle and thus regulate vesicle 
fusion depending on which isoform is activated by local Ca2+ concentration, or whether 
different syt isoforms define distinct vesicle pools that possibly contain different cargoes or 
have different release probabilities (Schonn et al., 2008; Gustavsson and Han, 2009; Rao et 
al., 2014)  
Besides investigating the colocalization of synaptotagmins with CGRP to give us hints 
about their role in peptide release, functional experiments were also used to assess syt4 and 
syt7 function. CGRP ELISA experiments on cells cultured from syt4 or syt7 KO mice did not 
find strong evidence that either of these isoforms affect basal or evoked CGRP release. 
Constitutive KO of genes can generate developmental changes that lead to functional 
compensation of the KO phenotype. Such effect has been observed for syt7 in SV 
exocytosis; neurons cultured from syt7 KO mice exhibited normal synaptic transmission in 
one study, but in a later study the same group showed that knockdown of syt7 eliminated 
asynchronous neurotransmitter release using multiple shRNAs and rescue experiments 
(Maximov et al., 2008; Bacaj et al., 2013). However, deletion of syt7 significantly reduces 
LDCV exocytosis in chromaffin cells and pancreatic B cells without genetic compensation 
(Gustavsson et al., 2008; Schonn et al., 2008). Thus further experiments using selective syt7 
knockdown should reinforce our findings in DRG neurons.  
A similar compensatory mechanism is possible in the case of syt4 as well, although 
studies done on syt4 KO mice consistently found enhanced LDCV exocytosis and secretion 
using different stimulation protocols. These studies found increased oxytocin secretion in 
the hypothalamus (70 mM KCl stimulation) (Zhang et al., 2011), increased BDNF secretion in 
the hippocampus (unstimulated, basal release over 2-3 days) (Dean et al., 2009), and 
increased LDCV exocytosis in low (but not high) Ca2+ concentration in the posterior pituitary 
nerve terminals (Zhang et al., 2009). Although we did not find such increase in secretion in 
syt4 KO mice using our stimulus conditions (continuous 40 mM KCl or 1 µM capsaicin), but 
different stimulations can induce different calcium signals and high frequency electrical 
stimulation induces more peptide and BDNF release in DRG neurons than continuous KCl 
depolarization (Balkowiec and Katz, 2000; Bost et al., 2017). Overall, these ELISA 
experiments showed that syt4 and syt7 are not involved in basic and evoked CGRP release 
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from DRG neurons, but different stimulation paradigms (such as different KCl 
concentrations of electrical stimulation) could also be tested in syt4 and syt7 KO/KD cells. 
So far we established that peptidergic DRG neurons express both Ca2+-binding and 
non-binding synaptotagmin isoform and that multiple isoforms are likely to be involved in 
regulating CGRP secretion as the colocalization analysis suggests. Deletion of syt4 or 7 did 
not significantly change basal or evoked CGRP release as measured by ELISA, but the 
increased syt4 gene expression in neuropathic pain models mirrors the increased 
neuropeptide expression (see section 3.1) and suggests that at least syt4 might be involved 
in pathological conditions. As syt4 is thought to serve its function at least partially by 
interacting with other isoforms, such as syt7 (section 1.2.6, (Mendez et al., 2011; Huang et 
al., 2018), subsequent experiments aimed to investigate the involvement of syt4 and syt7 in 






4. Studying single vesicle fusion in DRG neurons using pHluorin 
constructs 
4.1. Introduction 
Fluorescently tagged synaptic proteins (for example VAMP2, synaptophysin, VGLUT, 
synaptotagmins) coupled with high resolution imaging techniques provide a powerful tool 
for studying exo-endocytosis and, so long as the transfection protocol used to express the 
tagged proteins in target cells is properly optimized, this technique can be minimally 
invasive. Many different indicators of neuronal activity exist that are based on fluorescent 
proteins (Lee et al., 2016; Lin and Schnitzer, 2016), but we decided to use the pH indicator 
pHluorin. This molecule was created from GFP by shifting its pH sensitivity which results in a 
decreased fluorescence at acidic pH (~5.5) and increased fluorescence at higher (~7.4) pH 
(Miesenböck, De Angelis and Rothman, 1998). When a pHluorin molecule is tagged to the 
luminal domain of a vesicular protein, the fluorescence inside the acidic vesicle lumen in 
quenched but is increased rapidly upon vesicle fusion (figure 1.4.2). Thus by tagging 
pHluorin to different vesicular proteins, one can study their function in exo-endocytosis. 
This technique has been widely used, especially in pancreatic islet cells and CNS neurons 
(Obermüller et al., 2005; Rao et al., 2014; Xu et al., 2017), and in the recent years in DRG 
neurons as well (Bost et al., 2017; Wang et al., 2017; Shaib et al., 2018).  
The aim of these experiments was to establish a pHluorin-based assay of exocytosis in 
DRG neurons in our laboratory. Our first choice of fusion detector was VAMP2-pHluorin, 
which despite exhibiting relatively high surface expression (~ 15%) (Balaji and Ryan, 2007) 









4.2. Establishing exocytosis assay in DRG neurons using VAMP2-
pHluorin 
We set out to optimize the imaging and analysis of pHluorin fusion events using TIRF 
microscopy. Neurons from C57/bL6 mice were transfected with VAMP2-pHluorin and 
imaged 2 days later on a TIRF microscope. Because of the microscope setup, electrical 
stimulation was not possible and thus cells were stimulated by perfusion of 40 mM KCl for 3 
minutes. It should be noted that the number of cells that we could record from per culture 
was restricted (3-4 recordings could be made per dish or slide before the culture started 
perishing, times ~2-4 dishes or slides per experiment), and furthermore because the 
capsaicin sensitive (TRPV1 positive) neurons are only a fraction of the whole DRG culture 
and we could not identify those cells at the start of the experiment, we decided not to use 
capsaicin stimulation.  
Individual fusion events were highly variable in their amplitude and decay time course 
but the fluorescence rise was almost always rapid (within ~ 0.2 s) (figure 4.2.1). The HHD 
distribution (Figure 4.2.2 D) shows that the majority of events had a short (<1 s) open time 
with a median of 0.66 s, and decayed fast with a median of 0.65 s with a few slower events 
(figure 4.2.2 E). Only 2 out of 178 events did not decay exponentially and thus could not be 
fit with an exponential decay curve, these events appear as a separate 40 s bin on figure 
4.2.2 E. We then divided events according to cellular location (ie. soma or neurites) because 
there is evidence that pHluorin events differ on different locations (Dean et al., 2012) (figure 
4.2.1). There were 165 events on the soma and only 13 on the neurites, but neurite events 
had significantly larger HHD (the median was 2.1 on the neurites compared to 0.65 on the 
soma, figure 4.2.2 B), but the decay times and amplitudes were similar (figure 4.2.2A, C). 
These results show for the first time in DRG neurons that VAMP2-pHluorin reports fusion 
events with a brief pore open time and fast decay, especially compared to the syt4 and syt7 







Figure 4.2.1 Detection of VAMP2-pHluorin labelled vesicle fusion events using TIRF microscopy. A, 
TIRF images of a representative soma and neurites, with yellow circles showing fusion events. B, 
representative examples of somatic and neurite events. C, average time-courses (mean ± SD) of 




Figure 4.2.2 Graphs of syt2-pHluo amplitude, HHD and decay time.  A-C, scatter plots of VAMP2-
pHluorin amplitudes, HHD and decay times on the soma and neurites. ***p <0.0001, two-tailed t 
















4.3. Detecting peptide release using NPY-pHluorin 
VAMP2 is an essential SNARE protein that may be present on different types of 
vesicles (SVs and LDCVs) and is therefore a nonselective vesicle marker. In order to correlate 
exocytosis to peptide release, we conducted experiments using NPY-pHluorin. Since the 
start of this PhD two studies have used NPY-pHluorin in DRG neurons to study the 
mechanism of exocytosis and found that NPY release occurs with fast kinetics (~1 s) but had 
conflicting findings with regard to the type of fusion (kiss-and-run or full fusion) that KCl 
stimulation induces (Bost et al., 2017; Wang et al., 2017). Thus here we aimed to explore 
the NPY-pHluorin release kinetics induced by our KCl stimulation. 
We recorded 22 release events from three cells from C57/bL6 mice and analysed them 
similarly to VAMP2-pHluorin. All events were recorded from the soma, and were very fast, 
usually lasted only one frame in our recordings (figure 4.3 A-D). 13 events appeared diffuse, 
without a well-defined puncta at fusion, and their signal disappeared within one frame (100 
ms) without detectable spreading of fluorescence (figure 4.3 B). In 6 cases there was visible 
diffusion of the signal for 2-3 frames after fusion which can be interpreted as a full fusion of 
the vesicle and total content release (figure 4.3 A), and in 2 cases it was unclear whether 
there was diffusion. It is possible that in the 13 events with diffuse profile but no visible 
signal spreading, the NPY-pHluorin release and signal diffusion was faster than our temporal 
resolution ( <100 ms), while in those 6 cases where the spreading could be observed, 
content release was slower (2-300 ms). Indeed, the median decay time was 0.09 s, and the 
median HHD was 0.13 s (figure 4.3 E, F). There was one event that had a well-defined dot 
upon fusion which quickly disappeared without spreading, which could indicate a fast 
transient opening of the fusion pore (kiss-and-run) without NPY release and fast 
reacidification. The median fluorescence increase upon vesicle fusion was 1896 (figure 4.3 
G). These results show that the neuropeptide NPY is secreted from the soma of sensory 





Figure 4.3. Tracking peptide release using NPY-pHluorin.  A, examples of NPY-pHluorin release 
events. Top: two events are shown where the fluorescence signal visibly spreads out from the dot, 
probably indicating full fusion (FF) of the vesicle. Bottom: two events where the dot disappears 
without spreading of fluorescence (no diffusion), indicating fast release/pore closure. Scale bars = 1 
µm. B, schematic diagram of NPY-pHluorin. C, representative examples of NPY-pHluorin fluorescence 
time-courses. D, average NPY-pHluorin time-courses (mean ± SD, n = 22). E-G, distributions of event 
widths, decay times and amplitudes, events are shown as % frequency. Bin widths = 0.02 (E), 0.05 (F) 





4.4. Syt2-pHluorin mediated exocytosis has distinct fusion kinetics 
between soma and neurites 
Thus far we have established that VAMP-pHluorin can be used as a reporter of 
exocytosis in DRG neurons and that these neurons release NPY after KCl stimulation. In 
order to start investigating the involvement of chosen synaptotagmins in regulated 
exocytosis in DRG neurons, first we transfected cells with syt2-pHluorin, which reports SV 
fusion in hippocampal neurons (Dean et al., 2012), but has not been used in endocrine cells 
before to study LDCV exocytosis. 32 events were observed from four cells from across three 
transfections (syt4+/- mice); 56% (17/30) from neurites (figure 4.4.1 B) and 43% (13/30) from 
the soma (figure 4.4.1 A), example events for each category are shown in figure 4.4.1 C-D. 
The time-courses were normalized and averaged on figure 4.4.1 E, and this showed that 
averaged neurite and somatic events were only different in the late phase of decay. The 
amplitudes were similar on the soma and on the neurites, with mean increase of 2284 ± 908 
on the soma, and 1762 ± 1466 on the neurites (figure 4.4.2 A). The fluorescence decay times 
were also similar between cellular locations and the mean decay time was 1.53  ± 1.3 s on 
the soma and 4 ± 9 s on the neurite, while the medians were 0.53 and 0.9 respectively 
(figure 4.4.2 C). On the neurites, there was one event that could not be fit with an 
exponential decay function, this appears in a separate 40 s bin on the pooled frequency 
histogram (figure 4.4.2 E). There was significant difference between the mean HHD on the 
soma and neurites; this was 0.8 ± 0.3 s on the soma and 2.8 ± 2.2 s on the neurites (figure 
4.4.2 B). Overall, the characteristics of fusion events observed with syt2-pHluorin were 
different from those observed with VAMP2-pHluorin as revealed by longer decay times and 
HHD. Furthermore, the difference observed in the HHD between the neurites and the soma 





Figure 4.4.1 Comparison of syt2-pHluorin fusion events on the soma and neurites. A, montage of 
an example somatic event, red star above the 0.2 s frame indicates the initial time of fusion (scale 
bar=0.5 µm). TIRF image of the cell body underneath, yellow circles indicate syt2-pHluorin fusion 
events, scale bar=5 µm. Corresponding graph on C shows example time courses. B-D, same for 




Figure 4.4.2 Graphs of syt2-pHluo amplitude, HHD and decay time.  A-C, scatter plots of sy2-
pHluorin amplitudes, HHD and decay times on the soma and neurites. **p=0.0041, two-tailed t test. 




4.5. Syt4-bearing vesicles can release NPY and have differences in their 
fusion kinetics between soma and neurites 
Next, we transfected DRG neurons with a syt4-pHluorin construct. The role of syt4 in 
regulated exocytosis is less well understood and cargo release from syt4 containing vesicles 
needs to be confirmed, thus we also transfected neurons with NPY-mCherry in these 
experiments.  
Overall 33 syt4-pHluorin events were analysed from five cells from across four 
transfections. 57% (19/33) were observed on neurites and 42% (14/33) on the soma (figure 
4.5.1 E, similar percentages as for syt2-pHluorin above). Generally, syt4 events were slow 
(ie. decayed slowly over time), example time-courses from neurites or soma are shown 
figure 4.5.1 C. The averaged syt4-pHluo time-courses on the soma and neurites appeared 
different (figure 4.5.1 D). Indeed the average HHD was significantly larger on the neurites, 
4.9 ± 1.6 s compared to 3.5 ± 1.3 s on the soma (figure 4.5.2 C), although the fluorescence 
decay times were similar (figure 4.5.2 D). Most events had a short decay time of less than 2 
second with a median of 1.4 s, and only 2 out of 33 (6 %) events did not decay exponentially 
(figure 4.5.2 F). There were some apparent differences between soma and neurite syt4-
mediated fusion events and events with slower and faster kinetics were observed (examples 
are shown on figure 4.5.2 A), with the slower ones dominating on the neurites. These slower 
events also appeared as a second peak at ~7 s on the pooled HHD histogram (figure 4.5.2 E). 
Additionally, somatic events were significantly smaller in amplitude; the fluorescence 
increase was 1262 ± 431 on the soma compared to 3218 ± 2806 on the neurites (figure 4.5.2 
B).  
One could expect that a longer HHD (and possibly more stable fusion pore) on 
neurites might correspond to more cargo release, however we observed the opposite as 
concomitant NPY release was observed less frequently on the neurites (figure 4.5.1 E). On 
the soma, eight out of 14 syt4 bearing fusing vesicles contained NPY and it was released 
from seven vesicles; on the neurites however only five out of the 19 fusing vesicles 
contained NPY and it was only successfully released in two cases. Thus, larger HHD does not 
necessarily allow more content release from vesicles. Overall this data shows that vesicles 
undergoing exocytosis and releasing neuropeptides are positive for syt4, and the apparent 
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differences in fusion and NPY release properties between the soma and neurites suggest 













Figure 4.5.1 Comparison of Syt4-pHluorin fusion events on the soma and neurites. A, an example 
syt4pHluorin event with NPY release. Scale bars = 1 µm, red star above the 0.4 s frame indicates the 
initial time of fusion. White circles highlight the NPY-mCherry puncta. B, TIRF images of a soma and 
neurites with yellow circles indicating fusion events. C, example time-courses of individual fusion 
events from the soma or neurites. D, average traces (mean ± SD) of neurite (n = 19) and somatic (n = 





Figure 4.5.2 Graphs of syt4-pHluo amplitude, HHD and decay time.  A, Example montages of short 
(1) and long lasting (2) syt4-pHluorin events, scale bars=0.1 µm. Red star indicates the initial time of 
fusion. B-D, scatter plots of syt4-pHluorin amplitudes, HHD and decay times on the soma and 
neurites. *p=0.01, two-tailed t test. E-F, frequency histograms of HHD (bin width=0.5 s) and decay 








In this chapter we established a pHluorin-based fusion assay and analysis in 
transfected DRG neurons using VAMP2-, NPY-, syt2- and syt4-pHluorin constructs. The first 
pHluorin based construct developed to study regulated exocytosis used VAMP2 as a 
putative selective tag for synaptic vesicles (Miesenböck, De Angelis and Rothman, 1998). 
Using bafilomycin, a V-type ATPase inhibitor that prevents the re-acidification of recycling 
vesicles, it was shown in hippocampal neurons that the decaying component of VAMP2-
pHluorin and vGlut-pHluorin (another synaptic vesicle marker) events consists of 
endocytosis with average time constant of ~ 15 s and reacidification with average time 
constant of ~ 4 s (Atluri, 2006; Balaji and Ryan, 2007). Furthermore, Balaji & Ryan were able 
to distinguish three types of vGlut-pHluorin retrieval events: fast events that were only 
dictated by reacidification, slow events that had a dwell time (τ ~ 13 s) before start of 
fluorescence decay, and very slow events that lasted longer than 40 s; similar observations 
were reported earlier following analysis of the kinetics of VAMP2-pHluorin events (Gandhl 
and Stevens, 2003) 
Subsequent studies in endocrine cells extended the use of the pHluorin tag to study 
LDCV exocytosis (Tsuboi and Rutter, 2003; Obermüller et al., 2005; Felmy, 2007; Yuan et al., 
2015). These studies found lower values compared to the studies on SV exocytosis above, as 
they reported a plateau phase of around 1 s before decaying with a time constant of 1-2 s. 
We mostly observed fast VAMP2-pHluorin events with median decay time of 0.6 s and even 
the slowest ones had τ < 4 s. This, taken together with the low HHD values measured in our 
experiments (0.6-2.1 s), suggest that VAMP2-pHluorin mostly reported fast LDCV fusion 
events in DRG neurons. We cannot rule out the possibility that some of these fast decaying 
events represented full fusion and quick spreading of VAMP2-pHluorin outward from the 
fusion site, but bafilomycin could be used in future experiments to distinguish between 
these options, as only transient fusion with subsequent reacidification would be sensitive to 
bafilomycin. 
While VAMP2-pHlurin and other membrane attached fusion proteins are useful to 
study fusion pore behaviours and vesicle endocytosis, several studies have used NPY-based 
fluorescent constructs to study cargo release as this isn’t necessarily predicted by fusion 
(Tsuboi and Rutter, 2003). A study looking at NPY-Venus secretion from DRG neurons found 
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that KCl (60 mM) stimulation mostly induced transient (KR-type) fusion events (Bost et al., 
2017). The type and dynamics of vesicle fusion (ie. pore expansion or restriction, and vesicle 
retrieval or shrinking/collapsing) are likely regulated by the spatial and temporal properties 
of Ca2+ influx generated by different types of stimulation (section 1.2.5). In support of this, 
another recent study on DRG neurons found that high (70 mM) KCl stimulation was similar 
to repetitive electrical stimulation as they both induced large global Ca2+ influx through 
VGCCs, which lead to more full fusion, while the weaker capsaicin stimulation lead to 
smaller, localized Ca2+ increase at TRPV1 channels and to more KR type fusion (Wang et al., 
2017). The low (40 mM) and continuous KCl stimulation used in our experiments might have 
induced a more diffuse elevation of Ca2+ concentration (Xia, Lessmann and Martin, 2009) 
showed using Fluo-4 imaging that 30 mM KCl induced a much smaller Ca2+ increase in 
hippocampal neurons than 90 mM KCl), resulting in mixed full fusion / transient fusion 
events.  
The above studies using NPY-pHluorin also showed that NPY release is fast and 
happens within <100 ms after fusion of vesicles in DRG neuron soma; this is in agreement 
with previous findings that NPY release can be as fast as 33 ms in bovine chromaffin cells 
(Chiang et al., 2014), and similar decay times of NPY-pHluorin release were measured in 
DRG neurons before (Wang et al., 2017). In the latter study, full fusion and KR events were 
distinguished by different HHD values (0.1 s for full fusion and 0.3 s for KR), but in our 
experiments most event widths were in the lower range (median was 0.13 s). The different 
fusion profiles that we saw with NPY-pHluorin might indicate differences in fusion pore 
dilation, as at least 6 events were full fusion as suggested by the signal diffusion, one event 
with well-defined puncta and no spreading might indicate narrow fusion pore without NPY 
release, and the rest of the events with a diffuse appearance but no visible signal spreading 
could indicate pore expansion with partial release, which was suggested to occur through 
kiss-and-run or kiss-and-stay type fusion in DRG neurons before (Bost et al., 2017). An NPY-
pHluorin molecule is ~ 40 kDa, or its largest dimension is ~10 nm (Barg, Olofsson and 
Rorsman, 2001), which would mean that if the events with no signal spreading mean fast KR 
with incomplete cargo release, then the fusion pore only expanded to around 10 nm in 
these cases. In conclusion, our results of NPY-pHluorin kinetics support previous findings 
from neurons and endocrine cells and 40 mM KCl stimulation induces mixed full fusion and 
129 
 
transient fusion events, but we cannot unequivocally conclude the ratio of these fusion 
types.  
Compared to VAMP2-pHluorin, syt2 and syt4 reported fusion events with slower 
decay and longer HHD using the same stimulation (figure 4.4.2 and 4.5.2). One 
comprehensive study described the exo-endocytosis dynamics of almost all known 
synaptotagmin isoforms fused to pHluorin in hippocampal neurons (Dean et al., 2012). 
When compared to synaptophysin-pHluorin fusion events, which exclusively marks synaptic 
vesicle exocytosis, they found that syt2 mediated fusion events exhibited SV-like features, 
consistent with its function mostly in SV exocytosis, and occurred exclusively in axons. Syt4 
evens on the other hand occurred in both axons and dendrites with slower kinetics than 
synaptophysin-pHluorin, and they were not always synchronised to the stimulation, 
consistent with LDCV-like features. An important difference between the above study and 
our system is that due to the lack of synaptic specializations, our experiments likely report 
predominantly LDCV fusion with different dynamics. Our results suggest that both of these 
syt isoforms mediate LDCV fusion with similarly slow vesicle retrieval times (pooled median 
τ was ~1.4 s for both syt2 and syt4). However, syt4-mediated fusion events had a longer 
HHD than syt2- mediated ones (1.1 s for Syt2 compared to 4.7 s for syt4), suggesting slower 
endocytosis kinetics. Studies in PC12 cells found that syt4 increased the duration of KR run 
events, but not of full fusion events (Wang et al., 2003; Zhang, Zheng and Jackson, 2010). 
This agrees with the larger HHD seen in our experiments and might suggest that syt4 
mediated events are mostly transient rather than full fusion events in the DRGs, which is 
supported by the finding that syt4 promotes KR in PC12 cells (Wang et al., 2003). On the 
other hand, VAMP2-pHluorin HHD and decay times were both shorter, suggesting that 
VAMP2 drives vesicle fusion towards faster dynamics (short pore-open times and fast 
vesicle retrieval). 
The difference between fusion parameters in different cellular locations might point at 
differences in the fusion machinery. The HHD was significantly larger on the neurites using 
each pHluorin construct, and the amplitudes were larger using syt4-pHluorin. One possible 
explanation for this observation is that there is a difference in the maturity and number of 
synaptotagmin molecules on the vesicles. Upon fusion pore opening, the proton exchange is 
instantaneous between the vesicle lumen and extracellular space, increasing the 
fluorescence of the pHluorin molecules inside the vesicles rapidly, thus in our analysis the 
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pHluorin signal amplitude likely reflects the number of pHluorin molecules inside the 
vesicle. If this is the case, it means that on the neurites more syt4 molecules were present 
on LDCVs, which could suggest the presence of more functionally mature vesicles in the 
neurites, as indeed LDCV maturation continues during trafficking from soma along the 
neurites (see section 1.2.1). Alternatively, controlling the number of synaptotagmins on 
LDCVs could have implications in stimulus-secretion coupling, and this could also explain the 
observation that VAMP2-pHluorin amplitudes were essentially the same between soma and 
neurites, as we can reasonably expect less variability in the vesicular copy number of an 
essential v-SNARE. Similar observations were made in hippocampal neurons, where exocytic 
events in neurites exhibited slower time course, prolonged fusion pore dilation and 
increased cargo release than on the soma, and the differences in fusion dynamics were 
attributed to differences in L-type Ca2+-channel distribution and corresponding Ca2+-signals 
(Matsuda et al., 2009; Xia, Lessmann and Martin, 2009). It is possible that similar differences 
exist in cultured DRG neurons where LDCVs with different number of membrane 
synaptotagmins and/or different machinery would be needed in neurites compared to 
soma, to adjust to differences in Ca2+signals. Future experiments should address the spatial 
relationship of LDCV fusion sites and Ca2+-channels in DRG neurons.  
Another, possible explanation for differences in amplitudes could be the occurrence of 
fast events that are below the temporal resolution of our acquisition rate (faster than 100 
ms). Recently the pore expansion rate was determined for the first time to be > 8.9 ± 1 
nm/ms in chromaffin cells (Shin et al., 2018), meaning that it would be plausible for a fusion 
pore to expand enough within 100 ms that some of the pHluorin molecules could start 
diffusing away from the fusion site, resulting in a lower signal amplitude. This scenario 
would suggest that there are more ultrafast events occurring on the soma; however, the 
difference in amplitude was not observed with VAMP2-pHluorin.  
The results of this study showed for the first time that syt4 mediates NPY release from 
both the soma and neurites, which provides further evidence toward syt4 being present on 
neuropeptide containing LDCVs. We have chosen NPY-based constructs to monitor peptide 
release in our live-cell imaging experiments because they have been widely used in the 
literature, while CGRP-based constructs have not been made or used before to our 
knowledge. However, peptides and specifically NPY and CGRP are mostly co-stored in DRG 
neurons (see section 1.2.1), and whether peptides and other transmitters are released 
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together or separately and whether this is regulated at the vesicle fusion stage or during 
packaging or maturation is still unclear (Merighi, 2018; Zhang et al., 2019). The size of NPY 
and CGRP are very similar (NPY ~10 kDa, CGRP ~14 kDa) and thus information we learn 
about NPY release is likely applicable to CGRP as well in terms of release properties. In 
section 3.4, we established that syt4 does not play a major role in basic and KCl or capsaicin 
evoked CGRP release, but its presence on CGRP-containing vesicles (section 3.4), the NPY 
release observed from syt4-bearing vesicles (section 4.5) and that it was upregulated in 
neuropathic pain (section 3.1) prompted us to further investigate the involvement of syt4 in 




5. Investigating the effect of NGF on neuropeptide release 
5.1. Introduction 
NGF is produced during inflammation in peripheral tissues where it activates TrkA-
expressing nociceptors, leading to increased synthesis and secretion of CGRP, BDNF and 
other neuropeptides which contribute to hyperalgesia (see section 1.1.4). This effect of NGF 
on CGRP release has been observed in vitro as well: Park et al. (2010) found that acute (30 
minute) exposure to 100 ng/ml NGF increased capsaicin, but not KCl evoked CGRP release in 
DRG neurons. Long term NGF exposure (7 days, where cells were grown in the presence of 
NGF) also increased CGRP release compared to untreated cells that were not exposed to 
NGF, but this was due to increased CGRP content in the cells. In contrast, following acute 
NGF treatment the PI3/PKC pathway and Src family kinases mediated acute sensitization of 
sensory neurons, and the authors concluded that phosphorylation of TRPV1 channels by PKC 
activation after NGF treatment can explain the increased CGRP release (Park et al., 2010).  
 
Figure 5.1 NGF signalling pathways. Acute NGF treatment and dimerization of the TrkA receptor 
leads to activation PKC and PI3K/ras pathways, which in turn phosphorylate TRPV1 and contribute to 
its sensitization in DRG neurons. Activation of the p75 receptor on the other hand activates JNK 
pathways. This pathway has been shown to result in the phosphorylation of syt4, which promotes 
the detachment of DCVs from KIF1 and microtubules (in green), and increases DCV capture at the 




Other studies looking at the effect of acute NGF on exocytosis in PC12 cells provide 
evidence for the involvement of syt4 in NGF-induced potentiation of exocytosis. A group 
found that NGF induced the sorting of syt4 onto mature LDCVs, and this involved syt4 
phosphorylation by c-Jun N-terminal kinases (JNK) (Fukuda et al., 2003; Mori et al., 2008). 
Syt4 phosphorylation was essential for the enhancement of KCl-induced transmitter release 
by NGF, but not for basal or depolarization induced release without NGF treatment (Mori et 
al., 2008). In a more recent study, Bharat et al. found that JNK also phosphorylates syt4 in 
hippocampal neurons and this leads to decreased LDCV trafficking and increased capture of 
syt4 vesicles specifically at presynaptic sites (Bharat et al., 2017). They concluded that Syt4 
phosphorylation helps in vesicle tethering at synapses but has no effect on vesicle fusion; 
however previous findings indicate that overexpressing syt4 changes fusion pore dynamics 
and syt4-bearing vesicles favour KR fusion (Wang et al., 2001, 2003). As we found strong and 
ubiquitous syt4 expression in cultured DRG neurons and our previous results suggest that it 
is present on neuropeptide containing LDCVs, we hypothesised that syt4 contributes to the 
pathway by which NGF enhances peptide release from DRG neurons, possibly through a 
mechanism involving its phosphorylation. Thus in this chapter we investigated syt4 
phosphorylation in DRG neurons using mass spectrometry and its involvement in NGF 





5.2. 30 minutes NGF treatment enhances KCl induced CGRP release in 
wild type neurons 
First we set out to confirm the CGRP release potentiating effect of NGF in our culture 
conditions. For this, 3 DIV DRG neurons were treated with 100 ng/ml NGF for either 30 
minutes or 2 hours and then stimulated with 40 mM KCl or 1 µM capsaicin for 30 minutes. 
We chose a 30 minutes and 2 hour NGF treatment times because in the study of Mori et al. 
2008, JNK/syt4 phosphorylation started after about 30 minutes of NGF exposure, and 
increased further in two hours. Our results showed that KCl stimulation increased CGRP 
release from 0.32 ± 0.13 to 1.27 ± 0.6 ng/ml in untreated cells (figure 5.2 and table 5.2), and 
this failed to reach significance (p = 0.13) likely due to large standard deviations and small n 
numbers (n = 6 data points from 2 experiments), as in other experiments KCl consistently 
induced significant increase (figure 3.5). However, following 30 minutes exposure to NGF, 
KCl induced significantly increased CGRP release, from 0.29 ± 0.16 to 1.67 ± 0.96, and 
similarly 2 hours NGF treatment also induced significant potentiation, where 0.23 ± 0.14 
ng/ml CGRP was increased to 1.53 ± 1.04 ng/ml (basal release in the NGF treated groups 
was unaffected) (table 5.2).  
With the capsaicin stimulation there was a slight trend observed, but the increase 
was not significant in either condition (0.78 ± 0.37, 1.06 ± 0.56 and 0.92 ± 0.75 ng/ml CGRP 
release in the untreated, the 30-minute and the 2-hour NGF treated groups respectively, 
table 5.2). This somewhat contradicts the findings from Park et al. who only saw a significant 
potentiation in the capsaicin response (Park et al., 2010). Nevertheless, these results point 
























Figure 5.2. Acute NGF treatment enhances KCl induced CGRP release. ELISA result showing CGRP 
release from cells cultured from C57/bL6 mice that were either untreated or treated with NGF for 30 
minutes or two hours, and then stimulated with external solution (basal), 40 mM KCl or 1 µm 
capsaicin for 30 minutes (mean ± SEM). n = 6 data points from 2 cultures, ns = not significant, *p = 









30 min NGF  2 hr NGF 
basal  0.32 ± 0.13  0.29 ± 0.16  0.23 ± 0.14 
KCl  1.27 ± 0.6  1.67 ± 0.96  1.53 ± 1.04 
Capsaicin  0.78 ± 0.37  1.06 ± 0.56  0.92 ± 0.75 
Table 5.2 CGRP release (ng/ml) as measured by ELISA in cells either untreated or 
treated with 100 ng/ml NGF for 30 minutes or 2 hours, followed by 30 minutes 
stimulation with KCl, capsaicin or no stimulation. 
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5.3. Syt4 is expressed in the majority of TrkA+ neurons 
NGF is only expected to affect those DRG neurons that express its receptor TrkA (or 
p75, though the latter can be activated by all neurotrophins, see section 1.1.4). Therefore, 
before examining the functional relationship between NGF and syt4, we assessed the 
percentage of cells that co-express TrkA and syt4. We also analysed the co-expression of 
CGRP with TrkA, which would be expected to be present in a largely overlapping population 
(Bennett, Dmietrieva, Priestley, Clary, & McMahon, 1996; Usoskin et al., 2014).  
The results showed that TrkA and syt4 were co-expressed in ~33 % (27/82) of DRG 
neurons (figure 5.3B); nearly all TrkA+ neurons however, expressed syt4 (figure 5.3C). This 
result agrees with our previous finding that syt4 is likely not restricted to a specific 
population but is widely expressed in DRG neurons. CGRP had a slightly higher colocalization 
with TrkA (42 %, 33/78, figure 5.3B), but 70% of TrkA+ neurons were also positive for CGRP 
(figure 5.3C), confirming that TrkA is largely expressed in the peptidergic population. 
Moreover, analysis of soma diameters showed that the average diameters ranged between 
13-17 µm but the majority of TrkA+ cells were small diameter neurons and these mostly 
expressed syt4 (figure 5.3D). CGRP/TrkA colocalization also largely marked small diameter 
neurons, while CGRP and syt4 alone marked a wider population of neurons. In conclusion, 
these results support the notion that NGF activates TrkA receptors on largely small diameter 
peptidergic neurons that express syt4. Whether there is a functional interaction between 





Figure 5.3 Syt4 and CGRP are both co-expressed with TrkA. A, representative epifluorescent images 
of DRG cultures immunostained for syt4, TrkA on the top and CGRP, TrkA on the bottom. Blue shows 
DAPI staining. Arrows show colocalization, arrowhead shows a cell only expressing TrkA. Scale bar = 
25 µm. B, percentage colocalization of either syt4 or CGRP with TrkA (number of co-expressing cells 
divided by total number of cells, mean ± SD from two cultures). C, box charts showing the number of 
cells that were positive for the indicated proteins. Total numbers are shown from two cultures. D, 





5.4. NGF-enhancement of CGRP release is Syt4 dependent   
In order to investigate whether syt4 contributes to NGF potentiation of CGRP release 
in DRG neurons (Figure 5.4D), we performed ELISA experiments in syt4 KO and heterozygous 
mice following 30 minutes NGF treatment. The results showed that in syt4+/- cells, there was 
a significant increase in both KCl and capsaicin evoked CGRP release in cells pre-treated with 
NGF compared to untreated controls (figure 5.4A). KCl evoked release increased from 0.47 ± 
0.18 ng/ml to 0.77 ± 0.2 ng/ml, while capsaicin evoked release increased about two-fold, 
from 0.2 ± 0.15 to 0.54 ± 0.17 ng/ml. In DRG neurons isolated from syt4-/- mice, the 
potentiation of CGRP secretion by NGF was significantly reduced following both KCl and 
capsaicin stimulation (Figure 5.4B), indicating a requirement for syt4. The above results 
suggest that the NGF induced potentiation is reduced in the absence of syt4 and this is not 
restricted to a TRPV1+ population, but is a more generic effect in all cells, as KCl induced 
release was equally affected. Taken together, the above experiments provide evidence for 
syt4 being involved in TrkA receptor potentiation of peptide secretion from DRG neurones.  
 
 Syt4+/- Syt4-/- 
Untreated control 30 min NGF Untreated control 30 min NGF 
Basal 0.19 ± 0.07 0.29 ± 0.15 0.24 ± 0.15 0.23 ± 0.07 
KCl 0.47 ± 0.18 0.77 ± 0.2 0.52 ± 0.18 0.68 ± 0.14 




Table 5.4 CGRP release (ng/ml) as measured by ELISA in cells cultured from syt4+/- or syt4-/- mice 
that were  either untreated or treated with 100 ng/ml NGF for 30 minutes, followed by 30 minutes 




Figure 5.4 The effects of NGF treatment on CGRP release is syt4 dependent. A-B, CGRP release 
measured by ELISA from cells cultured from syt4-/- and syt4+/- mice that were either untreated or 
treated with NGF for 30 minutes, followed by stimulation as in A. n = 3 independent measurements 
from 3 cultures, ***p <0.001, ns = not significant, §: p <0.05, §§: p <0.01, §§§: p <0.001, §§§§: p 
<0.0001, compared to “basal” in each group (NGF treated/untreated), one-way ANOVA with Sidak’s 
multiple comparisons. C, same as A-B but CGRP release with NGF treatment was normalized to CGRP 
release without NGF treatment in both genotypes to show the fold increase (box-and-whiskers graph 





5.5. Identification of Syt4 phosphorylation sites in DRG neurons 
As previous studies have indicated that Syt4 phosphorylation regulates its function 
(Mori et al., 2008; Bharat et al., 2017), we next examined whether the S135 site of syt4 is 
phosphorylated in DRG neurons after NGF treatment. As currently there are no available 
phosphospecific antibodies for syt4, we employed mass-spectrometry (MS) to explore 
phosphorylation sites. In order to do this, we performed syt4 immunoprecipitation (syt4-IP) 
on DRG neuron lysates prepared from four mice (figure 5.5A) to purify syt4 and then 
analysed the lysates with MS. DRG lysates were pooled from the four mice and were 
incubated with polyclonal syt4 antibody bound to sepharose beads to capture syt4. As a pull 
down control, some of the lysate was incubated with a control IgG antibody bound to 
sepharose beads which is not expected to bind syt4 specifically. Indeed, in the syt4 IP 
western blots, syt4 could be identified in the elution (E) while it was missing from the 
supernatant (S), while syt4 was detectable in the supernatant but not the elution when 
pulled down with the control IgG antibody (red rectangle on figure 5.5 A).  
There was 14% sequence coverage of syt4 in the MS analysis. Nonetheless, we still 
managed to identify four phosphorylation sites on syt4, two of which were not previously 
described.  All phosphorylation sites (like all other post-translational modification sites) fell 
between the transmembrane and the C2A domain in the cytoplasmic side (figure 5.5B, top). 
The known phosphorylation sites found were serine-114 and the putative TrkA target 
serine-135 (Mori et al., 2008). The new phosphorylation sites found were serine-115 and 
threonine-122 (figure 5.5B, bottom). Both the S135 and S114 sites were previously 
identified in a high throughput phosphoproteomic study that used a shotgun approach to 
identify phosphorylation pathways involved in glucose secretion (Sacco et al., 2016). Four 
additional high-throughput phosphoproteome profiling studies also identified the syt4 S135 
site in murine brain (Huttlin et al., 2010; Wiśniewski et al., 2010; Goswami et al., 2012; 
Lundby et al., 2012). Two studies have investigated the functional role of S135 
phosphorylation in PC12 cells and neurons (Bharat et al., 2017; Mori et al., 2008); however 
to date, the putative function of all other phosphorylation sites in syt4 are unexplored. 
While the above experiment was only carried out once and could not be repeated due to 
very limited amount of protein that we were able to purify from each mouse, but 
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nonetheless the Serine-135 phosphorylation site in syt4, which is the putative target of 
NGF/JNK signalling, was successfully identified in DRG lysates. 
 
Figure 5.5. Identification of the S135 and other phosphorylation sites in syt4 in DRG neurons. A, 
western blot of a sy4-IP and a negative control IP, where the beads were incubated with a control 
IgG antibody. I = input from the original lysate, E = elution, S = supernatant, W = wash. Red rectangle 
marks the syt4 bands. (Note that syt4 is missing from the supernatant and is present in the elution 
and wash in the syt4-IP, while it is missing in the elution and is present in the supernatant in the 
control) B, structure of syt4 (exported from www.phosphosite.org). Top image shows the full length 
of the protein, lines indicate sites of posttranslational modification according to the number of 
references (Y axis) and the type of modification (blue circle: phosphorylation, green circle: 
acetylation, orange circle: ubiquitylation). TM = transmembrane domain. Bottom, enlarged section 
of the amino acid sequence as indicated, containing the identified phosphorylation sites from our 




From the experiments above, we can conclude that syt4 has a role in NGF induced 
potentiation of CGRP release in vitro. The molecular mechanisms that allow this increased 
exocytosis are unclear, but a study that looked at the effect of both chronic and acute NGF 
treatment on CGRP release provides some useful insights (Park et al., 2010). According to 
this study, chronic (7 days) exposure to 30-250 ng/ml NGF activates a ras/MEK/ERK 
pathway, which leads to increased CGRP content in the neurons due to increased gene 
expression, but neither this nor the PI3-kinase/Akt pathway contribute to the increased 
CGRP release after acute (20 minute) exposure to 100 ng/ml NGF. PKC and src family kinases 
on the other hand are required for potentiated secretion after acute NGF treatment. PKC 
may be acting as a downstream phosphorylation target of src (Joseloff et al., 2002) in this 
pathway, and phosphorylates TRPV1 channels to increase channel activity and peptide 
release (Bhave et al., 2003; Wang et al., 2015).  
The low-affinity NGF receptor, p75 however also activates a number of signalling 
proteins, one of which is JNK. Others have demonstrated that JNK leads to the 
phosphorylation of syt4 at serine-135, and although we have preliminary data confirming 
this phosphorylation site in DRG neurons (section 4.5), further studies are needed to 
establish whether phosphorylation of S135 is regulated through NGF signalling, and should 
also determine the relative contribution of syt4 to PKC-dependent pathways as described 
above. As we found that deletion of syt4 reduced but did not abolish the NGF-potentiation 
of CGRP release, we can assume that multiple pathways may contribute an additive effect, 
the net outcome of which is increased CGRP release. It is also important to determine if syt4 
is the downstream target of both receptors, or only of p75. Since p75 is a non-specific 
neurotrophin receptor, if syt4 phosphorylation happens through p75 activation then it is 
reasonable to assume that other neurotrophins could also engage this signalling pathway to 
increase peptide secretion. Therefore, here we showed for the first time that syt4 
contributes to the increased CGRP release following acute NGF exposure in DRG neurons, 




6. The effects of syt4 and its phosphorylation on syt7-mediated 
exocytosis and fusion kinetics 
6.1. Introduction 
To better understand the role of phosphorylation and the mechanisms by which syt4 
may help enhance release, we looked at vesicle exocytosis using the previously established 
imaging methods (chapter 4). In this chapter we first show that syt4 and 7 are trafficked 
together to a population of vesicles. Syt4 and 7 were found to interact before using 
proximity ligation assay in pancreatic beta cells, where syt4 inhibited syt7-mediated insulin 
secretion in mature beta cells (C. Huang et al., 2018). To assess whether syt4 and syt7 
colocalization has functional implications in sensory neurons, we analysed syt7 fusion 
events with or without syt4-mCherry, as well as in a syt4 knockout (KO) background. 
Additionally, to investigate the role of syt4 phosphorylation in the proposed NGF activated 
pathway, we double transfected cells with syt7-pHluorin and syt4 S135 phosphomutants 
that were created by site-directed mutagenesis (the target of NGF activation). The same 
syt4 mutation was tested previously in hippocampal neurons and was found to decrease 
mobility and increase capture of LDCVs at synapses (Bharat et al., 2017). Although multiple 
studies have examined the interaction of different synaptotagmin isoforms, and generally 
established that syt4 inhibits the function of other syts (section 1.2.6, also see (Bhalla et al., 
2008; Littleton et al., 1999)), interestingly, one study found that syt4 did not have any effect 
on the secretion rate or decay time of syt7-mediated fusion in PC12 cells, only on that of 
syt1 and syt9, but it did inhibit syt7-mediated fusion in liposome fusion assays (Zhen Zhang 
et al., 2011). The study by Bharat et al. however only looked at the function of syt4 
phosphorylation, not whether it interacts with other syts or whether phosphorylation 
affects these interactions. Thus, at the end of this chapter we aimed to study the effects of 




6.2. Overexpressed syt7 and syt4 can be trafficked to the same vesicles, 
where syt4 may affect syt7-mediated fusion 
We wanted to investigate directly if exogenously expressed syt4 and syt7 can be 
functionally targeted to the same secretory vesicles and whether this had any functional 
significance on syt7 mediated vesicle release. For this, Syt4+/- cells were transfected with 
syt7-pHluorin and wild type syt4-mCherry, and stimulated with 40 mM KCl while imaging on 
a TIRF microscope. Eight out of 28 co-transfected neurons examined responded to the 
stimulation, and overall 120 syt7-pHluorin fusion events were detected from across three 
transfections. First we examined their distribution according to cellular location and found 
that 24% (29/120) were on the soma while 76% (91/120) were in the neurites; a higher 
percentage of syt7 events colocalized with syt4 in the neurites (figure 6.2.1E).  As was 
expected, syt4-mCherry fluorescence did not change at the time of fusion as can be seen on 
the example montage on figure 6.2.1 A. Thus, syt7 mediated exocytic events follow the 
trend that was observed with syt2 and syt4, namely that there are more events on the 
neurites compared to the soma.  
Fusion of syt7-pHlourin vesicles showed varied kinetics in their rate of decay as well 
as amplitude depending on their cellular location. The averaged fluorescent traces of syt7-
pHluorin showed different rates of decay between soma and neurites (figure 6.2.1 D). As 
was seen with syt2- and syt4-pHluorin, syt7-pHluorin events were significantly larger in 
amplitude on the neurites compared to the soma (median = 4985 and 1259 respectively, 
figure 6.2.1 F). Neurite syt7-pHluorin events decayed significantly slower (median = 7.1 
compared to 1.5 at the soma, figure 6.2.1 H). Additionally, 24% of events on the neurites did 
not decay exponentially and were placed in a 40 s bin, while all somatic events could be fit 
with an exponential function (figure 6.2.1 H). With regards to HHD, this was also significantly 
larger on the neurites (median was 7.4 on the neurites and 4.5 on the soma, figure 6.2.1 F). 
These results support the evidence from chapter 4 that the kinetics of fusion events 
occurring at the soma of sensory neurons is different from those at neurites.  
To investigate whether overexpression of syt4 alters syt7 fusion, we separated 
events according to presence or absence of syt4-mCherry at the fusion site. The majority of 
the syt7 events (76%, 89/120) had no syt4-mCherry associated with them compared with 
24% (29/120) which clearly also had syt4-mCherry. In this analysis however we cannot rule 
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out the presence of endogenous syt4 on vesicles that had no syt4-mCherry signal; 
nonetheless the implication of this result is consistent with the view that trafficking of syt4 
to vesicles inhibits their fusion. The analysis of the time courses of syt7-pHluorin events with 
or without syt4-mCherry revealed that those associated with syt4-mCherry decayed more 
slowly (figure 6.2.2 A). The median decay time was 16.8 s for the Syt7-pHluorin+Syt4-
mCherry group and 4.7 s for the Syt7-pHluorin only group. It was observed that 44% of Syt7-
pHluorin+Syt4-mCherry events could not be described by a single exponential, suggesting a 
very slow endocytosis/reacidification, while this was only observed in 17% of the Syt7-
pHuorin only events. Syt7-pHuorin HHD was also significantly larger in the presence of syt4-
mCherry (median = 9.1 s) than in its absence (median = 6.3s, figure 6.2.2 C). The HHD 
frequency distributions also showed a shift of syt7-pHluorin events towards larger HHD in 
the presence of syt4-mCherry (figure 6.2.2 E, F), which may suggest that overexpression of 
syt4 shifts syt7-mediated fusion towards slower kinetics. The median of syt7-pHluorin event 
amplitudes was also significantly larger in the presence (8569) than in the absence (2459) of 
syt4-mCherry (figure 6.2.1 B). These results suggest that the fusion kinetics of vesicles 








Figure 6.2.1 Syt7-pHluorin fusion events differ on the soma and neurites. A, montage of a syt7-
pHluorin event with syt4-mCherry. Scale bar = 1 µm, red star above the 0.6 s frame indicates the 
initial time of fusion. B, TIRF images of example soma or neurites, with yellow circles indicating 
fusion events. C shows corresponding examples of syt7-pHluorin events. D, averaged time-courses 
(mean ± SD) of syt7-pHluorin events from neurites (n = 90) and soma (n = 29). E, pie charts showing 
the number of syt7-pHluorin events that occurred with or without syt4-mCherry on the same vesicle. 
F-H, scatter plots of syt7-pHluorin amplitudes, HHD and decay time on the soma and neurites. 




Figure 6.2.2 Syt4-mCherry favours syt7-mediated events with slower kinetics. A, averaged time-
courses (mean ± SD) of syt7-pHluorin events with (n = 29, orange symbols) or without (n = 91, green 
symbols) syt4-mCherry at the same vesicle. B-D, scatter plots of syt7-pHluorin amplitudes, HHD and 
decay time with or without syt4-mCherry. Black lines indicate medians. **p=0.01 on C and 0.002 on 
D, ****p<0.0001, Mann-Whitney test. E-F, frequency histograms of syt7-pHluorin events with or 




6.3. The kinetics of syt7-pHluorin events are altered in syt4-/- mice  
In the previous experiments, the effects of overexpressing syt4-Cherry on syt7-
mediated vesicle fusion were monitored in syt4+/- cells and found that the expression of 
syt4-mCherry slowed fusion kinetics. To better understand the possible impact of Syt4 on 
Syt7-mediated vesicle fusion, we transfected syt4-/- DRG neurons with syt7-pHluorin and 
compared these events to events recorded from syt4+/- neurons (see section 6.3). Due to the 
limited number of knockout mice in our colony, only two transfection experiments were 
possible; four out of 10 transfected neurons responded to KCl stimulation with measureable 
increases in pHluorin fluorescence. Similar to previous observations, the majority of fusion 
events (89%, n=18) were detected in the neurites; comparisons were made therefore 
between events observed in the neurites from DRG neurons isolated from syt4+/- and syt4-/- 
mice. 
Analysis of the kinetics of syt7-pHlourin events in the neurites revealed that fusion 
events in syt4-/- DRGs have faster kinetics of decay than events in syt4+/- DRGs (figure 6.3 A). 
This was reflected in a shorter decay time (median = 3.6 s in the syt4-/- compared with 26.4 s 
in the syt4+/- cells, figure 6.3 D), while the HHD remained similar in both groups (8.5 and 8.8 
s in the syt4+/- and syt4-/- cells, respectively). Analysis of the decay time frequency 
distributions showed that in the absence of syt4, there was a higher percentage of fast 
decaying events, while there was a higher percentage of events in the 40 s bin in the 
presence of syt4 (those that did not decay exponentially). This suggests that the presence of 
syt4 promotes syt7-pHluorin events with slower decay.  
Comparison of the fluorescence amplitudes also revealed significantly lower values in 
the KO neurons (medians were 2529 and 9435 in the syt4-/- and syt4+/- cells respectively, 
figure 6.3 B). This is in agreement with the previous results (figure 6.2 B), but what this 
difference in the event amplitudes reflects exactly is unclear (see discussion, section 6.6). 
Taken together, the results of this and the previous section indicate that syt4 and syt7 can 
be trafficked to the same secretory vesicles in sensory neurons and provide evidence that 




Figure 6.3 The kinetics of syt7-pHluorin events is altered in syt4-/- mice. A, averaged fluorescence 
time courses (mean ± SD) of syt7-pHluorin fusion events in syt4-/- (n = 18) and syt4+/- (n = 27) cells. B-
D, scatter plots of syt7-pHluorin amplitude, HHD and decay time in syt4-/- and syt4+/- cells. *p=0.02, 
****p <0.0001, ns = not significant, Mann-Whitney test. Black lines indicate medians. E-F, frequency 
distribution of syt7-pHluorin decay times in syt4-/- and syt4+/- cells. Bin width is 1 s in the first section 
of the graph, the second section shows the 40 s bin containing those events that could not be fit 





6.4. Trafficking dynamics of Syt4-S135A and S135E-mCherry  
Having established that syt4 favours longer lasting fusion events, we next investigated 
whether syt4 phosphorylation at the S135 site alters its influence on Syt7 fusion dynamics. 
We used the previously described phosphomutants: the phosphodeficient S135A and 
phosphomimetic S135E syt4 tagged to mCherry (Bharat et al., 2017). In these 
phosphomutants, a serine at the 135 site in the syt4 protein was changed to either an 
alanine or a glutamic acid to yield the phosphodeficient and phosphomimetic syt4 mutants 
respectively. First, we performed kymograph analysis to monitor their impact on vesicle 
trafficking dynamics. Kymographs and measurements of vesicle mobility (speed, pause 
duration, pause frequency) and the number of mobile vesicles were assessed and pooled 
from neurons imaged in the absence of any exogenous stimulus. Although information 
about directionality of vesicle movement (ie. anterograde or retrograde) has been extracted 
from the analysis, but we are unable to ascribe it as anterograde or retrograde, ie. whether 
the vesicle tracked was moving towards or away from the soma. This was because sensory 
neurons in culture often do not recapitulate the pseudounipolar morphology observed in 
vivo but instead grow complex and highly ramified neurites whose origins are difficult to 
identify. Thus, these vesicles were pooled into a “mobile vesicles” group, regardless of 
which way they moved. Frequency histograms of vesicle velocities revealed that S135A-syt4-
mCherry and S135E-syt4-mCherry show similar distributions of speeds, but with more slow 
vesicles measured in cells expressing the S135E-syt4-mCherry mutant (figure 6.4.1F). This is 
reflected in a significantly lower mean speed of 0.7 ± 0.5 µm/s compared to 0.8 ± 0.5 µm/s 
in the S135A-syt4-mCherry mutant (figure 6.4.1B). Comparison of the pause frequencies 
between the two mutants (mean = 1.6 ± 1.9 and 1.5 ± 1.4 pauses/sec for S135A and S135E 
respectively) revealed no significant difference. The average pause duration however was 
significantly higher in the phosphomimetic s135E-syt4-mCherry (13.3 ± 22.9 s with 95% 
confidence limit (CL) of 1.8) compared to the s135A syt4-mCherry phosphodeficient mutant 
(10 ± 19.5 s with 95% confidence limit of 1.2, figure 6.4.1D). This suggests that vesicles 
bearing S135E-syt4-mCherry do not stop more frequently but their pauses last longer, 
consistent with vesicle capture and docking that would be needed to precede exocytosis. 
Additionally, there were also more mobile vesicles recorded on average in neurites 
expressing S135A-syt4-mCherry (7.8 ± 7.6, with 95% CL of 1.7) than S135E-syt4-mCherry (4.5 
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± 3.8, with 95% CL of 0.8, figure 6.4.1 E), suggesting that syt4 phosphorylation at S135 
reduces vesicle mobility.  
 
Figure 6.4.1. Kymograph analysis of syt4-S135A and S135E before stimulation. A, kymographs 
showing the tracks (coloured lines) of S135A-syt4-mCherry or S135E-ssyt4-mCherry labelled vesicles. 
Colours indicate the net directionality of the vesicle, ie. red = anterograde, green = retrograde, 
yellow = reversal, blue = stationary. B-E, pooled vesicle mobility parameters (velocity, pause 
duration, pause frequency, number of mobile vesicles, mean ± SD) of the S135A and S134E 
phosphomutants from three experiments (mean ± SD). n numbers and their meaning are indicated 
below the graphs. **p = 0.0019, ***p = 0.0005, ****p <0.0001, ns = not significant, Mann-Whitney 
test. F, G, H, distribution of indicated mobility parameters of both phosphomutants, bin width = 0.2 
µm/s on G, 1 on I, and 10 s on K.  
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We then asked the question whether 40 mM KCl stimulation affect the mobility of 
phosphomutant-syt4-mCherry bearing vesicles.  For this, we compared the vesicle mobility 
parameters before and right after the onset of stimulation (representative kymographs are 
shown on figure 6.4.2A, B). This analysis revealed that both phosphomutants had reduced 
speed during the stimulation; the average reduction was 0.11 in the S135A- and 0.09 µm/s 
in the S135E-syt4-mCherry mutant (figure 6.4.2C, G). Interestingly, the pause duration was 
slightly but significantly increased after the onset of stimulation in the S135A-syt4-mCherry 
phosphodeficient, but not in the S135E-syt4-mCherry phosphomimetic mutant (figure 
6.4.2D, H), while the pause frequencies did not change (figure 6.4.2 E, I). Thus, it appears 
that while under ‘resting’ conditions, as has been shown in the analysis above (figure 6.4.1), 
the S135E-syt4-mCherry phosphomimetic mutant pauses for longer times than the S135A-
syt4-mCherry phosphodeficient mutant (figure 6.4.2D, J), but during stimulation, vesicles 
bearing S135A-syt4-mCherry increase their pause duration to around the same level as the 
phosphomimetic S135E-syt4-mCherry bearing ones. The number of mobile vesicles 
significantly decreased with both phosphomutants during stimulation (figure 6.4.2F, J), 
suggesting increased vesicle capture. Taken together, these results suggest that stimulation 
reduces syt4 vesicle mobility regardless of phosphorylation at the S135 site, and instead this 
site might be more important for vesicle docking at potential release sites before the onset 







  Figure 6.4.2. Syt4 phosphomutants have reduced mobility after stimulation. A-B, kymographs 
showing the tracks (coloured lines) of syt4-S135A or -S135E-labelled vesicles before and right after 
the onset of KCl stimulation. Colours indicate the net directionality of the vesicle, ie. red = 
anterograde, green = retrograde, yellow = reversal, blue = stationary. C-F, vesicle mobility 
parameters (mean ± SD) of S135A before and during stimulation. **p <0.005, ***p= 0.0006, ns = 
not significant, Mann-Whitney test. G-J, same as C-F for S135E. **p <0.005, ****p <0.0001. 
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6.5. S135 phosphorylation of syt4 shifts syt7 fusion events towards 
longer pore open time  
Finally, to assess the potential effect of syt4 phosphorylation on syt7 mediated 
fusion, syt4+/- cells were transfected with syt7-pHluorin and with either S135E-syt4-mCherry 
or with 135A-syt4-mCherry. Syt7-pHluorin events were separated according to whether they 
also had phosphomutant-syt4-mCherry signal or not (therefore the three groups were 
syt7+S135A-syt4-mCherry, syt7+ S135E-syt4-mCherry, and syt7 alone).  
In the syt7-pHluorin+S135A-syt4-mCherry co-transfection experiments, overall 170 
syt7-pHluorin events were detected, 30% (52/170) of which also had S135A-syt4-mCherry 
signal (figure 6.5 A). In the syt7-pHluorin+S135E-syt4-mCherry experiments, 215 syt7-
pHluorin events were detected, 17% (38/215) of which also had S135E-syt4-mCherry signal 
(figure 6.5 B). For further analysis, syt7-pHluorin alone events were pooled from the 
different experiments and compared to syt7-pHluorin+S135A/E-syt4-mCherry events. The 
averaged time-courses of syt7-pHluorin events were similar in the different groups (figure 
6.5 C), with smaller differences in the later phase of fluorescence decay. Statistical analysis 
however revealed that there was no significant difference between either the event 
amplitudes or decay times (figure 6.5 D, F). The syt7-pHluorin amplitude medians were 
3100, 3032 and 3007 with S135A-syt4-mCherry, S135E-syt4-mCherry or with no mCherry 
signal respectively (figure 6.5 D). The median decay time was the highest in the presence of 
the phosphodeficient S135A-syt4-mCherry mutant (3.2 s), while this was 1.9 s both in the 
presence of the phosphomimetic S135E-syt4-mCherry mutant and when syt7-pHluorin was 
not associated with either phosphomutants (figure 6.5 F). The percentage of slow events in 
the 40 s bin that could not be fit with an exponential decay was 5% in the syt7 alone group, 
8% in the syt7-pHluorin+S135E-syt4-mCherry group and 19% in the syt7+S135A-syt4-
mCherry group. This could suggest that the presence of the phosphodeficient S135A-syt4-
mCherry mutant promotes a slower form of vesicle retrieval, but there was no significant 
difference in the decay times between groups. 
Analysis of the syt7-pHluorin HHD showed that the median HHD was 4.8 s in the syt7 
alone group, while it was 7 s in the presence of S135A-syt4-mCherry and 8.8 s in the 
presence of S135E-syt4-mCherry (figure 6.5 E). Although the median HHD in the latter two 
groups was significantly higher than in the syt7 alone group, this significance was weak (*p 
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<0.05, non-parametric Kruskal-Wallis test) and was likely due to the much larger n number 
in the syt7 alone group, as the mean values in each group were similar and not significantly 
different (6.8 ± 3.7 s, 7.4 ± 4.6 s and 5.7 ± 5 s in the syt7+S135A-syt4-mCherry, syt7+ S135E-
syt4-mCherry, and syt7 alone groups respectively, ordinary one-way ANOVA). In conclusion, 
these results suggest that the phosphorylation of syt4 at serine-135 does not affect syt7-






















Figure 6.5 Phosphorylation of syt4 at Serine-135 does not alter syt7-mediated fusion. A-B, pie charts of 
syt7 events showing the fraction of events with S135A- or S135E-syt4-mCherry. B, averaged and 
normalized time-courses of syt7-pHluorin with S135A-syt4, S135E-syt4 or syt7-pHluorin alone. Error bars 
have been omitted for clarity. C-E, scatter plots of syt7-pHluorin amplitude, HHD and decay times with or 
without the syt4 phosphomutants. Horizontal black lines indicate median, *p <0.05, Kruskal-Wallis test.  
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6.6. Conclusions  
In this chapter, we set out to test whether the presence of syt4, or its 
phosphorylation at S135, affects the kinetics of syt7 mediated fusion. The main conclusion is 
that syt4 and 7 can be both trafficked to a subpopulation of vesicles, where syt4 alters syt7 
mediated vesicle fusion by promoting slower/longer lasting fusion events. An observation 
was that syt7-pHluorin events had larger amplitudes in the presence of syt4-mCherry, or 
conversely had smaller amplitudes in syt4 KO cells. A possible explanation for this is that 
syt4 promotes the sorting of syt7 onto vesicles, which would result in more syt7-pHluorin 
molecules in the Syt4+/- cells, giving rise to larger amplitudes, while smaller amplitudes in 
syt4 KO cells. In support of this idea is that syt4 has a role in vesicle maturation in PC12 cells, 
and due to its ubiquitous expression in DRGs, we could assume a similar role in these cells 
too (see section 3.5). Nevertheless, we can conclude that syt4 promotes slower fusion 
and/or slower endocytosis, which has been shown in pituitary nerve terminals before 
(Zhang et al., 2009)  
We have also shown that syt4 phosphorylation at the S135 site does not appear to 
affect syt7 mediated fusion kinetics, nor the overall number of fusion events. Whether other 
phosphorylation sites on syt4 that were identified by us or others have any significance in 
syt4 function remains to be determined. Thus, it is the presence or absence of sy4 rather 
than its phosphorylation which alters syt7-mediated vesicle fusion by promoting slower 
fusion. How the slowed kinetics relates to content release would be important to address in 
further experiments. Though it is generally accepted that longer fusion allows for more 
content release whereas fast closure limits it, Shin et al. found that the majority of NPY 
release is fast, less than 2 s, and even as fast as 33 ms (Chiang et al., 2014), but it can also be 
slow (~10 s) or even only partially released (Shin et al., 2018). However, the true limiting 
factor is the size of the fusion pore, but we were unable to measure this in our experimental 
setup. If we consider the fusion pore to be dynamically changing, then during longer open 
times there is also a higher probability of a large enough fusion pore to allow fuller content 
release. To draw however any conclusion regarding cargo release, further experiments 
should employ the simultaneous monitoring of cargo (NPY or CGRP) release from syt7/syt4 
tagged vesicles.  
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In chromaffin cells, syt7 regulates fusion pore dynamics and cargo release through its 
C2B domain, and Ca2+-binding to this domain stabilizes the fusion pore (Segovia et al., 2010; 
Bendahmane et al., 2018). It is possible that in DRG neurons, syt4 forms complexes with 
syt7 to perhaps disrupt the Ca2+-binding ability of Syt7 C2B domain, leading to more 
prolonged fusion pores (Chapman et al., 1998; Bhalla, Chicka and Chapman, 2008). To 
understand the nature of a syt4-syt7 interaction in DRG neurons, future experiments should 
first confirm the direct interaction of these two proteins, although the imaging experiments 
showed that these two proteins can be sorted onto the same secretory vesicles. 
Furthermore, biochemical experiments could answer whether syt4 disrupts the Ca2+-binding 
ability of the syt7 C2B domain or alters syt7 function in other ways. 
The observation that syt7-pHluorin events were larger in magnitude on the neurites 
compared to the soma was consistent with the larger amplitudes and HHD seen on neurites 
with the VAMP2-, syt2- and syt4-pHluorin constructs (chapter 4). In hippocampal neurons, 
syt7 was found to exclusively recycle on axons with LDCV like characteristics, similar to syt4, 
and these syt7-pHluorin events were slow and had small amplitudes (Dean et al., 2012). We 
observed syt7-pHluorin events on both the neurites and soma, but the ones on the neurites 
were larger in magnitude – these events had significantly larger amplitudes, slower decay 
and longer HHD (figure 6.2.1 F-H). pHluorin event amplitudes were consistently larger on 
the neurites with each syt construct, which supports the notion that these vesicles may be 
more mature or have got more synaptotagmin copies on them. The presence of more 
mature vesicles in axons/nerve terminals would also be consistent with the findings that the 
Ca2+ requirements of exocytosis are lower on nerve endings than on the soma (L. Y. M. 
Huang and Neher, 1996). The fact that more sy7 fusion events had syt4 associated with 
them on the neurites (figure 6.2.1 E) supports the notion that perhaps these were more 
mature vesicles. It should be noted here that although DRG neurons would not secrete 
peptides from their axons in vivo, the exocytic events we saw in vitro might represent the 
behaviour of vesicles that would normally be transported toward the axon endings and 
synapses.  
Expression of the phosphomimetic S135E-syt4-mCherry mutant resulted in 
decreased vesicle mobility (velocity, pause duration, and the number of mobile vesicles, 
section 6.4). The values that we measured for these parameters are similar to what was 
measured before using the same constructs in hippocampal neurons (Bharat et al., 2017). 
159 
 
Based on their results, Bharat et al. 2017 proposed a model whereby phosphorylation of 
syt4 by JNK breaks the interaction between syt4 and KIF1, the main anterograde motor 
protein in neurons, and this results in increased LDCV capture at synapses. After 
depolarization of the neurons with high KCl, the increased vesicle capture was dependent 
on the presence and phosphorylation of syt4. We found however that velocity and the 
number of mobile vesicles were similarly reduced in both phosphomutants after 
stimulation, but pause duration only decreased further with the phosphodeficient syt4 
mutant, possibly because the phosphomimetic mutant already had decreased pause 
duration. This would imply that while syt4 phosphorylation at S135 increases the pause 
duration (and possibly vesicle capture) pre-stimulation, upon stimulation of the neurons 
both phosphodeficient and phosphomimetic syt4 have similar chance of being captured at 
release sites.  
 The main motors responsible for axonal trafficking in neurons are kinesins in the 
anterograde and dynein in the retrograde direction; LDCVs and SVs are thought to contain 
multiple kinesins and dyneins that dictate movement speed according to the “tug of war” 
model (Maday et al., 2014). In DRG neurons, kinesin 1 and 3 control LDCV trafficking in a 
MAP2 dependent manner, where kinesin 1 acts as a “slower” motor with speeds of around 
1 µm/s, and kinesin 3 as a “fast” motor with a velocity of around 2 µm/s and therefore the 
speed of a vesicle is thought to be generated by the interplay of these motor proteins 
(Gumy et al., 2017). Syt4 was previously shown to be associated with kinesin 3 family 
protein Kif1a, however as in our experiments much slower Syt4 vesicle speed was measured 
compared to the average 2 µm/s speed of Kif1a, it seems likely that other motor proteins, 
like kinesin 1 or dynein (which is also a slow motor protein) play a more dominant role in 
syt4 vesicle trafficking. Taken together, we have shown that syt4 and syt7 can be trafficked 
to the same vesicles in DRG neurons where they may interact, and provided evidence 
indicating that phosphorylation of syt4 at S135, a putative NGF signalling target, decreases 




7. General discussion 
In this thesis, we set out to identify synaptotagmins controlling neuropeptide 
secretion from sensory neurons, to investigate their role in regulating LDCV exocytosis and 
in the process, establish methods for studying exocytosis directly in isolated DRG neurons. 
Four synaptotagmin isoforms have been described here in cultured DRG neurons for the 
first time: syt2, syt4, syt7 and syt11. Co-expression and colocalization analysis showed that 
these isoforms are expressed in peptidergic DRG neurons but are likely not limited to this 
single population, and that multiple isoforms may contribute to regulating CGRP release due 
to their presence on CGRP+ vesicles. Although ELISA experiments indicated that neither syt4 
nor syt7 were indispensable for basal release, or release evoked by capsaicin or KCl, live-cell 
imaging clearly showed that syt4-bearing vesicles contained and released NPY. Syt4 could be 
involved in the maturation process of LDCVs in DRG neurons as supported by its Golgi-like 
localization (chapter 3), which could explain its presence on NPY-containing vesicles even if 
it does not directly regulate CGRP release under ‘normal’ conditions. However further CGRP 
ELISA experiments confirmed that syt4 has a role in NGF mediated potentiation of peptide 
release, as acute potentiation of KCl or capsaicin evoked CGRP release was decreased in the 
absence of syt4. The fact that this increased release was only reduced but not completely 
blocked suggests that there are probably multiple, parallel pathways involved in the NGF 
effect.  
NGF is secreted during inflammation (see section 1.2), and binding to its main 
receptor TrkA leads to the activation of several signalling pathways. Activation of the 
PLC/PKC and Src family kinases (SFK) leads to the phosphorylation and sensitization of 
TRPV1 channels, while PI3 kinase/src signalling increases TRPV1 surface expression (Bhave 
et al., 2003; Zhang, Huang and McNaughton, 2005; Park et al., 2010). The increased TRPV1 
activity leads to more Ca2+ influx which in turn increases peptide release (Park et al., 2010). 
Activation of the low affinity NGF receptor, p75, leads to the activation of JNK, which was 
shown in hippocampal neurons and PC12 cells to directly phosphorylate syt4 at Ser135 
(Mori et al., 2008; Bharat et al., 2017), and in neurons, this caused the dissociation of syt4-
bearing LDCVs from the microtubule motor Kif1a and increased capture at release sites. We 
have identified the same Ser135 phosphorylation site in DRG neurons in MS experiments, 
and found that phosphomimetic S135E-syt4-mCherry slowed vesicle mobility, increasing the 
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probability of capturing vesicles at release sites, but it did not affect syt7-mediated vesicle 
fusion. Sy7-pHluorin fusion events had however slower or faster kinetics in the presence or 
absence of syt4 respectively, implying that perhaps syt4 and syt7 interact in DRG neurons to 
modify vesicle fusion. Interaction of syt4 and syt7 was recently shown in pancreatic β cells 
(Huang et al., 2018), and in these cells the calcium sensitivity of insulin secretion was altered 
by this interaction but individual fusion behaviour was not examined.  Taken together, 
according to our results it seems likely that in DRG neurons, the main function of syt4 
phosphorylation at S135 in the NGF pathway is to slow vesicle trafficking and increase 
vesicle capture without significantly affecting fusion.  
Others previously showed that Kif1a is responsible for the trafficking of TrkA 
containing vesicles to the axon endings in DRG neurons (Tanaka et al., 2016). The surface 
presentation of TrkA leads to a positive feedback loop, whereby upon NGF exposure, the 
increased TrkA-signalling leads to upregulation of Kif1a and increased TrkA transport to 
nerve endings. If syt4 is associated with Kif1a in DRG neurons, similarly to what was found in 
hippocampal neurons (Bharat et al., 2017), then perhaps the same vesicles also contain TrkA 
(figure 7). Although we did not perform colocalization analysis of syt4 and TrkA, but we 
found that TrkA was mostly expressed in syt4 positive cells (section 5.3). In this case, the 
Ser135 phosphorylation of syt4 by JNK would lead to the reduced mobility and increased 
capture of these vesicles, as we have shown using kymograph analysis. Furthermore, live-
cell imaging experiments showed that syt4 and syt7 are both present on a population of 
vesicles; further triple-labelling experiments would be needed to confirm whether these 
three proteins (syt4, syt7 and TrkA) actually reside on the same vesicles.  
With regards to vesicle fusion behaviours as observed with pHluorin constructs, an 
important finding was that syt7 preferentially induces transient fusion events with stable 
fusion pores, as most of the syt7-pHluorin events were slow and stayed at the site of fusion 
for several seconds. The fact that syt7 preferentially promotes slow KR events agrees with 
results from chromaffin cells, where it also slowed down cargo release (Rao et al., 2014; 
Bendahmane et al., 2019). In DRG neurons, the activation of TRPV1 by capsaicin leads to 
weaker and more spatially restricted Ca2+ rise close to TRPV1 channels and more KR fusion, 
but all fusion events are near TRPV1 channels (Wang et al., 2017). Stronger stimulation with 
KCl on the other hand leads to more robust and uniform Ca2+ rise near the membrane, 
resulting in more full fusion near VGCCs and importantly, KR events on the cell margins. This 
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study by Wang et al. provided evidence that differences in Ca2+ gradients near the 
membrane can control modes of fusion. As a high affinity calcium sensor with slow kinetics, 
syt7 is well-suited to trigger vesicle fusion following uniform Ca2+ rise or more distally from 
Ca2+ channels near the cell margins. These syt7-mediated events would be mostly KR as 
found by us and others (above), while at the same time syt4 may interact with syt7 to 
prolong the fusion pore lifetime, perhaps by stabilizing it (Figure 7). This could allow more 
time for peptide release or the diffusion of vesicular membrane proteins (such as TrkA, 
TRPV1 or other ion channels) into the plasma membrane. The increased surface 
presentation of TrkA in turn increases the NGF signalling in a positive feedback loop (Tanaka 
et al., 2016).  
 
 
Figure 7 Proposed pathways and mechanisms involved in NGF-induced increase of neuropeptide 
release in sensory neurons. JNK activation through NGF/p75 leads to phosphorylation of syt4 (in 
orange, P tag = phosphorylation), reduced mobility of neuropeptide containing LDCVs (red and 
orange circles inside the vesicle representing different co-stored neuropeptides (eg. CGRP, NPY)), 
and dissociation from Kif1 and microtubules (green). TrkA (in black) may be present on the same 
vesicles, along with syt7 (in blue). Ca2+ influx through TRPV1 or VGCCs triggers syt7-mediated 
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transient fusion with long lasting fusion pores, allowing for more cargo release and surface 
presentation of TrkA receptors. Interaction of syt4 with syt7 may promote prolonged fusion, 
regardless of syt4 phosphorylation at S135E. The activation of TrkA receptors and related signalling 
pathways lead to further sensitization of TRPV1 channels.  
  
As pointed out in sections 4.5 and 6.5, increased pore open time might not allow for 
more peptide release unless the pore is wide enough, and syt7 was found by several groups 
to restrict pore expansion and slow peptide release (Rao et al., 2014; Bendahmane et al., 
2019). Keeping the fusion pore open for longer however might lead to slow and prolonged 
peptide release and their build-up at nerve terminals. This could contribute to windup, a 
form of short term synaptic plasticity where dorsal horn neurons respond with progressively 
increasing firing rates to repeated C-fibre inputs, and co-release of glutamate and 
neuropeptides are thought mediate the process (Ji et al., 2003; D’Mello and Dickenson, 
2008). It is also important to remember that LDCV recycling is slower than SV recycling, thus 
a slow but prolonged peptide release could compensate for the limited LDCV resupply at 
synapses and help to precisely regulate membrane recycling in neurons.  
An important limitation of this work is that the results of syt4/7 mediated LDCV 
fusion in chapter 6 were not directly linked to peptide release or a peptidergic DRG 
population expressing TrkA or p75. In order to answer the question whether the possible 
interaction of syt4 and 7 plays a significant role in peptidergic neurons, imaging would have 
to be restricted to this population, using for example IB4 as a marker of non-peptidergic 
DRG neurons. This technique has been used historically, even though there is around 11-
20% overlap on average between the IB4-binding and CGRP expressing populations (Li et al., 
2016; Shaib et al., 2018). Identifying the peptidergic cells that also express NGF receptors 
and would be thus affected by NGF treatment is another level of complication, although 
according to our and others’ results, the majority of TrkA is expressed in the peptidergic 
population (sections 5.3 and 1.1). 
The discrepancies in results from literature regarding exactly how syt4 and 7 regulate 
fusion pore might be better explained by a dynamic pore theory, rather than a simple choice 
between full fusion or KR (Shin et al., 2018) (see section 1.2.5). Thus instead of readily 
distinguishing between two types of fusion, we measured the HHD and decay time of 
pHluorin-fusion events and related these to pore open time and vesicle retrieval. It should 
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be noted that the HHD values were measured by automatic peak detection of the Origin 
software, which may be inaccurate with very slowly decaying events, thus these are not 
exact measurements just approximations of the pore open/vesicle dwell times. According to 
our results and those from literature, syt7 triggers the fusion of LDCVs in lower/more 
generic elevation of calcium concentration, but the pore size and duration are differentially 
regulated based on other factors, such as stimulation strength/Ca2+ influx and interaction 
with other proteins, such as syt4 or actin cytoskeleton and microtubules.  
To the best of our knowledge, syt4 or syt7 KO mice have not been tested for 
behavioural pain phenotypes, thus it would be pivotal to assess if the above model 
translates in vivo using mouse models of inflammatory pain. Though in this work we could 
only test the effects of NGF in syt4-/- animals, we would expect similar results in syt7 KO 
mice if the two proteins work together. The next step would be to confirm the interaction of 
syt4 and syt7 in biochemical experiments and link the changes in fusion pore dynamics to 
peptide release. Nevertheless, the results presented above provide insights into a possible 
mechanism by which nociceptive DRG neurons may increase neuropeptide release in the 
skin or the spinal cord during inflammation. Additionally, the live-imaging and analysis 
technique established here together with the results obtained on synaptotagmin-mediated 
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